artesunic acid has been researched along with Malaria, Falciparum in 735 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 69 (9.39) | 18.2507 |
| 2000's | 291 (39.59) | 29.6817 |
| 2010's | 277 (37.69) | 24.3611 |
| 2020's | 98 (13.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ha, MT; Ho, TAT; Nguyen, AN; Nguyen, TA | 1 |
| Dogovski, C; Du, Y; He, W; Hu, R; Li, C; Li, X; Tao, Z; Wang, J; Wang, Y; Yao, C | 1 |
| Anstey, NM; Barber, BE; Cooper, DJ; Grigg, MJ; Rajahram, GS; van Schalkwyk, DA; William, T | 1 |
| Boechat, N; Campos Aguiar, AC; da Silva Araújo, M; Krettli, AU; Medeiros, JF; Penna-Coutinho, J; Pereira, DB; Rios, CT; Sá, PM | 1 |
| Chen, X; Guenther, G; Izem, R; Postels, D; Saidi, AM; Seydel, K | 1 |
| Chotivanich, K; Hanboonkunupakarn, B; Hiranrusme, T; Matsee, W; Pisutsan, P | 1 |
| Dondorp, AM; Peto, TJ; van der Pluijm, RW; van Vugt, M; Visser, MT; Zonneveld, R | 1 |
| Abohelwa, M; Agusala, V; Gharamti, A; Hassan, M | 1 |
| Aboh, PM; Adzemye, LM; Akam, LF; Ali, IM; Alifrangis, M; Ambani, MCE; Ango, Z; Bigoga, JD; Chedjou, JPK; Dinza, G; Dongmo, CH; Douanla, A; Ewane, MS; Fomboh, CT; Fosah, DA; Kotcholi, GB; Ludovic, AJ; Mbacham, WF; Moyeh, MN; Nana, WD; Ndikum, VN; Ngu, JA; Niba, PTN; Nji, AM; Nna, DRA; Oben, OLA; Omgba, PAM; Selly-Ngaloumo, AA; Tatah, FM; Ticha, JT | 1 |
| Bailly, J; Balikagala, B; Clain, J; Coppée, R; Dannaoui, E; Fukuda, N; Georges, H; Hamane, S; Houzé, S; Lavergne, RA; Mazars, E; Mita, T; Odongo-Aginya, EI; Sarrasin, V; Vianou, B; Zinsou, BE | 1 |
| Bartoloni, A; Bianchi, L; Botta, A; Castelli, F; Chechi, F; Comelli, A; Galli, L; Giulia, G; Spinicci, M; Tomasoni, LR; Vellere, I; Zammarchi, L | 1 |
| Baraka, V; Kamugisha, E; Kapesa, A; Kidenya, B; Konje, E; Marwa, K; Mukonzo, J; Swedberg, G | 1 |
| Bottieau, E; Huits, R; Rosanas-Urgell, A; Van den Bossche, D; Van Ierssel, S | 1 |
| Bienvenu, AL; Bonnot, G; Kouakou, YI; Lavoignat, A; Omorou, R; Picot, S; Said, IB | 1 |
| Creek, DJ; Dogovski, C; Du, Y; Giannangelo, C; He, W; Li, X; Shami, GJ; Tilley, L; Yang, T; Zhou, W | 1 |
| Behera, PK; Nair, AA; Tripathy, KP | 1 |
| Asinya, M; Jeuronlon, MK; Kamara, P; Koko, VS; Kollie, A; Ma, L; Menard, D; Nyansaiye, P; Parwon, S; Pratt, OJ; Ringwald, P; Taweh, F; Tehmeh, L; Vonhm, B; Warsame, M | 1 |
| Grundmann, O; Hernandez Maldonado, J | 1 |
| Bivona, DA; Bonacci, P; Marino, A | 1 |
| Jochum, J; Kurth, F; Mischlinger, J; Ramharter, M | 1 |
| Bruschi, F; Fabiani, S; L'Episcopia, M; Mangano, V; Motta, V; Severini, C; Sparavelli, R; Verdenelli, S | 1 |
| Fox, T; Hine, P; Pryce, J; Taylor, M | 1 |
| Cherkaoui-Rbati, MH; Davenport, MP; Demarta-Gatsi, C; Gobeau, N; Gower, J; Gumpp, C; Khoury, DS; McCarthy, JS; Möhrle, JJ; Radohery, GFR; Rebelo, M; Rottmann, M; Walz, A | 1 |
| Baguiya, A; Barry, N; Hien, D; Kaboré, JMT; Siribié, M; Sirima, SB; Soulama, I; Tchouatieu, AM; Tiono, AB | 1 |
| Amoh, G; Amuzu, DSY; Andoh, NE; Ansong, M; Hirst, J; Nyaaba, N; Ordóñez-Mena, JM | 1 |
| Daily, JP; Khan, N; Minuti, A | 1 |
| Andrianaranjaka, VHI; Jeannoda, V; Rakoto, DAD; Rakotomanga, TA; Rakotosaona, R; Ralinoro, F; Ramanantsahala, AD; Randrianarivo, RH; Ratsimbasoa, A; Ravaoarisoa, É | 1 |
| Bamadio, A; Chico, RM; Cohee, LM; Coumare, S; Dara, A; Diarra, M; Djimde, AA; Doumbo, OK; Kodio, A; Maiga, H; Opondo, C; Sagara, I; Sidibe, B; Tekete, M; Traore, OB; Traore, ZI | 1 |
| Abanyie, F; Ng, J; Tan, KR | 1 |
| Chaoratanakawee, S; Chin, G; Harrison, D; Lek, D; Menard, D; Rachmat, A; Rogers, WO; Saunders, D | 1 |
| Avery, VM; Duffy, S | 1 |
| Adegnika, AA; Akinosho, MA; Davi, SD; Dimessa-Mbadinga, LB; Handrich, C; Kreidenweiss, A; Kremsner, PG; Lell, B; Mombo-Ngoma, G; Ndzebe-Ndoumba, WF; Nordmann, T; Okwu, DG; Ramharter, M; Stelzl, D; Veletzky, L; Zoleko-Manego, R | 1 |
| Andrianaranjaka, VHI; Dodoson, BT; Fenomanana, J; Rakotoarisoa, MA; Ratsimbasoa, A | 1 |
| Barale, JC; Bouillon, A; Chy, S; Eam, R; Kauy, C; Ke, S; Khean, C; Khim, N; Kim, S; Kloeung, N; Kul, C; Leang, R; Mairet-Khedim, M; Ringwald, P; Roesch, C; Srun, S; Witkowski, B | 1 |
| Accrombessi, M; Cook, J | 1 |
| Bal, M; Das, A; Khan, N; Pati, S; Rana, R; Ranjit, M; Sandeepta, S | 1 |
| Mace, KE; Schultz, JS; Tan, KR | 1 |
| Chandelia, S; Gangwal, M; Patharia, N | 1 |
| Na-Bangchang, K; Saeheng, T | 1 |
| Keating, C | 1 |
| Bertault-Peres, P; Bonsergent, M; Flet, L; Honoré, S; Lepelletier, A; Perez, T; Tching-Sin, M | 1 |
| Choosri, N; Dondorp, AM; Pan-Ngum, W; Saralamba, S; Simpson, JA; White, L; White, NJ | 1 |
| Baraka, V; Francis, F; Geertruyden, JV; Gesase, S; Kyaruzi, E; Lusingu, JPA; Madebe, R; Makenga, G; Minja, DTR; Mtove, G; Nakato, S | 1 |
| Abdelkader, O; Boulotigam, K; Djimadoum, M; Djimrassengar, H; Doderer-Lang, C; Hassoumi, M; Issa, AH; Issa, MS; Mahamat, MHT; Menard, D; Ndihiokubwayo, JB; Rasmussen, C; Saleh, IDM; Warsame, M | 1 |
| Carn, G; Harimanana, AN; Hotahiene, R; Irinantenaina, J; Ralemary, N; Randriamiarinjatovo, DNAL; Randrianarivelojosia, M; Randriarison, M; Razafinjato, C; Razanatsiorimalala, S | 1 |
| Dini, S; Fanello, C; Fitzpatrick, P; Haghiri, A; Price, DJ; Rajasekhar, M; Simpson, JA; Tarning, J; Watson, J; White, NJ | 1 |
| Chellan, P; Harding, CR; Kaschula, CH; Munnik, BL | 1 |
| Angeli, A; Capasso, C; Carradori, S; Carta, F; D'Agostino, I; De Luca, V; Kocken, CHM; Supuran, CT; Zara, S; Zeeman, AM | 1 |
| Arama, C; Beavogui, AH; Dicko, A; Djimde, A; Djimde, M; Fofana, B; Kayentao, K; Mens, PF; Ouedraogo, JB; Sagara, I; Schallig, HD; Sirima, SB; Tshiongo, JK | 1 |
| Campagnucci, N; Chediack, V; Cunto, E; Gregori Sabelli, R; Lamberto, Y; Saul, P | 1 |
| Angoulvant, A; Bouchaud, O; Buffet, P; Caumes, E; Chamillard, X; Houzé, S; Izri, A; Jauréguiberry, S; Kendjo, E; Magne, D; Matheron, S; Ndour, AP; Paccoud, O; Surgers, L; Thellier, M; Vinatier, I; Wyplosz, B | 1 |
| Krey, RA; Travassos, MA | 1 |
| Obiebi, IP | 1 |
| Bienvenu, AL; Bonnot, G; Kouakou, YI; Lavoignat, A; Leboucher, G; Picot, S; Tod, M | 1 |
| Fungula, B; Inocencio da Luz, R; Kalabuanga, M; Lula Ntamba, Y; Lutumba, P; Muhindo Mavoko, H; Ntamabyaliro Nsengi, PM; Tona Lutete, G; Van Geertruyden, JP | 1 |
| André, G; Eric, C; Jean, G; Jordi, L; Stéphane, J; Xavier, A; Yves, H | 1 |
| Compaoré, G; Coulibaly, B; D Alessandro, U; Jahn, A; Kieser, M; Klose, C; Krisam, J; Lu, G; Meissner, P; Mendes Jorge, M; Mockenhaupt, FP; Müller, O; Nebie, E; Ouermi, L; Sié, A | 1 |
| Alberer, M; Bélard, S; Blohm, M; Brand, J; Gratopp, A; Hübner, J; Hufnagel, M; Janda, A; Kempf, C; Kobbe, R; Krüger, R; Kurth, F; Mall, M; Reiter, K; Schulze-Sturm, U; Stegemann, MS; Suttorp, N; Tacoli, C; Varnholt, V; von Bernuth, H; von Both, U; Zoller, T | 1 |
| Adisa, BA; Oludele, OJ; Olufunso, OO | 1 |
| Blessborn, D; Byakika-Kibwika, P; Lamorde, M; Ssenyonga, R; Tarning, J | 1 |
| Borgans, F; Eisermann, P; Giesbrecht, K; Goetsch, U; Just-Nübling, G; Kessel, J; Lieberknecht, S; Muntau, B; Schork, J; Tappe, D; Wieters, I; Wolf, T | 1 |
| de Sena, LWP; Ferreira, MVD; Rivera, JGB; Vieira, JLF | 1 |
| Aguiar, ACC; Bueno, RV; Cruz, FC; de Souza, GE; de Souza, JO; Guido, RVC; Oliva, G; Zanini, CL | 1 |
| Bonkian, LN; d'Alessandro, U; Kazienga, A; Lingani, M; Mens, PF; Ouédraogo, JB; Ravinetto, R; Schallig, HDFH; Sorgho, H; Tinto, H; Valéa, I; Yerbanga, I | 1 |
| Hastings, IM; Hodel, EM; Jones, S; Kay, K; Plucinski, M | 1 |
| Angus, BJ | 1 |
| Holmes, CC; Watson, JA | 1 |
| Beshir, KB; Coulibaly, A; Dembele, D; Diallo, N; Djimde, AA; Doumbo, OK; Fofana, B; Gil, JP; Haidara, AS; Haidara, K; Kone, A; Sagara, I; Sangare, CO; Sanogo, K; Sissoko, S; Toure, S; Traore, A | 1 |
| Friedman, A; Siewe, N | 1 |
| Duong, NTT; Duong, TT; Erhart, A; Guetens, P; Hien, NTT; Hieu, NL; Huan, RM; Kattenberg, JH; Mai, TT; Ngoc, NTH; Phuc, BQ; Rosanas-Urgell, A; Rovira-Vallbona, E; Van Hong, N; Xa, NX | 1 |
| Ariey, F; Chy, S; Dorina Bustos, M; Eam, R; Izac, B; Kauy, C; Ke, S; Khim, N; Kim, S; Kloeung, N; Leang, R; Mairet-Khedim, M; Marmai, C; Mey Bouth, D; Ringwald, P; Witkowski, B | 1 |
| Anvikar, AR; Ashley, EA; Chandramohan, D; Cohee, LM; D'Alessandro, U; Genton, B; Gilder, ME; Guérin, PJ; Juma, E; Kalilani-Phiri, L; Kennon, K; Kuepfer, I; Laufer, MK; Lwin, KM; Mansoor, R; McGready, R; Meshnick, SR; Mosha, D; Mwapasa, V; Mwebaza, N; Nambozi, M; Ndiaye, JA; Nosten, F; Nyunt, M; Ogutu, B; Parikh, S; Paw, MK; Phyo, AP; Pimanpanarak, M; Piola, P; Rijken, MJ; Saito, M; Sriprawat, K; Stepniewska, K; Tagbor, HK; Tarning, J; Tinto, H; Valéa, I; Valecha, N; White, NJ; Wiladphaingern, J | 1 |
| Chakraborty, A; Chowdhury, P; Dasgupta, AK; Ray, S; Sen, S; Sengupta, S | 1 |
| Garg, RK; Meena, RL; Mittal, A; Prajapati, MM; Samar, N; Sharma, M; Shristi, S; Singh, MM; Trivedi, C | 1 |
| Adebayo, JO; Adegunloye, AP; Balogun, EA; Ishola, AA; Malomo, SO; Tijjani, H | 1 |
| Abbas, FB; Ali, AS; Ali, AW; Barnes, R; Björkman, A; Frumento, P; Mårtensson, A; Morris, U; Msellem, M; Soe, A | 1 |
| Diwan, V; Gawariker, S; Mårtensson, A; Pathak, A; Purohit, M; Sharma, A; Ursing, J | 1 |
| Abd-Rahman, AN; Cascales, L; Chalon, S; Chen, N; Collins, KA; Marquart, L; McCarthy, JS; Möhrle, JJ; Odedra, A; Pasay, C; Pava, Z; Peatey, CL; Rebelo, M; Watts, RE; Webb, L | 1 |
| Anderson, K; Chen, N; Cheng, Q; Gatton, ML; Gresty, K; McCarthy, J; Peatey, C; Pickering, P; Watts, R | 1 |
| de Carvalho, LP; Held, J; Kreidenweiss, A | 1 |
| Lai, SK; Loo, HL; Preiser, PR; Sheriff, O; Sze, SK; Yaw, A | 1 |
| Davenport, MP; Gower, J; Khoury, DS; McCarthy, JS; Mitchell, H; Pava, Z; Pawliw, R; Rebelo, M; Watts, RE; Webb, L | 1 |
| Bailly, C | 1 |
| Patel, N; Re Ferre, L; Thomson, J | 1 |
| Eckardt, P; Khatiwada, P; Lemos-Ramirez, J; Leonso-Bravo, AA; Roa, AA; Rodriguez, JA | 1 |
| Baker, L; Barnes, KI; Blaylock, M; Blumberg, L; Frean, J; Misiani, E; Raman, J; Ukpe, IS | 1 |
| Leder, K; Leong, KW; Singh, KP; Tong, SYC | 1 |
| Barry, N; Compaoré, YD; Djimdé, A; Kaboré, TN; Kabré, Z; Nikiéma, F; Ouattara, A; Ouédraogo, JB; Sagara, I; Somé, AF; Wermi, K; Yerbanga, RS; Zongo, I; Zongo, M | 1 |
| Agarwal, K; Darokar, MP; Kumar, R; Kumar, S; Mina, PR; Pal, A; Tandon, S; Yadav, S; Yadav, SK | 1 |
| Denti, P; Kawuma, AN; Khoo, S; Lamorde, M; Pillai, GC; Walimbwa, SI; Wasmann, RE | 1 |
| Alessandri, F; Angeletti, S; Bazzardi, R; Ceccarelli, G; Celani, L; Ciccozzi, M; D'Ettorre, G; De Angelis, M; Fontanelli Sulekova, L; Gabrielli, S; Lopalco, M; Mattiucci, S; Mazzocato, V; Pugliese, F; Ruberto, F; Spagnolello, O; Vita, S | 1 |
| Angoulvant, A; Argy, N; Bouchaud, O; Bruneel, F; Buffet, P; Caumes, E; Chambrion, C; Courtin, D; Danis, M; Delacour, H; Gay, F; Henry, B; Houzé, S; Jauréguiberry, S; Kendjo, E; Larréché, S; Lebrun-Vignes, B; Mouri, O; Ndour, PA; Piarroux, R; Roussel, C; Siriez, JY; Taieb, A; Thellier, M | 1 |
| Ball, L; Bensman, TJ; Chilukuri, DM; Colangelo, PM; Earp, JC; Kitabi, E; O'Shaughnessy, E; Reynolds, KS; Smith, H; Yasinskaya, Y | 1 |
| Abraham, P; Argaud, L; Becker, A; Bienvenu, AL; Bonnot, G; Chidiac, C; Conrad, A; Kouakou, YI; Landre, S; Leboucher, G; Miailhes, P; Picot, S; Rimmelé, T; Simon, M | 1 |
| Cao, P; Dini, S; Dondorp, A; Fowkes, FJI; Kremsner, P; Krishna, S; Maude, RJ; McCaw, JM; Price, RN; Simpson, JA; Tarning, J; White, MT; White, NJ; Whyte, JM; Zaloumis, SG | 1 |
| Chenet, SM; Fernandez, J; Jercic, MI; Lucchi, NW; Oyarce, A; Tapia-Limonchi, R; Tejedo, JR; Udhayakumar, V; Weitzel, T | 1 |
| Adamo, G; Ascoli Bartoli, T; Bevilacqua, N; Buffet, P; Corpolongo, A; D'Abramo, A; Giancola, ML; Ippolito, G; Lepore, L; Mariano, A; Nicastri, E; Palazzolo, C; Scorzolini, L | 1 |
| Boonprasert, K; Cheoymang, A; Kosa, N; Muhamad, P; Na-Bangchang, K | 1 |
| Achan, J; Arbe-Barnes, S; Borghini-Fuhrer, I; Conteh, B; D'Alessandro, U; Dabira, ED; Duparc, S; Hachizovu, S; Lawal, B; Manyando, C; Mendy, A; Miller, R; Mulenga, JM; Mwanza, S; Ndiath, MO; Nyang, H; Shin, J | 1 |
| Nkene Mawamba, Y; Nkwabong, E; Tseunwo, C | 1 |
| Bancone, G; Carrara, VI; Chu, C; Duanguppama, J; Gilder, ME; Haohankhunnatham, W; Imwong, M; Konghahong, K; Lee, SJ; McGready, R; Min, AM; Nosten, F; Paw, MK; Phyo, AP; Pimanpanarak, M; Proux, S; Saito, M; Singhasivanon, P; Tun, NW; Turner, C; Viladpai-Nguen, J; White, NJ | 1 |
| Abanyie, F; Acharya, SD; Bowe, M; Leavy, I; Tan, KR | 1 |
| Adeagbo, B; Bolaji, O; Izevbekhai, O; Olagunju, A | 1 |
| Ataide, R; Beeson, JG; Boel, M; Drew, D; Fowkes, FJI; McGready, R; McLean, ARD; Nosten, F; Simpson, JA; Tsuboi, T | 1 |
| Ali, NA; Bharti, PK; Dhariwal, AC; Kashyotia, SS; Kumar, A; Mishra, S; Shukla, MM; Singh, N | 1 |
| Carter, C; Mukonka, PS | 1 |
| Apollo, D; Cantalloube, C; Djeriou, E; Held, J; Kombila, M; Kremsner, PG; Lell, B; Mombo-Ngoma, G; Ogutu, B; Ospina Salazar, CL; Otsula, N; Polhemus, ME; Supan, C; Waitumbi, J; Walsh, DS | 1 |
| Buffet, P; Chotivanich, K; Day, NPJ; Dondorp, AM; Fanello, C; Jauréguiberry, S; Lee, SJ; Onyamboko, M; Rockett, K; Setaphan, S; Stepniewska, K; White, NJ; Woodrow, C | 1 |
| Hasegawa, C; Kimura, M; Kudo, M; Maruyama, H | 1 |
| Chaijaroenkul, W; Na-Bangchang, K; Phompradit, P | 1 |
| Aniweh, Y; Ansah, F; Awandare, GA; Chirawurah, JD; Duodu, S; Nyarko, PB | 1 |
| Ashley, EA; Bonnington, CA; Imwong, M; Nosten, F; Parker, DM; Phyo, AP; Proux, S; Sriprawat, K; White, NJ | 1 |
| Ashley, EA; Beau, C; Htike, H; Imwong, M; Nosten, F; Phyo, AP; Proux, S; Sriprawat, K; Swe, LL; Thu, AM; Win, KK; Winterberg, M | 1 |
| Bani-Sadr, F; Brunet, A; Cousson, J; Floch, T; Giltat, A; Julien, G; Lebrun, D; N'Guyen, Y; Romaru, J; Toubas, D | 1 |
| Castro, P; Fernandez, S; Gascon, J; Marco Hernandez, J; Martinez, G; Nicolas, JM; Rodriguez-Valero, N | 1 |
| Alam, S; Anstey, NM; Charunwatthana, P; Chowdhury, MAH; Day, NPJ; Dondorp, AM; Dutta, PK; Faiz, MA; Ghose, A; Haider, MS; Hassan, MMU; Herdman, MT; Hossain, MA; Ishioka, H; Islam, MA; Jahangir, SM; Kingston, HWF; Lee, SJ; Leopold, SJ; Maude, RJ; Mukaka, M; Oates, JA; Piera, KA; Plewes, K; Roberts Ii, LJ; Sattar, MA; Silamut, K; Tarning, J; Turner, GDH; Wattanakul, T; White, NJ; Yeo, TW; Zahed, ASM | 1 |
| Aye, KH; Aye, MM; Bergstrand, M; Chit, K; Karlsson, MO; Kyaw, MP; Lohy Das, JP; Nyunt, MH; Tarning, J | 1 |
| Choy, F; Makio, N; Mens, P; Okach, S; Omweri, G; Osoti, V; Roth, JM; Sawa, P; Schallig, HDFH | 1 |
| Agasthi, P; Foreman, M; Valliani, S; Westney, G | 1 |
| Bousema, T; Bradley, J; Makio, N; Mens, PF; Omweri, G; Osoti, V; Roth, JM; Sawa, P; Schallig, HDFH | 1 |
| Attia, E; Everett, N; Koshy, J; Shah, PJ | 1 |
| Anvikar, AR; Arya, T; Bruce, J; Chandramohan, D; Greenwood, B; Kuepfer, I; Mishra, DR; Mishra, N; Mishra, V; Mohanty, R; Mohanty, S; Sharma, S; Srivastava, B; Valecha, N | 1 |
| Alejo-Cancho, I; Camprubí, D; Cisteró, P; García-Guijarro, E; Gupta, H; Llenas-García, J; Mayor, A; Muñoz, J; Rodríguez-Valero, N | 1 |
| Aloni, MN; Matangila, JR; Mbanzulu, KM; Mbaya Ntita, F; Mpoyi Wa Mpoyi, S; Muhindo, HM; Mukendi, JPK; Wumba, R; Zanga, JK | 1 |
| Hoglund, RM; Na-Bangchang, K; Ruengweerayut, R | 1 |
| Cao, P; Cromer, D; Davenport, MP; Dini, S; Fowkes, FJI; Khoury, DS; McCaw, JM; Simpson, JA; Zaloumis, SG | 1 |
| Aydin-Schmidt, B; Björkman, A; Di Santi, S; Inoue, J; Islam, A; Jovel, I; Mårtensson, A; Morris, U; Segurado, AC | 1 |
| Bartalesi, F; Bartolesi, AM; Bartoloni, A; Berni, A; Boccolini, D; Buonamici, C; Ciccone, N; Corti, G; Di Lauria, N; Garofalo, G; Gradoni, L; Mencarini, J; Niccolini, F; Poggesi, L; Romi, R; Rossolini, GM; Severini, C; Suardi, LR; Zammarchi, L | 1 |
| Byakika-Kibwika, P; Kiragga, AN; Lamorde, M; Nyakato, P | 1 |
| Baliga, S; Boloor, A; Devi, R; Gai, P; Gai, PP; Jain, A; Kulkarni, SS; Mahabala, C; Mockenhaupt, FP; Rasalkar, R; Shenoy, D; Siegert, K; Tacoli, C; Wedam, J | 1 |
| Assarian, M; Haghi, AM; Khalili, H; Khoshnam-Rad, N; Masoumi-Asl, H; Nikbakht, M; Salehi, M | 1 |
| Hastings, IM; Hodel, EM; Jones, S; Kay, K; Sharma, R | 1 |
| Hine, P; Pryce, J | 1 |
| Ang, SEL; Tan, EHN; Tan, KSW; Tong, JX | 1 |
| Djimde, AA; Djimde, M; Doumbo, OK; Fofana, B; Jacobs, J; Mgina, EJ; Niangaly, H; Sagara, I; Samouda, H; Sombie, SB; Tekete, M; Vaillant, M | 1 |
| Giblin, L; Gleeson, PJ; McHale, T; O'Regan, JA; Reddan, D; Tuite, H | 1 |
| Assoumou, L; Buffet, P; Caumes, E; Costagliola, D; El Ket, N; Jauréguiberry, S; Kendjo, E; Piarroux, R; Potard, V; Roussel, C; Taieb, A; Tantaoui, I; Thellier, M | 1 |
| Buffet, P; Chambrion, C; Chartrel, N; Mouri, O; Ndour, PA; Roussel, C; Smith, B; Smith, P; Thellier, M; Wojnarski, M | 1 |
| Rosenthal, PJ; Tan, KR | 1 |
| Kaaya, C; Kilonzi, M; Marealle, AI; Mikomangwa, WP; Mlyuka, H; Mutagonda, R | 1 |
| Jauréguiberry, S | 1 |
| Aouri, M; Carn, G; Csajka, C; Decosterd, LA; Guidi, M; Kiechel, JR; Mercier, T; Ogutu, B | 1 |
| Frosch, AEP | 1 |
| Amaratunga, C; Ashley, EA; Ataíde, R; Beeson, JG; Day, NP; Dhorda, M; Dondorp, AM; Fairhurst, RM; Faiz, MA; Feng, G; Fowkes, FJI; Hien, TT; Htut, Y; Lim, P; Mayxay, M; Nosten, F; O'Flaherty, K; Powell, R; Pukrittayakamee, S; Reiling, L; Simpson, JA; White, NJ; Zaloumis, SG | 1 |
| Effa, EE; Esu, EB; Meremikwu, MM; Opie, ON | 1 |
| Fidock, DA; Okombo, J | 1 |
| Bustos, MD; Cong Tran, D; Hong Huynh, Q; Khim, N; Quang Bui, P; Quang Nguyen, T; Ringwald, P; Thanh Le, D; Thanh Tran, D; Thi Ta, T; Van Truong, H; Witkowski, B | 1 |
| Ashley, EA; Dahal, P; Guerin, P; Humphreys, GS; Mansoor, R; Stepniewska, K | 1 |
| Ahmad, S; Bhattacharjee, S; Kannan, D; Lochab, B; Namdev, P; Singh, S; Yadav, N | 1 |
| Abdel-Muhsin, AA; Abdelraheem, MH; Al Dhuhli, A; Al Hosni, A; Al Rubkhi, M; Al-Hamidhi, S; Babiker, HA; Bakhiet, AMA; Gadalla, A; Gismelseed, L; Kheir, A; Mukhtar, M; Naiem, A; Omer, S; Sultan, AA | 1 |
| Brejt, JA; Golightly, LM | 1 |
| Singh, N; Singh, PS | 1 |
| Arbe-Barnes, S; Borghini-Fuhrer, I; Craft, CJ; Duparc, S; Fleckenstein, L; Miller, RM; Shin, CS | 1 |
| Anderson, JM; Chiang, S; Diakite, M; Diakite, SA; Doumbia, S; Doumbouya, M; Fairhurst, RM; Fay, MP; Keita, AS; Konate, DS; Long, CA; Lopera-Mesa, TM; Ndiaye, D; Sa, JM; Stepniewska, K; Traore, K; Zeituni, AE | 1 |
| Basu, S; Chandurkar, N; Gupta, PB; Karmakar, PS; Lakhani, J; Lakhani, S; Pareek, A; Pednekar, S; Ray, A; Srivastav, V; Suthar, N | 1 |
| Awab, GR; Day, NP; Dondorp, AM; Imwong, M; Jamornthanyawat, N; Pukrittayakamee, S; White, NJ; Woodrow, CJ; Yamin, F | 1 |
| Day, NP; Dondorp, AM; Gesase, S; Hendriksen, IC; Kent, A; Lemnge, MM; Lindegardh, N; Mtove, G; Reyburn, H; Tarning, J; von Seidlein, L; White, NJ | 1 |
| Aye, KH; Aye, MM; Chit, K; Imwong, M; Jacob, CG; Kyaw, MP; Lindegardh, N; Nyunt, MH; Nyunt, MM; Perin, J; Rasmussen, C; Ringwald, P; Tarning, J | 1 |
| de Vries, PJ; Koelewijn, R; Kreeftmeijer-Vegter, AR; Melo, Mde M; van Genderen, PJ; van Hellemond, JJ | 1 |
| Abiola, A; Alifrangis, M; Dieng, Y; Faye, B; Gaye, O; Hallett, R; Lo, AC; Ndiaye, D; Ndiaye, JL; Ndiaye, M; Sylla, K; Tine, R | 1 |
| Angus, B; Chierakul, W; Davis, TM; Day, NP; Dondorp, A; Hanson, J; Krishna, S; Newton, PN; Pukrittayakamee, S; Ruangveerayuth, R; Silamut, K; Stepniewska, K; Suputtamongkol, Y; White, NJ | 1 |
| Anvikar, AR; Das, MK; Mishra, N; Ratha, J; Shah, NK; Sharma, SK; Srivastava, B; Srivastava, P; Valecha, N | 1 |
| Aston, JA; Chappell, MJ; Hall, AJ; Ward, SA | 1 |
| Chaijaroenkul, W; Karbwang, J; Muhamad, P; Na-Bangchang, K; Ruaengweerayut, R | 1 |
| Dondorp, AM; Faiz, MA; Hien, TT; Mokuolu, OA; Pukrittayakamee, S; White, NJ | 1 |
| Naidoo, P; Saman, S | 1 |
| Borghini-Fuhrer, I; Duparc, S; Fleckenstein, L; Jung, D; Morris, CA; Shin, CS; Tan, B | 1 |
| Ariey, F; Duong, S; Kiechel, JR; Leang, R; Lim, P; Ménard, D; Navaratnam, V; Ros, S; Taylor, WR | 1 |
| Bellettre, X; Bouchaud, O; Michel, JF; Pull, L; Siriez, JY | 1 |
| Cremers, S; Fidock, DA; Henrich, PP; Kyle, DE; O'Brien, C; Sáenz, FE | 1 |
| Burkholder, B; Bustos, MD; Delacollette, C; Wongsrichanalai, C | 1 |
| Bethell, D; Char, M; Fukuda, MM; Gosi, P; Lanteri, CA; Lon, C; Manning, J; Pidtana, K; Saunders, DL; Se, Y; Sea, D; Spring, M; Sriwichai, S; Surasri, S; Tyner, SD; Walsh, DS; Wongarunkochakorn, S | 1 |
| Demiraslan, H; Erdoğan, E; Kuk, S; Metan, G; Türe, Z; Yazar, S | 1 |
| Krudsood, S; Tangpukdee, N; Wilairatana, P | 1 |
| Donegan, S; Gathu, M; Olliaro, PL; Sinclair, D; Zani, B | 1 |
| Anstey, NM; Charunwatthana, P; Chau, TT; Day, NP; Dondorp, AM; Faiz, MA; Hanson, J; Hien, TT; Htut, Y; Lee, SJ; Maude, RJ; Mishra, SK; Mohanty, S; Nosten, F; Phu, NH; Price, RN; Rahman, R; Tjitra, E; White, NJ; Yunus, EB | 1 |
| Anvikar, AR; Dash, AP; Dubhashi, NG; Ghosh, SK; Jullien, V; Kiechel, JR; Kumar, A; Rao, BH; Sharma, B; Singh, JP; Srivastava, B; Taylor, WR; Valecha, N | 1 |
| Bukirwa, H; Kramer, CV; Nair, S; Sinclair, D; Tharyan, P; Unnikrishnan, B | 1 |
| Li, GX; Wang, W; Wang, YH; Xu, FL; Zhang, XG; Zhao, SS | 1 |
| Awad, AI; Elamin, SB; Matar, KM | 1 |
| Chotivanich, K; Chuor, CM; Das, D; Day, NP; Dondorp, AM; Pukrittayakamee, S; Socheat, D; Tripura, R; White, NJ; Yi, P | 1 |
| Abdallah, TM; Adam, I; Desogi, MA; Elhag, MS; Elhassan, AH; Elmardi, KA; Omer, MB; Siddig, MF | 1 |
| Ader, F; Angoulvant, A; Biligui, S; Bricaire, F; Buffet, P; Caumes, E; Ciceron, L; Danis, M; Haldar, K; Jauréguiberry, S; Kendjo, E; Mayaux, J; Mazier, D; Mouri, O; Ndour, PA; Nguyen, M; Roussel, C; Safeukui, I; Thellier, M; Vray, M | 1 |
| Abdali, N; Malik, AM; Rizvi, SW; Shamim, MD | 1 |
| Jullien, V; Kiechel, JR; Sharma, B; Srivastava, B; Valecha, N | 1 |
| D'Alessandro, U; Davies, GR; Lindegardh, N; Tarning, J; Tinto, H; Toe, LC; Traore-Coulibaly, M; Valea, I; Van Geertruyden, JP; Ward, SA | 1 |
| Cheoymang, A; Muhamad, P; Na-Bangchang, K; Phompradit, P | 1 |
| Garner, P; Gelband, H; Graves, PM | 3 |
| Chaijaroenkul, W; Muhamad, P; Na-Bangchang, K; Phompradit, P | 1 |
| Arguin, PM | 1 |
| Hickman, MR; Li, Q; Melendez, V; Miller, SR; Ogutu, B; Otieno, W; Polhemus, M; Remich, S; Smith, B; Teja-Isavadharm, P; Weina, PJ | 1 |
| Anvikar, AR; Bharti, RS; Dev, V; Dhariwal, AC; Kaitholia, K; Mishra, N; Narayan, JP; Phookan, S; Rana, R; Shah, NK; Sonal, GS; Srivastava, B; Valecha, N | 1 |
| Burri, C; Duparc, S; Ferrari, G; Hugo, P; Kitoto, AT; Lengeler, C; Mitembo, DK; Ntuku, HM | 1 |
| Gebru, T; Gerth, K; Held, J; Jansen, R; Kalesse, M; Mordmüller, B; Müller, R | 1 |
| Basilico, N; Bosisio, E; Colombo, E; Dell'Agli, M; Haynes, RK; Magenta, D; Parapini, S; Sangiovanni, E; Taramelli, D | 1 |
| Bricaire, F; Buffet, P; Danis, M; Jauréguiberry, S; Thellier, M | 1 |
| Arguin, PM; Landman, KL; Paczkowski, MM | 1 |
| Biligui, S; Buffet, PA; Chiang, S; Ciceron, L; Claessens, A; Diakité, M; Diakité, SA; Fairhurst, RM; Jauréguiberry, S; Kendjo, E; Lopera-Mesa, TM; Mazier, D; Mouri, O; Ndour, PA; Roussel, C; Thellier, M | 1 |
| Effa, EE; Esu, E; Meremikwu, MM; Opie, ON; Uwaoma, A | 1 |
| Gebru, T; Held, J; Mordmüller, B | 1 |
| Berens-Riha, N; Bountogo, M; Bousema, T; Breitkreutz, J; Coulibaly, B; Drakeley, C; Kieser, M; Klose, C; Meissner, PE; Mockenhaupt, FP; Müller, O; Nebié, E; Pritsch, M; Schirmer, RH; Sié, A; Sirima, SB; Wieser, A | 1 |
| Carratalà, J; González-Costello, J; Manito, N; Oliver, E; Oriol, I; Ortega, S; Sabé, N; Sánchez-Salado, JC | 1 |
| Beguet, M; Lauroua, P; Malvy, D; Pistone, T; Raffray, L; Receveur, MC | 1 |
| Feng, J; Feng, X; Li, J; Xia, Z; Yan, H | 1 |
| Chierakul, W; Drake, T; Kyaw, SS; Lubell, Y; Newton, PN; Ruangveerayuth, R; White, NJ | 1 |
| Evans, AM; Navaratnam, V; Olliaro, PL; Reuter, SE; Upton, RN | 1 |
| Ashley, EA; Blessborn, D; Chairat, K; Day, NP; Hanboonkunupakarn, B; Jittamala, P; Lee, SJ; Nosten, F; Panapipat, S; Pukrittayakamee, S; Tarning, J; Thana, P; White, NJ | 1 |
| Ashley, E; Day, NP; Dondorp, A; Drake, T; Guérin, PJ; Lubell, Y; Meek, S; White, LJ; White, NJ | 1 |
| Carn, G; Jullien, V; Juma, E; Kiechel, JR; Obonyo, C; Ogutu, B; Taylor, WR; Vaillant, M | 1 |
| Boggild, AK; Graham, C; Kain, KC; Keystone, JS; Krajden, S; Lee, J; Pavenski, K | 1 |
| Chai, JY; Choi, JS; Je, JH; Jung, BK; Kim, MJ; Lee, HJ; Na, YJ; Park, SH; Seo, JH; Song, JY | 1 |
| Chaccour, C; Del Pozo, JL; Kaur, H | 1 |
| Blomberg, B; Heggheim, Å; Mørch, K | 1 |
| Wang, FY; Wang, YB; Wei, DD; Wei, YB; Yin, B; Yu, ZH; Zhang, BG; Zhao, GH | 1 |
| Maitland, K | 1 |
| Adedeji, ON; Ademowo, OG; Bolaji, OO; Falade, CO; Osonuga, OA | 1 |
| Anderson, T; Ashley, EA; Bethell, D; Cooper, BS; Dondorp, AM; Flegg, JA; Lubell, Y; Nair, S; Nguon, C; Nkhoma, S; Nosten, F; Pan-Ngum, W; Phyo, AP; Plowe, C; Silamut, K; Stepniewska, K; Tripura, R; White, LJ; White, NJ; Wiladpai-ngern, JH | 1 |
| Allan, EL; Clarke, S; Culzoni, MJ; Dwivedi, P; El Sherbiny, M; Fernández, FM; Green, MD; Hall, Z; Ibe, O; Kaur, H; Mamadu, I; Onwujekwe, O; Schellenberg, D; Swamidoss, I; van Wyk, A; Yeung, S | 1 |
| Burri, C; Duparc, S; Ferrari, G; Hugo, P; Lengeler, C; Luwawu, JN; Mitembo, DK; Musafiri, PN; Ngoie, SE; Ngwala, PL; Ntuku, HM; Ross, A; Tshefu, AK | 1 |
| Anstey, NM; Dondorp, AM; Ghose, A; Haider, MS; Hossain, MA; Kingston, HW; Plewes, K; Turner, GD; Yeo, TW | 1 |
| Hastings, IM; Hodel, EM; Kay, K | 1 |
| Asadi, L; Charles, M; Houston, S; Patterson, JM | 1 |
| Abdallah, AM; Bonkian, LN; Bouyou-Akotet, M; Cantalloube, C; Coulibaly, B; Din-Bell, C; Djeriou, E; Held, J; Kimutai, R; Koiwai, K; Kombila, M; Kremsner, PG; Lell, B; Mordmüller, B; Moulero, B; Nahum, A; Otieno, L; Otsyula, N; Salazar, CL; Sié, A; Siribie, M; Sirima, SB; Supan, C; Ter-Minassian, D; Tinto, H; Waitumbi, J | 1 |
| Akima, S; Chavada, R; Gosbell, IB; Hui, SH; O'Connor, S | 1 |
| Achu, D; Chiabi, A; Mah, E; Maka, DE; Mbacham, W; Mbonda, E; Nana, P; Ndikum, V; Nguefack, S; Njoumemi, Z | 1 |
| Bannister-Tyrrell, M; Coosemans, M; d'Alessandro, U; Dierickx, S; Durnez, L; Erhart, A; Gerrets, R; Gryseels, C; Hausmann-Muela, S; Hoibak, S; Muela Ribera, J; Peeters Grietens, K; Phoeuk, P; Set, S; Sluydts, V; Suon, S; Tho, S; Trienekens, S; Uk, S | 1 |
| Ayyoub, A; Borghini-Fuhrer, I; Djimde, AA; Duparc, S; Fleckenstein, L; Methaneethorn, J; Ramharter, M; Shin, JS; Tekete, M | 1 |
| Calvo-Cano, A; Gascón, J; Gómez-Junyent, J; Muñoz, J; Ruiz-Panales, P | 1 |
| Adegnika, AA; Agbenyega, T; Ansong, D; Bojang, KA; Bolte, S; Bouyou-Akotet, MK; Chimalizeni, Y; Engleitner, T; Geditz, M; Hounkpatin, AB; Issifou, S; Kazungu, M; Kerb, R; Köhler, C; Kombila, M; Kremsner, PG; Krishna, S; Liomba, A; Mawili Mboumba, DP; Mordmüller, B; Newton, CR; Nguetse, C; Njuguna, P; Ogutu, BR; Okomo, U; Otieno, GA; Sanya-Isijola, F; Schwab, M; Sylverken, J; Taylor, TE; Velavan, TP; Wangwe, A; Zinsou, JF | 1 |
| Alonso, P; Bhatt, S; Cibulskis, RE; Gething, PW; Ghani, AC; Griffin, JT; Lynch, M; Newman, RD; Patouillard, E; Shutes, E; Sinka, ME | 1 |
| Benoit-Vical, F; Berry, A; Cissé, NH; Coulibaly, CO; Dara, A; Djimdé, AA; Doumbo, OK; Guindo, CO; Niaré, K; Ringwald, P; Sagara, I; Sissoko, MS | 1 |
| Dama, S; Dembele, D; Djimde, AA; Doumbo, OK; Fofana, B; Maiga, AW; Ouologuem, D; Sagara, I; Sanogo, K; Sidibe, B; Toure, S | 1 |
| Cui, L; Guo, S; He, L; Kyaw, MP; Min, M; Tan, G; Wang, B; Zhang, W | 1 |
| Beeching, NJ; Bell, DJ; Chiodini, PL; Lalloo, DG; Shingadia, D; Whitty, CJM | 1 |
| Baro, N; Buckee, C; Childs, LM; Daniels, R; Dow, GS; Duraisingh, MT; Gerena, L; Kyle, D; Mantel, PY; Marti, M; Mukherjee, A; Obaldía, N; Otero, W; Volkman, SK; Wirth, DF | 1 |
| Almela, MJ; Boechat, N; Herreros, E; Krettli, AU; Miguel-Blanco, C; Penna-Coutinho, J; Sá, PM | 1 |
| Alim, F; Awab, GR; Day, NP; Dondorp, AM; Hanpithakpong, W; Imwong, M; Pukrittayakamee, S; Tarning, J; White, NJ; Woodrow, CJ | 1 |
| Borghini Fuhrer, I; Canavati, SE; Denis, MB; Dondorp, AM; Duparc, S; Heng, P; Huy, R; Khim, N; Kim, S; Leang, R; Menard, D; Ringwald, P; Tol, B; Vestergaard, LS | 1 |
| Baird, JK; Boni, MF; White, NJ | 1 |
| Bastos, MS; de Melo, GN; de Souza-Lima, Rde C; Ferreira, MU; Ladeia-Andrade, S; Luz, Fd; Rodrigues, PT; Salla, LC | 1 |
| Roberts, L | 1 |
| Abd-Elmajid, MB; Adam, MA; Adeel, AA; Ali, MS; Atta, H; Barrette, A; Elhelo, MM; Elmardi, KA; Elnour, FA; Mohammady, HE; Nada, RA; Warsame, M; Zamani, G | 1 |
| Chavchich, M; Dai, B; Edstein, MD; Phong, NC; Quang, HH; Shanks, GD; Thanh, NX; Trung, TN | 1 |
| Al-Jasari, A; Al-Mekhlafi, HM; Atroosh, WM; Lau, YL; Nasr, NA; Sady, H; Snounou, G; Surin, J | 1 |
| Cabral, L; Cristiano, ML; Lobo, L; Nogueira, F; Sousa, Bd | 1 |
| Abdul-Ghani, R; Alareqi, LMQ; Fong, MY; Lau, YL; Mahdy, MAK; Mahmud, R | 1 |
| Adam, I; Ali, EA; Bilal, JA; Eltahir, HG | 1 |
| Eziefula, AC | 1 |
| Ackermann, I; Aubin, F; Carn, G; Gesase, S; Lusingu, JPA; Mnkande, E; Mrango, Z; Mtoro, A; Ngocho, JS; Ogutu, B; Onyango, KO; Ouedraogo, A; Sirima, SB; Strub, N; Vanraes, J; Yaro, JB | 1 |
| Angoulvant, A; Dauger, S; de Suremain, N; Faye, A; Levy, M; Miatello, J; Naudin, J; Pham, LL; Rambaud, J | 1 |
| Conroy, AL; Crowley, V; Hawkes, M; Hay, JG; Higgins, SJ; Kain, KC; Liles, WC; Opoka, RO; Purcell, LA; Quaggin, SE; Silver, KL; Thurston, G; Tran, V | 1 |
| Anstey, NM; Barber, BE; Grigg, MJ; William, T; Yeo, TW | 1 |
| Meena, S; Nigam, H; Sharda, M; Singh, A; Soni, A | 1 |
| Arez, AP; Berzosa, P; de Sousa, B; Guerra, M; Mendes, C; Ndong-Mabale, N; Neres, R; Salgueiro, P | 1 |
| Muhamad, P; Na-Bangchang, K; Phompradit, P; Thiengsusuk, A | 1 |
| Chiabi, A; Mah, E; Maka, DE; Mbacham, W; Mbonda, E; Nana, P; Nguefack, S; Obadeyi, B | 1 |
| Afonne, C; Ajayi, IO; Balyeku, A; Castellani, J; Diarra, A; Falade, CO; Fouque, F; Gansane, Z; Gomes, M; Jegede, AS; Kabarungi, V; Kyaligonza, J; Nsungwa-Sabiiti, J; Oshiname, FO; Petzold, M; Sanou, AK; Sermé, L; Singlovic, J; Siribié, M; Sirima, SB; Tiono, AB; Yusuf, OB | 1 |
| Amalvict, R; Benoit, N; Briolant, S; Diatta, B; Diawara, S; Diémé, Y; Fall, B; Fall, M; Gendrot, M; Kounta, MB; Madamet, M; Nakoulima, A; Pradines, B; Wade, B; Wade, KA | 1 |
| Amran, JG; Arale, AM; Barrette, A; Hassan, AH; Hassan, AM; Jibril, AM; Mohamud, SA; Muse, AY; Nada, RA; Warsame, M; Yusuf, FE | 1 |
| Attanasio, V; Carannante, N; Chiesa, D; Coppola, G; Corcione, A; Fraganza, F; Rossi, M; Sbrana, F; Tascini, C | 1 |
| Dev, AV; Peter, JV; Sathyendra, S; Seshadri, P; Viggeswarpu, S | 1 |
| Clark, TD; Dorsey, G; Jagannathan, P; Kamya, MR; Maiteki-Sebuguzi, C; Njama-Meya, D; Nzarubara, B; Rosenthal, PJ; Staedke, SG; Talisuna, AO; Yau, VM | 1 |
| Chonsawat, P; Kano, S; Krudsood, S; Phophak, N; Srivilairit, S; Tangpukdee, N; Wilairatana, P; Yanpanich, W | 1 |
| Brittenham, GM; Kano, S; Krudsood, S; Li, G; Looareesuwan, S; Pengruksa, C; Phophak, N; Tangpukdee, N; Thanachartwet, V; Wilairatana, P | 1 |
| Adedeji, AA; Balogun, ST; Fehintola, FA; Folarin, OA; Gbotosho, GO; Happi, CT; Sijuade, AO; Sowunmi, A | 1 |
| Day, NP; Ferguson, DJ; Jones, M; Medana, IM; Pongponratn, E; Roberts, R; Sachanonta, N; Turner, GD; White, NJ | 1 |
| Beck, HP; Borrmann, S; Genton, B; Hodel, EM; Marfurt, J; Müller, D; Müller, I; Reeder, JC; Rippert, A; Siba, P | 1 |
| Bacon, DJ; Cabezas, C; Cairo, J; Durand, S; Lachira, A; Marquiño, W; Quintana, F; Ruebush, TK; Utz, G; Vegas, W | 1 |
| Itskowitz, MS | 1 |
| Ashley, EA; Balkan, S; Bukirwa, H; Checchi, F; Dorsey, G; Guthmann, JP; Olliaro, P; Pinoges, L; Taylor, WR; Turyakira, E; Urruta, PP; van den Broek, I; van Herp, M; Zongo, I | 1 |
| Bélard, S; Cisse, B; Fleckenstein, L; Glasenapp, Iv; Issifou, S; Kammer, J; Koumba, PK; Kremsner, PG; Kurth, F; Lell, B; Mordmüller, B; Nemeth, J; Oeuvray, C; Ramharter, M; Schlie, M; Schreier, AC | 1 |
| Andrade, AA; Boechat, N; Botelho, AC; de Paula, RC; de Pilla Varotti, F; de Souza, MV; Fagundes, EM; Krettli, AU; Mayer, LM; Mendonça, JS; Valverde, A | 1 |
| Arango, E; Blair, S; Carmona-Fonseca, J | 1 |
| Bienvenu, AL; Picot, S | 1 |
| Adjei, GO; Alifrangis, M; Goka, BQ; Hoegberg, LC; Kristensen, K; Kurtzhals, JA; Rodrigues, OP | 1 |
| Amenga-Etego, L; Ansah, NA; Ansah, P; Anto, F; Anyorigiya, T; Atobrah, P; Hodgson, A; Koram, K; Oduro, AR | 1 |
| Bhowmik, D; Gupta, A; Gupta, V; Khaira, A; Mahajan, S; Tiwari, SC | 1 |
| Alker, AP; Ariey, F; Duong, S; Maguire, JD; Meshnick, SR; Muth, S; Sem, R; Shah, NK; Susanti, AI; Wongsrichanalai, C | 1 |
| Berg, A; Dunlop, O; Jensenius, M; Langeland, N; Leiva, RA; Longva, JA; Mørch, K; Sjursen, H; Skrede, S; Strand, Ø; Sundal, J | 1 |
| Coulibaly, M; Diallo, A; Diawara, SI; Dicko, A; Djimde, A; Doumbo, OK; Guindo, O; Kone, M; Maiga, H; Niambele, MB; Sagara, I; Sissoko, M | 1 |
| Arunkamomkiri, J; Carrara, VI; Htoo, H; Nosten, F; Nwee, P; Phyo, AP; Singhasivanon, P; Soe, M | 1 |
| Balogun, ST; Gbotosho, GO; Happi, CT; Sowunmi, A | 1 |
| Benoit-Vical, F; Berry, A; Garcia-Alvarez, MC; Nicolau, ML; Olagnier, D; Soh, PN; Witkowski, B | 1 |
| Agnamey, P; Badiane, M; Brasseur, P; Cisse, M; Gaye, O; Olliaro, P; Taylor, WR; Vaillant, M | 1 |
| Alker, AP; Bloland, PB; Kazadi, WM; Kutelemeni, AK; Meshnick, SR; Tshefu, AK | 1 |
| Agbenyega, T; Babiker, A; Baiden, F; Binka, F; Clerk, C; Faiz, MA; Folb, P; Gomes, MF; Gyapong, JO; Hassan, R; Hossain, MA; Kimbute, O; Kitua, A; Krishna, S; Makasi, C; Mensah, N; Mrango, Z; Olliaro, P; Peto, R; Peto, TJ; Rahman, MR; Ribeiro, I; Samad, R; Warsame, M; White, NJ; Yunus, EB | 1 |
| Davis, TM; Gomorrai, PS; Griffin, S; Ilett, KF; Karunajeewa, HA; Kotab, K; Lautu, D; Law, I; Lin, E; Mueller, I; Oa, O; Page-Sharp, M; Salman, S; Senn, M; Siba, P; Suano, P; Tarongka, N; Ura, A; Wong, R | 1 |
| Avellino, P; Bancone, G; d'Alessandro, U; Fanello, CI; Karema, C; Lee, SJ; Modiano, D; Uwimana, A | 1 |
| Abul Faiz, M; Bin Yunus, E; Charunwatthana, P; Day, NP; Dondorp, AM; Hasan, MU; Hoque, MG; Lee, SJ; Maude, RJ; Moore, K; Newton, PN; Pukrittayakamee, S; Rahman, MR; Roberts, LJ; Ruangveerayut, R; White, NJ | 1 |
| Ariey, F; Chim, P; Lim, P; Muth, S; Rogers, WO; Sem, R; Socheat, D; Tero, T; Wongsrichanalai, C | 1 |
| Alker, AP; Ariey, F; Bouchier, C; Bouth, DM; Doung, S; Fandeur, T; Incardona, S; Khim, N; Le Bras, J; Lim, P; Meshnick, SR; Puijalon, OM; Ringwald, P; Shah, NK; Wongsrichanalai, C; Yi, P | 1 |
| Anders, RF; Beeson, JG; Gilson, PR; King, CL; McCallum, FJ; Michon, P; Mueller, I; Murphy, VJ; Richards, JS; Schoepflin, S; Stanisic, DI | 1 |
| Chen, D; Chen, PQ; Fu, CW; Fu, LC; He, KR; Li, GQ; Ou, FZ; Xu, Y | 1 |
| Abbasi-Boroudjeni, N; Häussinger, D; Koch, S; Müller-Stöver, I; Richter, J | 1 |
| Alifrangis, M; Bousema, T; Gouagna, LC; Howitt, C; Oesterholt, MJ; Omar, SA; Sauerwein, RW; Sawa, P; Sutherland, CJ | 1 |
| Anderson, T; Ashley, EA; Barends, M; Brockman, A; Carrara, VI; Hutagalung, R; Imwong, M; Lwin, KM; McGready, R; Nosten, F; Phaiphun, L; Phyo, AP; Preechapornkul, P; Price, RN; Proux, S; Pukrittayakamee, S; Singhasivanon, P; Stepniewska, K; van Vugt, M; White, NJ; Zwang, J | 1 |
| Ahounou, D; Akogbeto, M; Bonou, D; Coosemans, M; D'Alessandro, U; Erhart, A; Massougbodji, A; Menten, J; Nahum, A; Van Overmeir, C | 1 |
| Ashley, EA; Barends, M; Keereecharoen, L; Laochan, N; Lindegardh, N; McGready, R; Nosten, F; Phaiphun, L; Pimanpanarak, M; Singhasivanon, P; Tan, SO; Viladpai-Nguen, J; White, NJ; Wüstefeld, K | 1 |
| Bacon, DJ; Durand, S; Ganguly, B; Green, M; Gutman, J; Quezada, WM; Rojas, OV; Ruebush, TK; Slutsker, L; Utz, GC | 1 |
| Adam, I; Dara, N; Dicko, A; Dicko, YT; Djimdé, A; Doumbo, OK; Jansen, FH; Maiga, H; Mbacham, W; Rulisa, S; Sagara, I; Sissoko, K; Traore, OB | 1 |
| Bélard, S; Kremsner, PG; Kurth, F; Mordmüller, B; Pongratz, P; Ramharter, M | 1 |
| Coulibaly, B; Klose, C; Mansmann, U; Meissner, PE; Mockenhaupt, FP; Müller, O; Schirmer, RH; Zoungrana, A | 1 |
| Adeothy, A; Amedome, H; Aubouy, A; Cot, M; Cottrell, G; Deloron, P; Doritchamou, J; Faucher, JF; Gourmel, B; Houzé, P; Kossou, H; Massougbodji, A | 1 |
| Barger, B; Dara, A; Djimde, AA; Doumbo, OK; Gantt, S; Maiga, H; Tekete, M; Tembine, I; Traore, OB; Traore, ZI | 1 |
| Bandyopadhyay, N; Duparc, S; Kirby, PL; Miller, AK; Ward, SA; Winstanley, PA; Wootton, DG | 1 |
| Allen, EN; Barnes, KI; Boulle, A; Camba, T; Cassam, Y; Little, F; Raman, J | 1 |
| Kar, AK; Mohapatra, MK; Murmu, M; Srinivas, D | 1 |
| Donegan, S; Garner, P; Olliaro, P; Sinclair, D; Zani, B | 1 |
| Alvarez-Doval, A; Angulo-Barturen, I; Gargallo-Viola, D; Garuti, H; Gómez, V; Ibáñez, J; Jiménez-Díaz, MB; Martínez, A; Mulet, T; Shultz, LD; Viera, S | 1 |
| An, SS; Ariey, F; Chotivanich, K; Das, D; Day, NP; Dondorp, AM; Hanpithakpong, W; Herdman, T; Imwong, M; Lee, SJ; Lim, P; Lindegardh, N; Lwin, KM; Nosten, F; Phyo, AP; Ringwald, P; Silamut, K; Singhasivanon, P; Socheat, D; Tarning, J; White, NJ; Yeung, S; Yi, P | 1 |
| Ashley, E; Bonnet, M; Broek, Iv; Guthmann, JP; Kyomuhendo, J; Ndosimao, CN; Urrutia, PP; van Herp, M; van Overmeir, C | 1 |
| Borrmann, S; Duparc, S; Esamai, F; Ezedinachi, EU; Greenwood, B; Guiguemdé, R; Kellam, L; Kirby, PL; Oguche, S; Owusu-Agyei, S; Pamba, A; Premji, Z; Sowunmi, A; Umeh, RE; Ward, SA; Winstanley, PA | 1 |
| Ambler, MT; Arunjerdja, R; Dubowitz, LM; Hla, EP; Luxemburger, C; McGready, R; Nosten, F; Singhasivanon, P; Thwai, KL; Viladpainguen, J | 1 |
| Huntrup, A; Krudsood, S; Silachamroon, U; Suwannakudt, P; Treeprasertsuk, S; Vannaphan, S; Wilairatana, P | 1 |
| Chaijaroenkul, W; Na-Bangchang, K; Wisedpanichkij, R | 1 |
| Oudijk, JM; Overbosch, D; Ting, L; van Genderen, PJ; Waalewijn, BP | 1 |
| Joloba, M; Kiggundu, M; Nawaz, F; Nsobya, SL; Rosenthal, PJ | 1 |
| Agbenyega, T; Awobusuyi, J; Carter, N; Dicko, A; Duparc, S; Goh, LE; Greenwood, B; Harrell, E; Ndububa, DA; Pamba, A; Pitmang, S; Tiono, AB; Ward, SA; Winstanley, PA | 1 |
| Balogun, S; Folarin, O; Gbotosho, GO; Happi, C; Michael, O; Okuboyejo, T; Sowunmi, A | 1 |
| Giha, HA | 1 |
| Adewoye, EO; Gbotosho, GO; Happi, CT; Nkogho, OO; Okuboyejo, TM; Sowunmi, A | 1 |
| Chakraborty, D; Dey, N; Mishra, K; Pal, A | 1 |
| Faye, B; Gaye, O; Gueye, A; Lô, AC; Ndiaye, JL; Sylla, K; Tine, R | 1 |
| Lang, HJ; Maitland, K; Ohuma, E; Shebbe, M; Timbwa, M; Tulloh, R; Yacoub, S | 1 |
| Bartoloni, A; Bettocchi, D; Consales, G; Durval, A; Luzzio, MG; Zamidei, L | 1 |
| Alvarez, LG; Blair, S; Ríos, A; Sanín, F; Tobón, A; Vásquez, AM | 1 |
| Barragán, MJ; Benoit-Vical, F; Berry, A; Laurent, V; Lelièvre, J; Su, XZ; Witkowski, B | 1 |
| Ariey, F; Beck, HP; Bouth, DM; Chim, P; Chy, S; Coppee, JY; Duong, S; Fandeur, T; Genton, B; Gobert, JG; Khim, N; Kim, S; Le Bras, J; Lim, P; Mercereau-Puijalon, O; Nhem, S; Ringwald, P; Rogers, WO; Sem, R; Wongsrichanalai, C; Yi, P | 1 |
| Bousema, T; Daou, M; Drakeley, C; Kavishe, R; Koenderink, JB; Luty, AJ; Sauerwein, RW; Shekalaghe, SA; ter Braak, R; van den Bijllaardt, W; van den Bosch, S; Whitty, CJ | 1 |
| Ngure, RM; Omar, SA; Yusuf, RU | 1 |
| Anstey, NM; Fobia, W; Hasanuddin, A; Kenangalem, E; Lampah, DA; Poespoprodjo, JR; Price, RN; Sugiarto, P; Tjitra, E | 1 |
| Adoubryn, KD; Hatz, C; Keiser, J; N'Goran, EK; N'Guessan, NA; Silué, KD; Utzinger, J; Vounatsou, P | 1 |
| Agnandji, ST; Bélard, S; Bouyou-Akotet, MK; Heidecker, JL; Issifou, S; Kombila, M; Kremsner, PG; Kurth, F; Mamfoumbi, MM; Mihindou, MP; Missinou, MA; Ngoungou, EB; Ramharter, M; Trapp, S | 1 |
| Alam, MT; Ariey, F; Barnwell, JW; Escalante, AA; Fandeur, T; Lim, P; Maguire, JD; Meshnick, SR; Muth, S; Rogers, WO; Sem, R; Shah, NK; Susanti, AI; Udhayakumar, V; Vinayak, S; Wongsrichanalai, C | 1 |
| Chau, TT; Chuong, LV; Day, N; Farrar, J; Hien, TT; Mai, NT; Phu, NH; Sinh, DX; Tuan, PQ; White, NJ | 1 |
| Nosten, FH | 1 |
| Bedu-Addo, G; Bhatt, KM; Borghini-Fuhrer, I; Bustos, DG; Duparc, S; Fleckenstein, L; Gaye, O; Kayentao, K; Sesay, SS; Shin, CS; Thompson, R; Tjitra, E; Tshefu, AK | 1 |
| Barnes, KI; Cassam, Y; Kleinschmidt, I; Little, F; Maharaj, R; Raman, J; Roper, C | 1 |
| Gomes, MF; Johansson, E; Kakoko, DC; Premji, Z; Simba, DO; Tomson, G; Warsame, M | 1 |
| Biswas, B; Ghosh, A; Mallick, D; Thapa, R | 1 |
| Bousema, T; Drakeley, C; Ghani, AC; Griffin, JT; Okell, L; Omar, S; Sauerwein, R; Sawa, P; Shekalaghe, S; Sutherland, C | 1 |
| Nau, JY | 1 |
| Das Gupta, RK; Dhillon, GP; Sonal, GS; Thakor, HG | 1 |
| Chelo, D; Djoukoue, FM; Frentzel, A; Frey, S; Hatz, C; Mina Ntoto, NK; Mueller, EA; Tietche, F; Trapp, S; Zielonka, R | 1 |
| Chalermrut, K; Kiechel, JR; Krudsood, S; Leowattana, W; Looareesuwan, S; Navaratnam, V; Olliaro, P; Phumratanaprapin, W; Ramanathan, S; Tangpukdee, N; Taylor, WR; Vaillant, M; Wilairatana, P | 1 |
| Akter, J; Haque, R; Khan, WA; Ley, B; Marma, AS; Noedl, H; Starzengruber, P; Swoboda, P; Thriemer, K; Vossen, MG | 1 |
| Biggs, BA; Casey, GJ; Cowman, AF; Hung, NM; Phuc, BQ; Thanh, NV; Tien, NT; Toan, TQ | 1 |
| Han, SC; Heger, T; Husums, H; Larsen, S; Sundet, M; Van Heng, Y | 1 |
| Duangdee, C; Krudsood, S; Looareesuwan, S; Pothipak, N; Tangpukdee, N; Warrell, DA; Wilairatana, P | 1 |
| Alvarez, G; Blair, S; Piñeros, JG; Ríos, A; Tobón, A | 1 |
| Bartalesi, F; Bartoloni, A; Castelli, F; Galli, L; Pini, A; Sani, S; Tomasoni, L; Veloci, S; Zammarchi, L | 1 |
| Fatunmbi, B; Folarin, O; Gbotosho, GO; Happi, CT; Michael, O; Okuboyejo, T; Sowunmi, A | 1 |
| Chaudhary, SC; Gupta, A; Kumar, V | 1 |
| Bacchieri, A; Bhattacharya, PC; Corsi, M; Dev, V; Dubhashi, N; Duparc, S; Ghosh, SK; Keomany, S; Khanthavong, M; Krudsood, S; Kumar, A; Mayxay, M; Newton, PN; Phyo, AP; Pongvongsa, T; Pukittayakamee, S; Pukrittayakamee, S; Rao, BH; Ruangveerayuth, R; Ubben, D; Uthaisil, C; Valecha, N | 1 |
| Balogun, ST; Fehintola, FA | 1 |
| Adam, I; Eltahir, HG; Mohamed, AA; Omer, AA | 1 |
| Nosten, F | 2 |
| Hancock, D; Khairnar, K; Lau, R; Pillai, DR; Shahinas, D | 1 |
| Aggarwal, V; Basu, S; Kumar, P; Maheshwari, A; Rath, B | 1 |
| Chaijaroenkul, W; Mahamad, P; Na-Bangchang, K; Ruengweerayut, K; Ruengweerayut, R | 1 |
| Chelo, D; Djoukoue, F; Frey, SG; Hatz, C; Kinkela, MN; Tietche, F; Weber, P | 1 |
| Bardsley, B; Barry, SJ; Drozdz, MA; Hancock, SA; Okafo, GN; Szafran, MM | 1 |
| Shanks, GD | 1 |
| Adedoyin, OT; Agbenyega, T; Anunobi, N; Bethell, D; Bojang, K; Chhaganlal, KD; Day, NP; Deen, J; Dondorp, AM; Evans, J; Fanello, CI; Gesase, S; Gomes, E; Hendriksen, IC; Johnson, WB; Kahabuka, C; Karema, C; Kivaya, E; Maitland, K; Mokuolu, OA; Mtove, G; Mwanga-Amumpaire, J; Nadjm, B; Nansumba, M; Nguah, SB; Ngum, WP; Olaosebikan, R; Oneko, M; Onyamboko, MA; Peto, TE; Sakulthaew, T; Seni, A; Silamut, K; Stepniewska, K; Tshefu, AK; Umulisa, N; Uwimana, A; von Seidlein, L; White, NJ; Wills, B; Woodrow, CJ | 1 |
| Bethell, D; Darapiseth, S; Fukuda, MM; Khemawoot, P; Kuntawungin, W; Lee, SJ; Lin, J; Lon, C; Sarim, S; Saunders, D; Se, Y; Smith, B; Socheat, D; Sriwichai, S; Surasri, S; Teja-Isavadharm, P; Tyner, S | 1 |
| Olliaro, P; Vaillant, MT | 1 |
| Keola, S; Keomany, S; Khanthavong, M; Khomthilath, T; Mayxay, M; Newton, PN; Phompida, S; Pongvongsa, T; Souvannasing, P; Stepniewska, K; Ubben, D; Valecha, N; White, NJ | 1 |
| Chotivanich, K; Day, NP; Dondorp, AM; Lee, SJ; Lindegårdh, N; Maude, RJ; Nosten, F; Pan-Ngum, W; Saralamba, S; Socheat, D; Tarning, J; White, LJ; White, NJ | 1 |
| Arora, U; Dash, AP; Dhillon, GP; Meshnick, SR; Shah, NK; Valecha, N | 1 |
| Ayede, IA; Falade, AG; Jansen, FH; Sowunmi, A | 1 |
| Berenger, AA; Didier, YJ; Djerea, K; Genevieve, GO; Kouame, MG; Penali, LK; Toure, OA | 1 |
| Chalermrut, K; Kiechel, JR; Krudsood, S; Leowattana, W; Looareesuwan, S; Navaratnam, V; Olliaro, P; Ramanathan, S; Tangpukdee, N; Taylor, WR; Vaillant, M; Wilairatama, P | 1 |
| Bisvigou, U; Dinzouna Boutamba, SD; Ekomy, H; Lekana-Douki, JB; Toure-Ndouo, FS; Zang Edou, SE; Zatra, R | 1 |
| Cochupanachimootil, J; Harris, P; Norton, R; Price, S; Senthuran, S | 1 |
| Alemu, H; Anbessie, J; Diro, E; Mao, P; Pinchouk, N; Seboxa, T | 1 |
| Terlouw, DJ; van Eijk, AM | 1 |
| Atibu, J; Bose, C; Capparelli, EV; Douoguih, M; Fleckenstein, L; Hemingway-Foday, J; Koch, MA; Lokomba, V; Meshnick, SR; Onyamboko, MA; Ryder, RW; Tshefu, AK; Wesche, D; Wright, LL | 1 |
| Flick, H; Foroutan, B; Gjorup, I; Hugo-Persson, M; Junghanss, T; Kapaun, A; Mørch, K; Richter, J; Suttorp, N; Yürek, S; Zoller, T | 1 |
| Atibu, J; Bose, C; Capparelli, E; Douoguih, M; Fleckenstein, L; Hemingway-Foday, J; Koch, MA; Lokomba, V; Meshnick, S; Morris, CA; Onyamboko, MA; Ryder, RW; Tshefu, AK; Wesche, D; Wright, L | 1 |
| Na-Bangchang, K; Ruengweerayut, R; Wernsdorfer, WH | 1 |
| Jansen, FH | 1 |
| Duffull, SB; Jamsen, KM; Lindegardh, N; Simpson, JA; Tarning, J; White, NJ | 1 |
| Basco, L; Menemedengue, V; Sahnouni, K; Tahar, R | 1 |
| Chaudhary, SC; Gupta, A; Kumar, V; Sonkar, SK | 1 |
| Callender, DM; Hsue, G | 1 |
| Carter, N; Duparc, S; Pamba, A; Waitumbi, JN | 1 |
| Chaijaroenkul, W; Maensathian, T; Muhamad, P; Na-Bangchang, K; Phompradit, P; Rueangweerayut, R; Sornjai, W | 1 |
| Gil, JP; Piedade, R | 1 |
| Chaisri, U; Chotivanich, K; Day, NP; Ferguson, DJ; Pongponratn, E; Sachanonta, N; Turner, GD | 1 |
| Hanpithakpon, W; Hlaing, N; Lindegardh, N; McGready, R; Nosten, F; Phyo, AP; Rijken, MJ; Singhasivanon, P; Tarning, J; Than, HH; White, NJ; Zin, NT | 1 |
| Afsharpad, M; Djadid, ND; Pirahmadi, S; Zakeri, S | 1 |
| Adeleke, MA; Agbeyangi, OA; Akinloye, OA; Ekpo, UF; Mafiana, CF; Sam-Wobo, SO | 1 |
| Abdullah, S; Bloland, P; Kachur, PS; Malisa, AL; Mshinda, H; Mutayoba, BM; Pearce, RJ; Roper, C | 1 |
| Akinrinola, IA; Gbotosho, GO; Happi, CT; Okuboyejo, TM; Sowunmi, A | 1 |
| Flegg, JA; Guerin, PJ; Stepniewska, K; White, NJ | 1 |
| Brooms, JD; Cruz, L; España, R; Giron, A; Magris, M; Metzger, WG; Peña Pimentel, FN; Perez, L; Villalobos, N; Vivas-Martínez, S | 1 |
| Bassene, C; Bygbjerg, IC; Faye, B; Gaye, O; Magnussen, P; Ndiaye, JL; Ndiaye, M; Ndour, CT; Ndour, JD; Sylla, K; Tine, RC | 1 |
| Bouyou Akotet, MK; Chimalizeni, Y; Duparc, S; Duscha, M; Humberg, A; Issifou, S; Kawaza, K; Köhler, C; Kombila, M; Kösters, K; Kremsner, PG; Krishna, S; Kun, JF; Miller, RS; Möhrle, J; Mordmüller, B; Planche, T; Simpson, JA; Taylor, T; Teja-Isavadharm, P; Weina, P | 1 |
| Barón, C; Carrasquilla, G; Cousin, M; Fisher, LM; Lefèvre, G; Monsell, EM; Sander, O; Walter, V | 1 |
| Arango, EM; Carmona-Fonseca, J; Upegui, YA | 1 |
| Alonso, PL; Bassat, Q; Betuela, I; Kiniboro, B; Mueller, I; Robinson, LJ; Rosanas-Urgell, A; Siba, PM; Stanisic, D | 1 |
| Huda, MF; Kaif, M; Kamali, NI; Srivastava, VK | 1 |
| Ali, I; Barends, M; Beshir, K; Durrani, N; Hallett, R; Kolaczinski, K; Lee, S; Leslie, T; Ord, R; Rowland, M | 1 |
| Bera, DK; Biswas, A; Chattopadhyay, G; Das, M; Das, S; Ganguly, S; Guha, SK; Kundu, PK; Maji, AK; Mullick, S; Ray, K; Saha, P | 1 |
| Chanthongthip, O; Hongvanthong, B; Imwong, M; Khanthavong, M; Lee, SJ; Mayxay, M; Newton, PN; Phompida, S; Pongvongsa, T; Ringwald, P; Soonthornsata, B; Stepniewska, K; White, NJ | 1 |
| Adedoyin, OT; Agbenyega, T; Bojang, K; Day, NP; Deen, JL; Dondorp, AM; Evans, J; Fanello, CI; Gesase, S; Gomes, E; Hendriksen, IC; Kahabuka, C; Karema, C; Kivaya, E; Lee, SJ; Maitland, K; Mokuolu, OA; Mtove, G; Mwanga-Amumpaire, J; Nadjm, B; Nansumba, M; Nguah, SB; Ngum, WP; Olaosebikan, R; Onyamboko, MA; Pedro, AJ; Reyburn, H; Sakulthaew, T; Silamut, K; Tshefu, AK; Umulisa, N; von Seidlein, L; White, NJ | 1 |
| Abdulla, S; Binh, TQ; Borghini-Fuhrer, I; Duparc, S; Fleckenstein, L; Pénali, LK; Phyo, AP; Poravuth, Y; Rueangweerayut, R; Shin, CS; Tien, NT; Tinto, H; Uthaisin, C; Valecha, N | 1 |
| Abdulla, SM; Charlwood, JD; Ferguson, HM; Huho, BJ; Kachur, SP; Kihonda, A; Kihonda, J; Killeen, GF; Lengeler, C; Smith, TA; Tami, A | 1 |
| Balbiano, R; Calleri, G; Caramello, P; Chiriotto, M; De Blasi, T; Deagostini, M | 1 |
| Burchard, GD; Cramer, JP; Rolling, T; Schmiedel, S; Wichmann, D; Wittkopf, D | 1 |
| Chatterjee, SK; Das, BK; Guh, P; Mandal, B; Ray, A; Shai, S; Sharma, A | 1 |
| Fidock, DA; Ng, CL | 1 |
| Dama, S; Dara, A; Dembele, D; Djimde, AA; Doumbo, OK; Fofana, B; Kone, A; Maiga, AW; Plowe, CV; Sagara, I; Sanogo, K; Sidibe, B; Thera, MA; Toure, S; Traore, OB | 1 |
| Bacchieri, A; Bhattacharyya, PC; Corsi, M; Dev, V; Dubashi, N; Gargano, N; Ghosh, SK; Kumar, A; Rao, BH; Srivastava, B; Tommasini, S; Ubben, D; Valecha, N | 1 |
| Buffet, P; Caumes, E; Clair, B; Dournon, N; Jauréguiberry, S | 1 |
| Bethell, D; Chanthap, L; Fukuda, M; Khemawoot, P; Lin, J; Noedl, H; Ringwald, P; Rutvisuttinunt, W; Saunders, D; Se, Y; Siripokasupkul, R; Smith, B; Socheat, D; Sriwichai, S; Teja-Isavadharm, P; Timmermans, A; Tyner, S; Vanachayangkul, P | 1 |
| Huang, F; Liu, H; Sun, X; Tang, L; Yang, H; Zhou, S | 1 |
| Boulos, M; Daher, A; dos Santos, RL; Junger, W; Ladislau, JL; Leon, AP; Lucena, MB; Magalhães, I; Marchesini, PB; Ribeiro, I; Santelli, AC | 1 |
| Amos, B; Chotivanich, K; Day, NP; Dondorp, AM; Fanello, CI; Gesase, S; Gomes, E; Hendriksen, IC; Joseph, S; Karema, C; Lee, SJ; Maitland, K; Mtove, G; Mwanga-Amumpaire, J; Olaosebikan, R; Pan-Ngum, W; Reyburn, H; Saiwaew, S; Silamut, K; Tshefu, AK; von Seidlein, L; White, LJ; White, NJ; Woodrow, C | 1 |
| Alker, AP; MacArthur, JR; Meshnick, SR; Satimai, W; Vijaykadga, S; Wongsrichanalai, C | 1 |
| Delacollette, C; Kaewkungwal, J; Khamsiriwatchara, A; Lawpoolsri, S; Potithavoranan, T; Sangvichean, A; Satimai, W; Sawang, S; Singhasivanon, P; Sudathip, P; Vijaykadga, S | 1 |
| Charman, SA; Gamo-Benito, J; Humberstone, A; Jamsen, KM; McCaw, J; Moehrle, J; Price, RN; Simpson, JA; Smith, K; Zaloumis, S | 1 |
| Alonso, PL; Bassat, Q; Betuela, I; de Lazzari, E; Del Portillo, HA; Kiniboro, B; Mueller, I; Rosanas-Urgell, A; Samol, L; Siba, P; Stanisic, DI | 1 |
| Bethell, D; Chaichana, P; Chaorattanakawee, S; Fukuda, M; Lon, C; Noedl, H; Rutvisuttinunt, W; Saunders, DL; Schaecher, K; Se, Y; Socheat, D; Teja-Isavadharm, P; Tyner, SD; Walsh, DS; Yingyuen, K | 1 |
| Kusriastuti, R; Surya, A | 1 |
| Chaccour, CJ; Del Pozo, JL; Kaur, H; Mabey, D | 1 |
| Anstey, NM; Auburn, S; Barber, BE; Grigg, MJ; Marfurt, J; Menon, J; William, T; Yeo, TW | 1 |
| Holtermann, MK | 1 |
| Boni, MF; Dolecek, C; Dong, le T; Farrar, J; Hien, TT; Long, le T; Merson, L; Nha-Ca, NT; Phu, NH; Ringwald, P; Stepniewska, K; Thai, CQ; Thai, le H; Thanh, NV; Thuan, PD; Thuy-Nhien, NT; Toi, PV; White, NJ; Wolbers, M | 1 |
| Bhatt, KM; Borghini-Fuhrer, I; Bustos, MD; de Salazar, PM; Doumbo, OK; Duparc, S; Fleckenstein, L; Kayentao, K; Kimani, J; Kokolomami, JH; Offianan, AT; Ouédraogo, A; Pénali, LK; Quicho, F; Ramharter, M; Shin, CS; Tiono, AB; Tshefu, AK | 1 |
| Dondorp, AM | 1 |
| Chotivanich, K; Das, D; Day, NP; Dondorp, AM; Hanpithakpong, W; Imwong, M; Lee, SJ; Lindegardh, N; Lwin, KM; Menard, D; Nguon, C; Nosten, F; Phyo, AP; Ringwald, P; Silamut, K; Socheat, D; Stepniewska, K; Tarning, J; Tripura, R; White, NJ; Yi, P | 1 |
| Abiola, A; Ba, MC; Faye, B; Gaye, O; Lo, AC; Ndiaye, JL; Ndiaye, M; Sow, D; Sylla, K; Tine, RC | 1 |
| Abbara, A; Cargill, T; Davidson, RN; Eder, M; Farne, H | 1 |
| Phan, VT | 1 |
| Batty, KT; Binh, TQ; Burchell, B; Davis, TM; Edwards, G; Ethell, BT; Hung, NC; Ilett, KF; Maggs, JL; Park, BK; Pirmohamed, M; Thu, le TA | 1 |
| Hatabu, T; Itoda, I; Kano, S; Kikuchi, K; Mizoguchi, H; Teramura, M; Totsuka, K; Yamaura, H; Yasunami, T; Yoshinaga, K | 1 |
| Cheng, Q; Rieckmann, K | 1 |
| Dzeing, A; Kombila, M; Kremsner, PG; Krishna, S; Müller-Römer, U; Nealon, C; Parzy, D; Planche, T; Sinou, V | 1 |
| Furuya, N; Hike, K; Kano, S; Kimura, K; Matsumoto, T; Tateda, K; Yamaguchi, K; Yoshizawa, S | 1 |
| Faizal, HM; Fernando, WP; Galappaththy, G; Weerasinghe, KL; Wickremasinghe, AR; Wickremasinghe, DR | 1 |
| Brockman, A; Leonardi, E; Looareesuwan, S; McGready, R; Nosten, F; Phaipun, L; Slight, T; Thway, KL; van Vugt, M; Villegas, L; White, NJ | 1 |
| Cambon, N; Chalermrut, K; Krudsood, S; Looareesuwan, S; Mueller, EA; Pittrow, D; Silachamroon, U | 1 |
| Campos, SB; Seguro, AC | 1 |
| Agus, C; Batty, KT; Binh, TQ; Chiswell, GM; Davis, TM; Ilett, KF; Phuöng, HL; Phuong, VD | 1 |
| Dyk Dao, L; Rabinovich, SA; Van Ha, N | 1 |
| Hijar, G; Kain, KC; Marouiño, W; Montoya, Y; Pillai, DR; Ruebush, TK; Wongsrichanalai, C | 1 |
| Adegnika, AA; Binder, RK; Borrmann, S; Issifou, S; Kremsner, PG; Krishna, S; Kun, JF; Lell, B; Matsiegui, PB; Missinou, MA; Schindler, A | 1 |
| Alpers, MP; Batty, KT; Davis, TM; Ilett, KF; Karunajeewa, HA; Kemiki, A; Lorry, K | 1 |
| Cattamanchi, A; Dorsey, G; Hubbard, A; Kyabayinze, D; Rosenthal, PJ | 1 |
| Faiz, MA; Hossain, MA; Miller, RS; Noedl, H; Pang, LW; Rahman, MR; Samad, R; Wongsrichanalai, C; Yunus, EB | 1 |
| Emery, K; Ittarat, W; Looareesuwan, S; Low, J; Meshnick, SR; Pickard, AL; Rattanasinganchan, P; Udomsangpetch, R; Wilairatana, P | 1 |
| Alkadru, AM; Awad, MI; Baraka, OZ; Behrens, RH; Eltayeb, IB | 1 |
| Chalermrut, K; Krudsood, S; Looareesuwan, S; Pengruksa, C; Silachamroon, U; Srivilairit, S; Treeprasertsuk, S; Wilairatana, P | 1 |
| Cabezas, C; Calampa, C; Falconí, E; Huilca, M; Marquiño, W; Naupay, R; Ruebush, TK | 1 |
| Chaikachonpatd, S; Chanthapakajee, K; Chindarat, S; Kaewkaukul, N; Lim, K; Silpasakorn, S; Suputtamongkol, Y; Thamlikitkul, V | 1 |
| Angus, BJ; Chierakul, W; Dondorp, A; Looareesuwan, S; Newton, PN; Ruangveerayuth, R; Silamut, K; Suputtamongkol, Y; Teerapong, P; White, NJ | 1 |
| Batty, KT; Davis, TM; Ilett, KF; Kotecka, BM; Rieckmann, KH | 1 |
| D'Alessandro, U; Dujardin, JC; Karema, C; Mugisha, V; Niyitegeka, F; Rwagacondo, CE; Sarushi, J; van den Ende, J; Van Overmeir, C | 1 |
| Coleman, R; Drakeley, CJ; Jawara, M; Milligan, P; Obisike, U; Pinder, M; Sutherland, CJ; Targett, GA; Walraven, G | 1 |
| Cho, T; Edstein, MD; Gilveray, G; Looareesuwan, S; McGready, R; Nosten, F; Stepniewska, K; White, NJ | 1 |
| Brittenham, G; Carroll, J; Krudsood, S; Kuhn, WF; Looareesuwan, S; Maek-A-Nantawat, W; Saengnetswang, T; Tosukhowong, T; Treeprasertsuk, S; Vannaphan, S | 1 |
| Brittenham, GM; Gourdeuk, VR; Krudsood, S; Looareesuwan, S; Phomrattanaprapin, W; Silachamroon, U; Treeprasertsuk, S; Vannaphan, S; Wilairatana, P | 1 |
| Binh, TQ; De Vries, PJ; Giao, PT; Hung, LQ; Kager, PA; Nam, NV | 1 |
| Chen, RJ; Fu, LC; Guo, WZ; Guo, XB; Ou, FZ; Tan, B; Zheng, QJ | 1 |
| Dorsey, G; Kamya, MR; Rosenthal, PJ; Staedke, SG; Vlahos, J | 1 |
| Cox-Singh, J; Davis, TM; Doan, HN; Hewitt, S; Le, DC; Nguyen, MH; Nguyen, TH; Tran, BK; Tran, QT; Vo, NP | 1 |
| Feng, XP; Liu, DQ | 1 |
| Cambon, N; Gomez, EA; Jurado, MH | 1 |
| Deshpande, A; Kalgutkar, S; Udani, S | 1 |
| Adjuik, M; Babiker, A; Garner, P; Olliaro, P; Taylor, W; White, N | 1 |
| Coleman, R; Drakeley, CJ; Jawara, M; Obisike, U; Pinder, M; Sutherland, CJ; Targett, GA; Walraven, G | 1 |
| Balkan, S; Depoortere, E; Fermon, F; Guthmann, JP; Legros, D; Nkandu, E; Sipilanyambe, N | 1 |
| Brewer, TG; Kyle, DE; Peggins, JO; Teja-Isavadharm, P; Webster, HK; White, NJ | 1 |
| Brockman, A; Katterman, N; Kyaw, MK; Lwin, S; Smithuis, F; van der Broek, I; White, NJ | 1 |
| Avila, JC; Marquiño, W; Mollinedo, R; Ruebush, TK; Villaroel, R; Zegarra, J | 1 |
| Chantra, A; Chotivanich, K; Clemens, R; Looareesuwan, S; Pukrittayakamee, S; White, NJ | 1 |
| Barennes, H; Koussoubé-Balima, T; Nagot, N; Ouedraogo, A; Sanou, T; Valea, I; Yé, S | 1 |
| Mishra, K; Mohanty, AK; Mohanty, R; Rath, BK; Samal, AK | 1 |
| Amklad, I; Looareesuwan, S; Rojanawatsirivej, C; Vijaykadga, S; Wilairatna, P | 1 |
| Bunnag, D; Chittamas, S; Kanda, T; Looareesuwan, S; Pornkulprasit, V; Rojanawatsirivej, C; Thimasarn, K; Wattanakoon, Y | 1 |
| Barnes, KI; Folb, PI; Gomes, M; Little, F; McIlleron, H; Molyneux, ME; Mwenechanya, J; Ribeiro, I; Tembo, M | 1 |
| Barihuta, T; Barutwanayo, M; Bosman, A; Ciza, A; Delacollette, C; Kamana, J; Karenzo, J; Mizero, L; Moyou-Somo, R; Nahimana, A; Ndaruhutse, J; Ndayiragije, A; Niyungeko, D; Niyungeko, E; Nyarushatsi, JP; Ringwald, P | 1 |
| Chim, P; Fandeur, T; Lim, P; Maciejewski, L; Nhem, S; Sem, R | 1 |
| Binh, TQ; de Vries, PJ; Giao, PT; Holman, R; Hung, le Q; Kager, PA; Nam, NV | 1 |
| D'Alessandro, U; Dujardin, JC; Erhart, A; Karema, C; Mugisha, V; Ringwald, P; Rwagacondo, CE; Van Overmeir, C | 1 |
| Annerberg, A; Barends, M; Keola, S; Khanthavong, M; Lindegårdh, N; Mayxay, M; Newton, PN; Phetsouvanh, R; Phompida, S; Pongvongsa, T; White, NJ; Yapom, R | 1 |
| Ashley, EA; Brockman, A; Hutagalung, R; Krudsood, S; Leowattana, W; Looareesuwan, S; McGready, R; Nosten, F; Phaiphun, L; Srivilairit, S; White, NJ; Wilairatana, P | 1 |
| Agus, C; Chiswell, GM; Chuong, LV; Davis, TM; Farrar, J; Hien, TT; Ilett, KF; Phu, NH; Sinh, DX; White, NJ | 1 |
| Annerberg, A; Christophel, EM; Dittrich, S; Jelinek, T; Lindegardh, N; Monti, F; Phetsouvanh, R; Phompida, S; Stohrer, JM; Thongpaseuth, V; Vanisaveth, V | 1 |
| Kyaw, MK; Lwin, S; Savran, O; Shahmanesh, M; Smithuis, F; White, NJ | 1 |
| Chim, P; Denis, MB; Fandeur, T; Lim, C; Lim, P; Nemh, S; Poravuth, Y; Seila, S; Sem, R; Socheat, D; Tsuyuoka, R | 1 |
| Imwong, M; Krudsood, S; Looareesuwan, S; Nonprasert, A; Pukrittayakamee, S; Snounou, G; White, NJ; Wilairatana, P | 1 |
| Ando, M; Kanda, E; Kida, Y; Negishi, M; Saito, H; Sasaki, S; Suzuki, H | 1 |
| Abdulla, SM; Bloland, PB; Fox, SS; Kachur, SP; Kaizer, E; Khatib, RA | 1 |
| Peters, W; Robinson, BL; Stewart, LB | 1 |
| Balkan, S; de Pécoulas, PE; Depoortere, E; Guthmann, JP; Legros, D; Nkandu, E; Pressé, J; Sipilanyambe, N | 1 |
| Pilz, JB; Rojanawatsirivet, C; Sirichaisinthop, J; Wernsdorfer, G; Wernsdorfer, WH; Wiedermann, G | 1 |
| Bangchang, KN; Congpuong, K; Rojanawatsirivet, C; Thongphua, S; Thongsri, K; Vijaykadga, S; Wernsdorfer, WH; Wilairatana, P | 1 |
| Al-Faith, M; Alemu, E; Amsalu, R; Balasegaram, M; Checchi, F; Hepple, P; Hussein, el B; Montgomery, J; van den Broek, I | 1 |
| Hastings, IM; Sibley, CH; Watkins, WM | 1 |
| Havlik, I; Kaneko, Y; Kozbor, D; Krudsood, S; Looareesuwan, S; Thuma, PE; Vannaphan, S; Watanabe, N; Wilairatana, P | 1 |
| Brockman, A; Chaulet, JF; Chierakul, W; Dondorp, A; Looareesuwan, S; Mounier, C; Newton, PN; Ruangveerayuth, R; White, NJ | 1 |
| A-Elbasit, IE; Adam, I; Elbashir, MI | 1 |
| Atkin, S; Checchi, F; Ford, N; Hamour, S; Hook, C; Keus, K; Melaku, Y; Montgomery, J; Wambugu, J | 1 |
| Ampuero, J; Balkan, S; D'Alessandro, U; Denoncin, A; Dujardin, JC; Dunand, J; Fortes, F; Franco, J; Gaboulaud, V; Gillet, P; Guthmann, JP; Legros, D; Saraiva, N; Tobback, S; van Herp, M; van Overmeir, C | 1 |
| Das, P | 1 |
| Arróspide, N; Cabezas, C; Falconí, E; Gutierrez, S; Hermenegildo, Y; Marquiño, W; Palacios, AM; Ruebush, TK; Ylquimiche, L | 1 |
| Adégnika, AA; Agnandji, ST; Borrmann, S; Graninger, W; Issifou, S; Klein Klouwenberg, P; Kremsner, PG; Krishna, S; Kun, JF; Lell, B; Matsiégui, PB; Missinou, MA; Mordmüller, B; Oyakhirome, S; Ramharter, M | 1 |
| Anderson, TJ; Brockman, A; Nair, S; Nosten, F; Paiphun, L; Qin, H; Singlam, S | 1 |
| Anemana, SD; Bienzle, U; Cramer, JP; Dzisi, SY; Eggelte, TA; Ehrhardt, S; Mockenhaupt, FP; Otchwemah, RN; Sauerwein, RW; Schreiber, J; Teun Bousema, J; Wassilew, N | 1 |
| Ahmad, F; Durrani, N; Graham, K; Leslie, T; Rahim, S; Rowland, M | 1 |
| A-Elbasit, IE; Adam, I; Elbashir, MI; Idris, SM; Malik, EM | 1 |
| Ashley, EA; Barends, M; Hutagalung, R; Looareesuwan, S; McGready, R; Nosten, F; Phaiphun, L; Proux, S; Slight, T; Thwai, KL; White, NJ | 1 |
| Abuaku, B; Duah, N; Koram, KA; Quashie, N | 1 |
| Ashley, EA; Barends, M; Cho, T; Hutagalung, R; Looareesuwan, S; McGready, R; Moo, E; Nosten, F; White, NJ | 1 |
| Bangali, AM; Barends, M; Das, S; Faiz, AM; Kamal, M; Liem, L; Maung, UA; Peters, A; Rahman, M; Rahman, MR; van den Broek, IV | 1 |
| Gupta, RK; Looareesuwan, S; Nosten, F; Paiphun, L; Slight, T; Van Vugt, M; White, NJ | 1 |
| Chalermrut, K; Krudsood, S; Leowattana, W; Looareesuwan, S; Silachamroon, U; Srivilairit, S; Tangpukdee, N; Thanachartwet, W; Thimasarn, K; Wilaiaratana, P | 1 |
| Attanath, P; Chaivisuth, A; Chanthavanich, P; Na-Bangchang, K; Pengsaa, K; Pojjaroen-Anant, C; Sabchareon, A; Sirivichayakul, C; Thaiarporn, I; Wisetsing, P; Wongsuwan, A | 1 |
| Adegnika, AA; Borrmann, S; Esser, G; Hutchinson, D; Issifou, S; Jomaa, H; Kombila, M; Kremsner, PG; Lundgren, I; Matsiegui, PB; Moussavou, F; Oyakhirome, S; Ramharter, M; Wiesner, J | 1 |
| Agnamey, P; Brasseur, P; Cisse, M; Dumoulin, J; Gaye, O; Olliaro, P; Rigal, J; Taylor, WR | 1 |
| Garner, P; Jones, K; Taylor-Robinson, D | 1 |
| Binh, VQ; Dai, B; Dao, NV; Edstein, MD; Ngoa, ND; Quoc, NP; Rieckmann, KH; The, ND; Thuy, le T | 1 |
| Abdelgadir, T; Adam, I; Ahmed, ES; Elamin, SB; Khamiss, AH; Malik, EM; Mohammed, MM | 1 |
| Ali, AS; Björkman, A; Gil, JP; Mårtensson, A; Montgomery, SM; Msellem, MI; Olliaro, P; Sisowath, C; Strömberg, J | 1 |
| Djalle, D; Dolmazon, V; Manirakiza, A; Matsika-Claquin, MD; Menard, D; Sarda, J; Talarmin, A; Yapou, F | 1 |
| Ashley, EA; Brockman, A; Hutagalung, R; Jelinek, T; McGready, R; Nosten, FH; Paiphun, L; Singhasivanon, P; Thwai, KL; White, NJ | 1 |
| A/elbasit, IA; Adam, I; Elbashir, MI; Ibrahim, MH | 1 |
| Adegnika, AA; Altun, H; Gläser, B; Grobusch, MP; Issifou, S; Klein Klouwenberg, P; Kremsner, PG; Kun, JF; Oyakhirome, S; Pötschke, M; Schwarz, NG | 1 |
| Bukirwa, H; Orton, L | 1 |
| Adedeji, AA; Fateye, BA; Fehintola, FA; Gbotosho, GO; Happi, TC; Oduola, AM; Sowunmi, A; Tambo, E | 1 |
| Baruah, S; Campbell, P; Narain, K; Rogers, CC | 1 |
| Bienzle, U; Forst, T; Lambertz, U; Mockenhaupt, FP; Otchwemah, RN; Pfützner, A; Röwer, S; Weise, A | 1 |
| Krishna, S; Planche, T; Woodrow, CJ | 1 |
| Toovey, S | 1 |
| Ahmed, OA; Elamin, SB; Eltaib, EH; Malik, EM; Mohamed, AO | 1 |
| Abdalla, MA; Adam, I; Ali, DM | 1 |
| Bukirwa, H; Critchley, J | 1 |
| Chalermrut, K; Kano, S; Krudsood, S; Looareesuwan, S; Pengruksa, C; Phongtananant, S; Silachamroon, U; Srivilairit, S; Tangpukdee, N; Thanachartwet, W; Wilairatana, P | 1 |
| Cholpol, S; Nakavej, A; Phoungmanee, D; Rojanawatsirivej, C; Vijaykadga, S; Wongsrichanalai, C | 1 |
| Chiswell, GM; Dabod, E; Davis, TM; Hamzah, J; Ilett, KF; Karunajeewa, HA; Lorry, K; Page-Sharp, M; Reeder, J | 1 |
| Bousema, T; Gouagna, L; Omar, S; Sauerwein, R; Sawa, P; Schallig, H; Schneider, P | 1 |
| Alexander, N; Bâ, el H; Boulanger, D; Cissé, B; Gaye, O; Greenwood, B; Hallett, R; Lines, J; Milet, J; Richardson, K; Simondon, F; Simondon, K; Sokhna, C; Sutherland, C; Targett, G; Trape, JF | 1 |
| Cho, T; Gilveray, G; Looareesuwan, S; McGready, R; Nosten, F; Stepniewska, K; Ward, SA; White, NJ | 1 |
| Balkan, S; Checchi, F; Guerin, PJ; Guthmann, JP; Pinoges, L; Rolland, E | 1 |
| Counillon, E; Del Giudice, P; Delaunay, P; Vandenbos, F | 1 |
| Alaribe, A; Ejemot, R; Ekenjoku, J; Ezedinachi, E; Meremikwu, M; Nwachukwu, C; Ordu, D; Oyo-Ita, A | 1 |
| Ashley, EA; Brockman, A; Carrara, VI; Gilbos, V; Krudsood, S; Leemingsawat, S; Looareesuwan, S; McGready, R; Nosten, F; Proux, S; Rojanawatsirivet, C; Singhasivanon, P; Sirilak, S; Thonglairuam, J; White, N | 1 |
| Konthiang, P; Nakornchai, S | 1 |
| Duffy, PE; Mutabingwa, TK | 1 |
| Ashley, E; Aye, KZ; Barends, M; Htet, L; Kyaw, MK; Lindegardh, N; Lwin, S; Phe, O; Singtoroj, T; Smithuis, F; Stepniewska, K; White, NJ | 1 |
| Ashley, EA; Hae, R; Hutagalung, R; Lindegårdh, N; McGready, R; Nosten, F; Singhasivanon, P; Stepniewska, K; White, NJ | 1 |
| Ashley, E; McGready, R; Nosten, F; Price, R | 1 |
| Balkan, S; Checchi, F; Durand, R; Grandesso, F; Guthmann, JP; Hagerman, A; Kamara, S; Lam, E; Scollo, G | 1 |
| Balkan, S; Cohuet, S; Fortes, F; Francis, M; Guthmann, JP; Kiguli, J; Kyomuhendo, J; Mulemba, M; Noël, F; Rigutto, C; Saraiva, N | 1 |
| Bhatt, KM; Bhatt, SM; Samia, BM; Wasunna, KM | 1 |
| Ahmed, ES; Elamin, SB; Elhassan, AH; Elmardi, KA; Malik, EM; Mannan, AA; Mohamed, TA; Mowien, RM | 1 |
| Barends, M; Keola, S; Khanthavong, M; Lindegårdh, N; Mayxay, M; Newton, PN; Phetsouvanh, R; Phompida, S; Pongvongsa, T; Stepniewska, K; Thongpraseuth, V; White, NJ | 1 |
| Adjuik, M; Beck, HP; Mshinda, H; Mugittu, K; Ntoumi, F; Olliaro, P; Snounou, G; Taylor, W | 1 |
| Christophel, EM; Denis, MB; Incardona, S; Lim, C; Lim, P; Narann, TS; Poravuth, Y; Ringwald, P; Seila, S; Sem, R; Socheat, D; Tsuyuoka, R | 1 |
| Adam, I; Alifrangis, M; Elmardi, KA; Khalil, IF; Magzoub, M; Osman, ME | 1 |
| Bisser, S; Mazier, D; Mezui-Me-Ndong, J; Ollomo, B; Ouwe-Missi-Oukem-Boyer, O; Touré, FS | 1 |
| Kayembe, G; Montgomery, J; Pota, H; Roper, C; Swarthout, TD; van den Broek, IV | 1 |
| Chappuis, F; Jackson, Y; Loutan, L; Taylor, W | 1 |
| Dicko, A; Djimde, A; Doumbo, OK; Fofana, M; Guindo, O; Jansen, HF; Kone, M; Ouattara, A; Sagara, I; Sissoko, M; Sogoba, M; Thera, MA; Tolo, Y | 1 |
| Bhattacharyya, H; Chalermratana, K; Fukuda, M; Jongsakul, K; Knirsch, C; Krudsood, S; Leowattana, W; Looareesuwan, S; Miller, RS; Noedl, H; Ohrt, C; Rowan, J; Silachamroon, U; Sriwichai, S; Tangpukdee, N | 1 |
| Ashley, EA; Barends, M; Leowattana, W; Lwin, KM; McGready, R; Nawamaneerat, W; Nosten, F; Olliaro, P; Phaiphun, L; Proux, S; Simon, WH; Singhasivanon, P; Stepniewska, K; Taylor, W; Thwai, KL; Wangseang, N; White, NJ | 1 |
| Barnes, KI; Chierakul, W; Evans, AC; Newton, PN; Ruangveerayuth, R; Smith, PJ; White, NJ | 1 |
| Fukuda, M; Jongsakul, K; Knirsch, C; Krudsood, S; Leowattana, W; Looareesuwan, S; Miller, RS; Noedl, H; Ohrt, C; Sriwichai, S; Tangpukdee, N; Thanachartwet, W; Yingyuen, K | 1 |
| Al Attas, S; Balasegaram, M; Guthmann, JP; Kitz, C; Libama, F; van den Broek, I | 1 |
| Bustamante, LY; Krishna, S; Matile, H; Uhlemann, AC; Wittlin, S | 1 |
| Annerberg, A; Christophel, EM; Denis, MB; Fandeur, T; Lim, P; Lindegardh, N; Ringwald, P; Socheat, D; Top, SN; Tsuyuoka, R; Yi, P | 1 |
| Ashley, E; Carrara, V; McGready, R; Nosten, F; Price, R; Singhasivanon, P | 1 |
| Fujimoto, H; Genka, I; Kanagawa, S; Kano, S; Kato, Y; Kawana, A; Kimura, S; Kudo, K; Mizuno, Y; Oka, S; Yokota, K | 1 |
| Atemnkeng, MA; De Cock, K; Plaizier-Vercammen, J | 1 |
| Adam, I; Alifrangis, M; Elmardi, KA; Ibrahium, AM; Khalil, IF; Kheir, MM; Malik, EM; Osman, ME | 1 |
| Williams, J | 1 |
| Anderson, T; Barends, M; Brockman, A; Jaidee, A; Mayxay, M; Nair, S; Newton, PN; Phetsouvanh, R; Phompida, S; Pongvongsa, T; Sudimack, D; White, NJ | 1 |
| Adjuik, M; Beck, HP; Guthmann, JP; Kiguli, J; Mshinda, H; Mugittu, K; Olliaro, PL; Priotto, G; Snounou, G; Taylor, WR | 1 |
| Ashley, EA; Brockman, A; Chan, S; Goubert, L; Janssens, B; Nong, S; Socheat, D; Uong, S; Van Damme, W; van Herp, M | 1 |
| Cravo, P; do Rosário, VE; Ferreira, C; Ferreira, ID; Lopes, D; Martinelli, A | 1 |
| Keola, S; Khanthavong, M; Mayxay, M; Newton, PN; Phetsouvanh, R; Phompida, S; Pongvongsa, T; Taylor, AM; White, NJ | 1 |
| Kimbi, HK; Ndamukong, KN; Nkuo-Akenji, TK; Nkwescheu, A; Patchong, AF | 1 |
| Adedeji, AA; Balogun, T; Fehintola, FA; Gbotosho, GO; Happi, CT; Sowunmi, A | 1 |
| Gonzalez, I; Olliaro, P; Osorio, L; Taylor, WR | 1 |
| Gupta, A; Gustafsson, LL; Haule, AF; Kagashe, GA; Massele, AY; Minzi, OM | 1 |
| Dörnemann, J; Grobusch, MP; Kremsner, PG; Kun, JF; Laengin, M; Lell, B; Oyakhirome, S; Pötschke, M; Salazar, CO; Schwarz, NG | 1 |
| Anstey, NM; Ebsworth, EP; Hasugian, AR; Kenangalem, E; Laihad, F; Maristela, R; Penttinen, PM; Price, RN; Purba, HL; Tjitra, E; Wuwung, RM | 1 |
| Cravo, P; do Rosário, VE; Fernandes, N; Figueiredo, P | 1 |
| Checkley, AM; Whitty, CJ | 1 |
| Auwun, A; Davis, TM; Hinton, RL; Karunajeewa, HA; Oa, O; Pongua, G; Reeder, JC | 1 |
| Alker, AP; Ariey, F; Bouth, DM; Fandeur, T; Lim, P; Maguire, JD; Meshnick, SR; Sem, R; Shah, NK; Tsuyuoka, R; Wongsrichanalai, C; Yi, P | 1 |
| Day, NP; Dondorp, AM | 1 |
| Chaivisuth, A; Chanthavanich, P; Na-Bangchang, K; Pengsaa, K; Pojjaroen-Anant, C; Sabchareon, A; Sirivichayakul, C; Thaiarporn, I; Wisetsing, P | 1 |
| Bonnet, M; Coulibaly, L; Félix, M; Guthmann, JP; Kankolongo, GM; Roper, C | 1 |
| Andrianina, NN; Jahevitra, M; Ménard, D; Ramiandrasoa, Z; Randriamanantena, A; Rasoarilalao, N; Ratsimbasoa, A; Raveloson, A; Tuseo, L | 1 |
| Clark, TD; Dokomajilar, C; Dorsey, G; Kamya, MR; Maiteki-Sebuguzi, C; Njama-Meya, D; Nzarubara, B; Rosenthal, PJ; Staedke, S | 1 |
| Bjorkman, A; Ekvall, H; Kaneko, A; Obonyo, CO; Olliaro, P; Oloo, AJ; Taylor, W; Ter Kuile, F | 1 |
| Abuaku, B; Duah, NO; Koram, KA; Quashie, NB | 1 |
| Beeson, JG; Cole-Tobian, JL; Dabod, E; Igu, J; King, CL; Michon, P; Mueller, I; Reeder, JC; Schoepflin, S; Schofield, L; Susapu, M; Tarongka, N; Zimmerman, PA | 1 |
| Dokomajilar, C; Dorsey, G; Joloba, M; Nsobya, SL; Rosenthal, PJ | 1 |
| Ariey, F; Bedja, SA; Rabarijaona, LP; Randrianarivelojosia, M; Robert, V; Tall, A | 1 |
| Dieng, Y; Faye, B; Faye, O; Gaye, O; Ndiaye, D; Ndiaye, JL | 1 |
| Gansané, A; Sirima, SB | 1 |
| De-Eknamkul, W; Matangkasombut, O; Putalun, W; Shoyama, Y; Tanaka, H | 1 |
| Durrani, N; Kolaczinski, K; Rahim, S; Rowland, M | 1 |
| Anto, F; Anyorigiya, T; Atobrah, P; Hodgson, A; Koram, K; Oduro, AR | 1 |
| Adegnika, AA; Agnandji, ST; Bélard, S; Bouyou-Akotet, MK; Cambon, N; Heidecker, JL; Issifou, S; Kombila, M; Kremsner, PG; Kurth, FM; Mamfoumbi, MM; Missinou, MA; Ramharter, M | 1 |
| Alifrangis, M; Bousema, T; Drakeley, C; Enevold, A; Gosling, R; Mosha, F; Ndaro, A; Sauerwein, R; Shekalaghe, S; van Meegeren, M | 1 |
| Bernasconi, A; Casapia, M; D'Alessandro, U; Delgado, C; Erhart, A; Fanello, C; Gamboa, D; Grande, T; Llanos-Cuentas, A; Torres, K | 1 |
| Gatarayiha, JP; Kabarisa, T; Ndayisaba, G; Rulisa, S | 1 |
| Alker, AP; Chaponda, M; Kalilani, L; Kwiek, JJ; Meshnick, SR; Mofolo, I; Rogerson, SJ | 1 |
| Agnamey, P; Brasseur, P; Gaye, O; Olliaro, PL; Taylor, WR; Vaillant, M | 1 |
| Ageep, T; Babiker, A; Babiker, H; Baraka, O; El-Sayed, B; El-Zaki, SE; Gadalla, N; Mansour, F; Milligan, P | 1 |
| Agbowai, C; Akogbeto, M; Coosemans, M; D'Alessandro, U; Erhart, A; Gazard, D; Massougbodji, A; Menten, J; Nahum, A; van Loen, H; Van Overmeir, C | 1 |
| Abdalla, E; Adam, I; Elhadi, MO; Elhardello, OA; Elmardi, KA; Jansen, FH | 1 |
| Brasseur, P; Cisse, M; Diouf, AM; Faye, B; Gaye, O; Kuété, T; Lameyre, V; Ndiaye, JL; Same-Ekobo, A; Seck, PA | 1 |
| Adedeji, AA; Balogun, T; Fehintola, FA; Olasupo, NO; Sowunmi, A | 1 |
| Bouyou-Akotet, M; Durand, R; Guiyedi, V; Kombila, M; Le Bras, J; Loembet, R; Mabika-Mamfoumbi, M; Mourou-Mbina, JR; Ngoungou, E; Nsimba, B | 1 |
| Coulibaly, B; Klose, C; Kouyaté, B; Mansmann, U; Meissner, P; Mockenhaupt, FP; Müller, O; Schirmer, RH; Sié, A; Walter-Sack, I; Zoungrana, A | 1 |
| Cravo, P; do Carmo, EL; do Rosário, VE; Ferreira, ID; Martinelli, A; Póvoa, MM; Rodrigues, LA | 1 |
| Biagini, GA; Blencowe, H; Dube-Mbeye, Q; Dunyo, S; Duparc, S; Kanjala, MK; Kanyok, T; Kirby, PL; Molyneux, M; Neate, C; Nyirenda, M; Opara, H; Ward, S; Winstanley, PA; Woessner, M; Wootton, DG | 1 |
| Curtis, J; D'Alessandro, U; Fanello, CI; Karema, C; Ndahindwa, V; Ngamije, D; Uwimana, A; Van Doren, W; Van Overmeir, C | 1 |
| Dama, S; Dembele, D; Dicko, A; Djimdé, AA; Doumbo, OK; Fofana, B; Ouologuem, D; Sagara, I; Sidibe, B; Toure, S | 1 |
| Ademowo, OG; Falade, CO; Ladipo, SM; Ogundele, AO; Yusuf, BO | 1 |
| Ashley, EA; Lwin, KM; McGready, R; Nosten, F; Proux, S; Silamut, K | 1 |
| Zarocostas, J | 1 |
| Rosenthal, PJ | 1 |
| Baisor, M; Felger, I; Goroti, M; Marfurt, J; Mueller, I; Schoepflin, S | 1 |
| Chongsuphajaisiddhi, T; Luxemburger, C; Nosten, F; Raimond, SD; White, NJ | 1 |
| Andrial, M; Looareesuwan, S; Vanijanonta, S; Viravan, C; Wilairatana, P | 1 |
| Graninger, W; Looareesuwan, S; Presterl, E; Wenisch, C | 1 |
| Burgmann, H; Graninger, W; Hollenstein, U; Looareesuwan, S; Thalhammer, F; Wenisch, C | 1 |
| Chongsuphajaisiddhi, T; Eh, JP; Luxemburger, C; Nosten, F; ter Kuile, FO; White, NJ; Woodrow, C | 1 |
| Canfield, CJ; Charoenlarp, P; Kyle, DE; Looareesuwan, S; Vanijanonta, S; Viravan, C; Wilairatana, P | 1 |
| Fu, LC; Guo, XB; Jian, HX; Li, GQ; Wang, XH | 1 |
| Looareesuwan, S | 1 |
| Hien, TT | 1 |
| Andrial, M; Charoenlarp, P; Looareesuwan, S; Vanijanonta, S; Viravan, C; Wilairatana, P | 1 |
| Hopperus Buma, AP; Kager, PA; Leentvaar-Kuijpers, A; Tendeloo, CH; van Gool, T; van Thiel, PP | 1 |
| Back, DJ; Bunnag, D; Harinasuta, T; Karbwang, J; Na Bangchang, K; Thanavibul, A | 1 |
| Bunnag, D; Chongsuphajaisiddhi, T; Harinasuta, T; Karbwang, J; Na-Bangchang, K; Thanavibul, A | 1 |
| Canfield, C; Charoenlarp, P; Kyle, DE; Looareesuwan, S; Vanijanonta, S; Viravan, C; Wilairatana, P | 1 |
| Barradell, LB; Fitton, A | 1 |
| Alin, MH; Ashton, M; Bjorkman, A; Bwijo, BA; Kihamia, CM; Mtey, GJ; Premji, Z | 1 |
| Abrahamowicz, M; Duarte, EC; Fontes, CJ; Gyorkos, TW | 1 |
| Andrial, M; Looareesuwan, S; Pitisuttithum, P; Vanijanonta, S; Viravan, C; Wilairatana, P | 1 |
| Angus, B; Bates, I; Krishna, S; Kyle, DE; Pipitaporn, B; Pukrittayakamee, S; Suputtamongkol, Y; Udomsangpetch, R; White, NJ | 1 |
| Graninger, W; Looareesuwan, S; Rumpold, H; Schönthal, E; Vannaphan, S; Wagner, O; Wenisch, C; Wenisch, H; Wilairatana, P | 1 |
| Anh, TK; Batty, KT; Binh, TQ; Davis, TM; Ilett, KF; Thu, LT | 1 |
| Ezedinachi, E | 1 |
| Davis, TM; Johnston, WA; Manning, LS; Skinner, TS | 1 |
| Burgmann, H; Graninger, W; Looareesuwan, S; Vanijanonta, S; Viravan, C; Vorbach, H; Zedwitz-Liebenstein, K | 1 |
| Brittenham, GM; Gordeuk, VR; Looareesuwan, S; Meshnick, SR; Taylor, TE; Vannaphan, S; Wilairatana, P | 1 |
| Miller, LG; Panosian, CB | 1 |
| Batty, KT; Breheny, FX; Daly, F; Davis, TM; Ilett, KF; Kendall, PA; Singh, A | 1 |
| Andrial, M; Looareesuwan, S; Pitisuttithum, P; Ratanapong, Y; Vanijanonta, S; Wilairatana, P | 1 |
| Davis, TM; Edwards, GO; McCarthy, JS | 1 |
| Brockman, A; Gathmann, I; Gemperli, B; Looareesuwan, S; Luxemburger, C; Nosten, F; Royce, C; Slight, T; van Vugt, M; White, NJ | 1 |
| Attanath, P; Brewer, TG; Chanthavanich, P; Chongsuphajaisiddhi, T; Heppner, DG; Mookmanee, D; Phanuaksook, P; Poonpanich, Y; Prarinyanupharb, V; Sabchareon, A; Teja-Isavadharm, P | 1 |
| Batty, KT; Binh, TQ; Davis, TM; Hung, NC; Ilett, KF; Kim, NV; Mai, TX; Powell, SM; Thien, HV; Thu, LT; Tien, NP | 1 |
| Congpoung, K; Karbwang, J; Na-Bangchang, K; Thanavibul, A; Ubalee, R | 1 |
| Graninger, W; Looareesuwan, S; Parschalk, B; Vannapann, S; Wanaratana, V; Wenisch, C; Wernsdorfer, W; Wilairatana, P | 1 |
| Aikawa, M; Brittenham, G; Graninger, W; Looareesuwan, S; Vannaphan, S; Wanaratana, V; Wenisch, C; Wernsdorfer, WH; Wilairatana, P | 1 |
| Benakis, A; Halpaap, B; Kremsner, PG; Ndjave, M; Paris, M | 1 |
| Burgmann, H; El Menyawi, I; Knapp, S; Looareesuwan, S; Stoiser, B; Thalhammer, F | 1 |
| Chanyakhun, P; Palananth, C; Rooney, W; Sirichaisinthop, J; Thimasarn, K | 1 |
| Chongsuphajaisiddhi, T; Looareesuwan, S; Viriyavejakul, P; Wilairatana, P | 1 |
| Bunnag, D; Harinasuta, T; Kanda, T; Karbwang, J; Pungpak, S; Thimasarn, K | 1 |
| Chung, SY; Das, R; Oon, CT | 1 |
| Aung, S; Lwin, M; Shwe, T | 1 |
| Fungladda, W; Honrado, ER; Kamolratanakul, P; Karbwang, J; Kitayaporn, D; Masngammueng, R; Thimasarn, K | 1 |
| Bian, WX; Fu, YX; Li, GQ | 1 |
| Brockman, A; Chongsuphajaisiddhi, T; Luxemburger, C; Nosten, F; Phaipun, L; Price, R; van Vugt, M; White, N | 1 |
| Chongsuphajaisiddhi, T; Heppner, DG; Luxemburger, C; Nosten, F; Price, R; Simpson, JA; Teja-Isavatharm, P; Than, MM; White, NJ | 1 |
| Linnau, KF; Looaresuwan, S; Rumpold, H; Wenisch, C | 1 |
| de Vries, PJ; Ha, LD; Kager, PA; Khanh, NX; Koopmans, R; van Boxtel, CJ | 1 |
| Fungladda, W; Honrado, ER; Kamoiratanaku, P; Karbwang, J; Kitayaporn, D; Masngammueng, R; Thimasarn, K | 1 |
| Li, Y; Wu, YL | 1 |
| Looareesuwan, S; Wilairatana, P | 1 |
| Chongsuphajaisiddhi, T; Kham, A; Luxemburger, C; McGready, R; Nosten, F; Phaipun, L; Price, R; Simpson, J; ter Kuile, F; van Vugt, M; White, NJ | 1 |
| Heppner, DG; Kyle, DE; Laoboonchai, A; Sookto, P; Wernsdorfer, WH; Wimonwattrawatee, T; Wongsrichanalai, C | 1 |
| de Vries, PI; Ho, PL; Kager, PA; Le, NH; Le, TD; Nguyen, VN; Trinh, KA | 1 |
| Hills, F; Krudsood, S; Looareesuwan, S; Porter, RS; Sjostrom, L; Warrell, DA; Wilairatana, P | 1 |
| Aarons, L; Chongsuphajaisiddhi, T; Looareesuwan, S; Nosten, F; Price, R; Simpson, JA; Teja-Isavatharm, P; ter Kuile, F; White, NJ | 1 |
| Alloueche, A; Anyalebechi, C; Bojang, K; Coleman, R; Doherty, T; Duraisingh, M; Gosling, R; Greenwood, B; McAdam, K; Milligan, P; Olliaro, P; Pinder, M; Sadiq, A; Targett, G; Ude, JI; von Seidlein, L; Walraven, G; Warhurst, D | 1 |
| Dang, CT; Le, DC; Le, NB; Nguyen, BN; Pham, TL; Pham, TY | 1 |
| Chotivanich, KT; Ittarat, W; Looareesuwan, S; Udomsangpetch, R | 1 |
| Burgmann, H; Chullawichit, S; Daxböck, F; El-Menyawi, I; Graninger, W; Looareesuwan, S; Stoiser, B; Thalhammer, F | 1 |
| Bates, I; Navaratnam, V; Newton, P; Pukrittayakamee, S; Suputtamongkol, Y; Teja-Isavadharm, P; White, N | 1 |
| Angus, BJ; Htoo, SE; Looareesuwan, S; Mann, C; Nosten, F; Poletto, C; Price, RN; Simpson, JA; Van Vugt, M; White, NJ | 1 |
| Agbenyega, T; Angus, BJ; Baffoe-Bonnie, B; Bedu-Addo, G; Guyton, T; Krishna, S; Stacpoole, PW | 1 |
| Bussaratid, V; Chokejindachai, W; Hendriksen, C; Krudsood, S; Looareesuwan, S; Scheiwe, MW; Silachamroon, U; Viriyavejakul, P; Wilairatana, P | 1 |
| Aung, S; Lwin, M; Mar, KK; Shwe, T; Win, LL; Zaw, AK | 1 |
| Agrawal, JK; Chaturvedi, R; Mandal, AK; Pal, S; Singh, KK; Singh, SK; Sinha, SK | 1 |
| Sirichaisinthop, J; Thimasarn, K; Wongsrichanalai, C | 1 |
| Brittenham, G; Kreil, A; Looareesuwan, S; Peck-Radosavljevic, M; Wenisch, C | 1 |
| Angus, B; Chotivanich, K; Dondorp, A; Looareesuwan, S; Newbold, CI; Pukrittayakamee, S; Simpson, JA; Udomsangpetch, R; White, NJ; Williams, T | 1 |
| Brockman, A; Looareesuwan, S; Luxemburger, C; McGready, R; Nosten, F; Price, R; ter Kuile, F; Thway, KL; van Vugt, M; White, NJ | 1 |
| Ginsburg, H; Hoshen, MB; Na-Bangchang, K; Stein, WD | 1 |
| Chantharaksri, U; Dangdoungjai, J; Looareesuiwan, S; Pipitaporn, B; Sibmooh, N; Udomsangpetch, R; Wilairatana, P | 1 |
| Batty, KT; Binh, TQ; Davis, TM; Hung, NC; Ilett, KF; Phuong, HL; Phuong, VD; Powell, SM; Thien, HV | 1 |
| Marshall, E | 1 |
| Coleman, R; Doherty, T; Jawara, M; Targett, G; von Seidlein, L; Walraven, G | 1 |
| Coleman, R; Deen, J; Doherty, T; Drakeley, C; Jawara, M; Milligan, P; Pinder, M; Sutherland, C; Targett, G; von Seidlein, L; Walraven, G | 1 |
| Chalermrut, K; Krudsood, S; Phophak, N; Phumratanaprapin, W; Popa, C; Silachamroon, U; Singhasivanon, P; Wilairatana, P | 1 |
| Chotivanich, K; Farrar, J; Green, M; Looareesuwan, S; Mayxay, M; Newton, P; Nosten, F; Prakongpan, S; Proux, S; Rozendaal, J; Smithuis, F; White, NJ | 1 |
| Congpuong, K; Karwacki, JJ; Miller, RS; Pang, L; Sirichaisinthop, J; Thimasarn, K; Wongsrichanalai, C | 1 |
| Bockarie, MJ; Gbakima, AA; Sahr, F; Willoughby, VR | 1 |
| Genka, I; Hatabu, T; Kano, S; Kohno, S; Oka, S; Yamamoto, Y; Yasuoka, A; Yasuoka, C | 1 |
| Reithinger, R | 1 |
| Anstey, NM; Currie, BJ; Morris, PS; Saunders, JR; Suprianto, S; Tjitra, E | 1 |
| Anh, CV; Davis, TM; Giang, LT; Hang, NT; Hewitt, S; Quang, HH; Thoa, NT; Thuan, LK; Thuy, PT; Trung, TN; Tuan, NT | 1 |
| Angus, B; Keeratithakul, D; Newton, PN; Pukrittayakamee, S; Rasameesoraj, M; Suputtamongkol, Y; Teja-Isavadharm, P; White, NJ | 1 |
| Brewer, TG; Eamsila, C; Jongsakul, K; Keeratithakul, G; Kyle, DE; Li, Q; Luesutthiviboon, L; Sirisopana, N; Teja-Isavadharm, P; Watt, G | 1 |
| Bounyasong, S | 1 |
| Dejo, R; Gopinathan, VP; Jayraj, PM | 1 |
| Batty, KT; Binh, TQ; Davis, TM; Hung, NC; Ilett, KF; Phuong, HL; Powell, SM; Thu, le TA | 1 |
| Angus, BJ; Chanthapadith, K; Suputtamongkol, Y; Thaiaporn, I; White, NJ | 1 |
| Looareesuwan, S; Newton, PN; Nosten, F; Rasameesoroj, M; Ruangveerayuth, R; Siriyanonda, D; Slight, T; Suputtamongkol, Y; Teerapong, P; Teja-Isavadharm, P; van Vugt, M; White, NJ | 1 |
| Adjuik, M; Agnamey, P; Babiker, A; Borrmann, S; Brasseur, P; Cisse, M; Cobelens, F; Diallo, S; Faucher, JF; Garner, P; Gikunda, S; Kremsner, PG; Krishna, S; Lell, B; Loolpapit, M; Matsiegui, PB; Missinou, MA; Mwanza, J; Ntoumi, F; Olliaro, P; Osimbo, P; Rezbach, P; Some, E; Taylor, WR | 1 |
| Chotivanich, K; Looareesuwan, S; McGready, R; Newton, P; Proux, S; Pukrittayakamee, S; Udomsangpetch, R; White, NJ | 1 |
| Fan, B; Huang, Z; Ma, X; Wen, Y; Yang, J; Yang, Z; Zhao, W | 1 |
| Belsare, H; Patel, AB | 1 |
| Lalloo, D; Trevett, A | 1 |
| Arnold, K; Canfield, C; Charoenlarp, P; Kyle, D; Looareesuwan, S; Suntharasamai, P; Vanijanonta, S; Viravan, C; Webster, K; Wilairatana, P | 1 |
| Canfield, CJ; Charoenlarp, P; Kyle, DE; Looareesuwan, S; Vanijanonta, S; Viravan, C; Webster, HK; Wilairatana, P | 1 |
| Bunnag, D; Harinasuta, T; Karbwang, J; Looareesuwan, S; Viravan, C | 3 |
57 review(s) available for artesunic acid and Malaria, Falciparum
| Article | Year |
|---|---|
Clinical management of Plasmodium knowlesi malaria.
Topics: Antimalarials; Artesunate; Humans; Malaria; Malaria, Falciparum; Plasmodium knowlesi | 2021 |
Are national treatment guidelines for falciparum malaria in line with WHO recommendations and is antimalarial resistance taken into consideration? - A review of guidelines in non-endemic countries.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artesunate; Drug Resistance; Guidelines as Topic; Humans; Malaria, Falciparum; World Health Organization | 2022 |
Therapeutic efficacy of artemether-lumefantrine, artesunate-amodiaquine and dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in Sub-Saharan Africa: A systematic review and meta-analysis.
Topics: Africa South of the Sahara; Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Drug Combinations; Ethanolamines; Humans; Malaria; Malaria, Falciparum; Piperazines; Plasmodium falciparum; Quinolines | 2022 |
Drug-Drug Interactions of Artemisinin-Based Combination Therapies in Malaria Treatment: A Narrative Review of the Literature.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Humans; Malaria; Malaria, Falciparum | 2022 |
Updates in central nervous system malaria: literature review and considerations.
Topics: Adult; Antimalarials; Artesunate; Central Nervous System; Child; Humans; Malaria; Malaria, Falciparum; Plasmodium falciparum | 2022 |
Pyronaridine-artesunate for treating uncomplicated Plasmodium falciparum malaria.
Topics: Antimalarials; Artemisinins; Artesunate; Bilirubin; Child; Drug Combinations; Humans; Malaria, Falciparum; Naphthyridines | 2022 |
Comparative efficacy and safety of the artemisinin derivatives compared to quinine for treating severe malaria in children and adults: A systematic update of literature and network meta-analysis.
Topics: Adult; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Humans; Malaria, Cerebral; Malaria, Falciparum; Network Meta-Analysis; Quinine | 2022 |
Diagnosis, Treatment, and Prevention of Malaria in the US: A Review.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Resistance; Humans; Malaria; Malaria, Falciparum; Travel; Travel-Related Illness; United States | 2022 |
Efficacy of three anti-malarial regimens for uncomplicated Plasmodium falciparum malaria in Cambodia, 2009-2011: a randomized controlled trial and brief review.
Topics: Antimalarials; Artemisinins; Artesunate; Cambodia; Child, Preschool; Humans; Malaria, Falciparum; Mefloquine; Randomized Controlled Trials as Topic; Recurrence | 2022 |
Systematic review of artesunate pharmacokinetics: Implication for treatment of resistant malaria.
Topics: Administration, Intravenous; Administration, Oral; Antimalarials; Artemisinins; Artesunate; Asia, Southeastern; Drug Monitoring; Drug Resistance; Humans; Malaria; Malaria, Falciparum | 2019 |
An evaluation of rectal artesunate for the pre-hospital management of severe malaria.
Topics: Administration, Rectal; Africa South of the Sahara; Antimalarials; Artesunate; Child; Drug Monitoring; Emergency Medical Services; Female; Humans; Malaria, Falciparum; Randomized Controlled Trials as Topic; Severity of Illness Index; Treatment Outcome | 2020 |
Efficacy and tolerability of artemisinin-based and quinine-based treatments for uncomplicated falciparum malaria in pregnancy: a systematic review and individual patient data meta-analysis.
Topics: Amodiaquine; Anti-Bacterial Agents; Antimalarials; Artemisinins; Artesunate; Atovaquone; Clindamycin; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Mefloquine; Pregnancy; Pregnancy Complications, Parasitic; Proguanil; Pyrimethamine; Quinine; Quinolines; Sulfadoxine | 2020 |
Enhancing the antimalarial activity of artesunate.
Topics: Antimalarials; Artemisinins; Artesunate; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Plasmodium falciparum | 2020 |
The preclinical discovery and development of rectal artesunate for the treatment of malaria in young children: a review of the evidence.
Topics: Administration, Rectal; Age Factors; Animals; Antimalarials; Artesunate; Child; Child, Preschool; Drug Development; Drug Evaluation, Preclinical; Humans; Malaria, Falciparum; Plasmodium falciparum; Severity of Illness Index; Suppositories | 2021 |
Pyronaridine: An update of its pharmacological activities and mechanisms of action.
Topics: Animals; Antimalarials; Artesunate; Humans; Malaria, Falciparum; Naphthyridines; Plasmodium falciparum | 2021 |
Systematic analysis of direct antiglobulin test results in post-artesunate delayed haemolysis.
Topics: Adult; Antimalarials; Artesunate; Coombs Test; Female; Hemolysis; Humans; Malaria, Falciparum; Malaria, Vivax; Male; Middle Aged; Parasitemia; Young Adult | 2021 |
Delayed Hemolytic Anemia after Treatment with Artesunate: Case Report and Literature Review.
Topics: Adult; Anemia, Hemolytic; Antimalarials; Artesunate; Diagnosis, Differential; Female; Humans; Malaria, Falciparum; Time Factors; Treatment Outcome | 2019 |
Pyronaridine-artesunate for treating uncomplicated Plasmodium falciparum malaria.
Topics: Adult; Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child; Drug Combinations; Drug Therapy, Combination; Humans; Liver; Lumefantrine; Malaria, Falciparum; Mefloquine; Naphthyridines; Randomized Controlled Trials as Topic | 2019 |
[Severe and complicated malaria].
Topics: Adult; Anemia, Hemolytic; Antimalarials; Artesunate; Child; Female; France; Humans; Malaria; Malaria, Falciparum; Pregnancy; Severity of Illness Index | 2019 |
Artemether for severe malaria.
Topics: Adolescent; Adult; Africa; Age Factors; Antimalarials; Artemether; Artesunate; Asia; Child; Child, Preschool; Coma; Fever; Humans; Infant; Injections, Intramuscular; Malaria, Cerebral; Malaria, Falciparum; Oceania; Quinine; Randomized Controlled Trials as Topic; Treatment Outcome | 2019 |
Severe malaria: update on pathophysiology and treatment.
Topics: Administration, Intravenous; Antimalarials; Artesunate; Humans; Malaria, Falciparum; United States | 2019 |
Malaria.
Topics: Africa South of the Sahara; Amodiaquine; Animals; Anopheles; Antimalarials; Artemisinins; Artesunate; Asia, Southeastern; Chloroquine; Drug Administration Schedule; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Humans; Insecticide-Treated Bednets; Insecticides; Malaria; Malaria Vaccines; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Pregnancy; Pregnancy Complications, Infectious; Primary Prevention; Pyrimethamine; Quinine; Quinolines; Seasons; Sulfadoxine | 2014 |
Monitoring antimalarial drug efficacy in the Greater Mekong Subregion: an overview of in vivo results from 2008 to 2010.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Asia, Southeastern; Chloroquine; Directly Observed Therapy; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Parasitemia; Quinolines | 2013 |
Dihydroartemisinin-piperaquine for treating uncomplicated Plasmodium falciparum malaria.
Topics: Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Malaria, Falciparum; Mefloquine; Parasitemia; Quinolines; Randomized Controlled Trials as Topic | 2014 |
Artesunate plus pyronaridine for treating uncomplicated Plasmodium falciparum malaria.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Child; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Liver; Lumefantrine; Malaria, Falciparum; Mefloquine; Naphthyridines; Randomized Controlled Trials as Topic | 2014 |
A review of dihydroartemisinin as another gift from traditional Chinese medicine not only for malaria control but also for schistosomiasis control.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Drugs, Chinese Herbal; Female; Malaria, Falciparum; Mice; Praziquantel; Schistosomiasis japonica; Schistosomicides | 2014 |
Primaquine or other 8-aminoquinoline for reducing P. falciparum transmission.
Topics: Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Combinations; Glucosephosphate Dehydrogenase Deficiency; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Primaquine; Pyrimethamine; Quinine; Randomized Controlled Trials as Topic; Sulfadoxine | 2014 |
Artemether for severe malaria.
Topics: Adolescent; Adult; Africa; Antimalarials; Artemether; Artemisinins; Artesunate; Asia; Child; Child, Preschool; Humans; Infant; Injections, Intramuscular; Malaria, Cerebral; Malaria, Falciparum; Oceania; Quinine; Randomized Controlled Trials as Topic | 2014 |
Falsified antimalarials: a minireview.
Topics: Adult; Africa South of the Sahara; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Counterfeit Drugs; Fraud; Humans; Infant; Law Enforcement; Malaria, Falciparum; Plasmodium falciparum; Quality Control; Survival Analysis | 2015 |
Primaquine or other 8-aminoquinoline for reducing Plasmodium falciparum transmission.
Topics: Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Combinations; Glucosephosphate Dehydrogenase Deficiency; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Primaquine; Pyrimethamine; Quinine; Randomized Controlled Trials as Topic; Sulfadoxine | 2015 |
Management of severe paediatric malaria in resource-limited settings.
Topics: Africa South of the Sahara; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Clinical Trials as Topic; Developing Countries; Humans; Malaria, Falciparum; Quinine | 2015 |
The Treatment of Plasmodium knowlesi Malaria.
Topics: Antimalarials; Artemisinins; Artesunate; Asia, Southeastern; Chloroquine; Coinfection; Humans; Malaria; Malaria, Falciparum; Plasmodium knowlesi | 2017 |
Acute pancreatitis and subdural haematoma in a patient with severe falciparum malaria: case report and review of literature.
Topics: Adult; Animals; Anti-Bacterial Agents; Antimalarials; Artemisinins; Artesunate; Blood; Brain; Doxycycline; Hematoma, Subdural; Humans; Malaria, Falciparum; Male; Pancreatitis; Parasitemia; Plasmodium falciparum; Quinine; Radiography; Sesquiterpenes | 2008 |
Artemisinin-based combination therapy for treating uncomplicated malaria.
Topics: Antimalarials; Artemisinins; Artesunate; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Parasitemia; Pyrimethamine; Quinolines; Randomized Controlled Trials as Topic; Sulfadoxine | 2009 |
Artemisinin derivatives for treatment of uncomplicated Plasmodium falciparum malaria in Sudan: too early for too much hope.
Topics: Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Combinations; Drug Therapy, Combination; Humans; Malaria, Falciparum; Pyrimethamine; Sudan; Sulfadoxine; Treatment Failure | 2010 |
Antimalarial drug resistance of Plasmodium falciparum in India: changes over time and space.
Topics: Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Combinations; Drug Resistance; Geography; Humans; India; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Time Factors; Treatment Outcome | 2011 |
Azithromycin for treating uncomplicated malaria.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Atovaquone; Azithromycin; Chloroquine; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Proguanil; Pyrimethamine; Randomized Controlled Trials as Topic; Sulfadoxine; Treatment Failure | 2011 |
Artesunate: investigational drug for the treatment of severe falciparum malaria in Hawai'i.
Topics: Antimalarials; Artemisinins; Artesunate; Drugs, Investigational; Follow-Up Studies; Hawaii; Humans; Infusions, Intravenous; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Severity of Illness Index; Treatment Outcome | 2011 |
The pharmacogenetics of antimalaria artemisinin combination therapy.
Topics: Aminoquinolines; Antimalarials; Artemisinins; Artesunate; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2A6; Cytochrome P-450 CYP2C8; Cytochrome P-450 CYP3A; Drug Combinations; Drug Resistance; Ethanolamines; Evidence-Based Medicine; Fluorenes; Genetic Markers; Humans; Lumefantrine; Malaria, Falciparum; Mefloquine; Pharmacogenetics; Plasmodium falciparum; Polymorphism, Single Nucleotide | 2011 |
Primaquine for reducing Plasmodium falciparum transmission.
Topics: Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Combinations; Glucosephosphate Dehydrogenase Deficiency; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Primaquine; Pyrimethamine; Quinine; Randomized Controlled Trials as Topic; Sulfadoxine | 2012 |
Artesunate combinations for treatment of malaria: meta-analysis.
Topics: Adolescent; Adult; Africa; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Resistance; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Peru; Plasmodium falciparum; Randomized Controlled Trials as Topic; Sesquiterpenes; Thailand | 2004 |
Malaria: uncomplicated, caused by Plasmodium falciparum.
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Artesunate; Chloroquine; Dapsone; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Mefloquine; Proguanil; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 2005 |
Artesunate plus mefloquine versus mefloquine for treating uncomplicated malaria.
Topics: Antimalarials; Artemisinins; Artesunate; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Sesquiterpenes | 2005 |
Sulfadoxine-pyrimethamine plus artesunate versus sulfadoxine-pyrimethamine plus amodiaquine for treating uncomplicated malaria.
Topics: Amodiaquine; Artemisinins; Artesunate; Drug Combinations; Drug Therapy, Combination; Humans; Malaria, Falciparum; Pyrimethamine; Randomized Controlled Trials as Topic; Sesquiterpenes; Sulfadoxine | 2006 |
Artesunate, artemether or quinine in severe Plasmodium falciparum malaria?
Topics: Animals; Artemether; Artemisinins; Artesunate; Humans; Malaria, Falciparum; Quinine; Sesquiterpenes | 2007 |
The treatment of severe malaria.
Topics: Adult; Africa; Antimalarials; Artemisinins; Artesunate; Asia; Child; Child, Preschool; Female; Humans; Malaria, Falciparum; Pregnancy; Quinine; Randomized Controlled Trials as Topic; Sesquiterpenes; Suppositories | 2007 |
Artesunate-amodiaquine for the treatment of uncomplicated malaria.
Topics: Amodiaquine; Animals; Artemisinins; Artesunate; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Drugs, Investigational; Female; Follow-Up Studies; Humans; Malaria, Falciparum; Male; Maximum Tolerated Dose; Plasmodium falciparum; Randomized Controlled Trials as Topic; Sesquiterpenes; Severity of Illness Index; Treatment Outcome | 2007 |
Artesunate for the treatment of severe falciparum malaria.
Topics: Adult; Animals; Antimalarials; Artemisinins; Artesunate; Humans; Life Cycle Stages; Malaria, Falciparum; Male; Plasmodium falciparum; Practice Guidelines as Topic; Sesquiterpenes | 2008 |
Overview of clinical studies on artemisinin derivatives in Thailand.
Topics: Antimalarials; Antiprotozoal Agents; Artemether; Artemisinins; Artesunate; Clinical Trials as Topic; Drug Resistance; Humans; Malaria, Falciparum; Sesquiterpenes; Thailand | 1994 |
An overview of the clinical use of artemisinin and its derivatives in the treatment of falciparum malaria in Viet Nam.
Topics: Adolescent; Adult; Antimalarials; Antiprotozoal Agents; Artemether; Artemisinins; Artesunate; Clinical Trials as Topic; Double-Blind Method; Drug Resistance; Humans; Malaria, Falciparum; Middle Aged; Sesquiterpenes; Vietnam | 1994 |
Artesunate. A review of its pharmacology and therapeutic efficacy in the treatment of malaria.
Topics: Antimalarials; Artemisinins; Artesunate; Clinical Trials as Topic; Humans; Malaria, Falciparum; Sesquiterpenes | 1995 |
Artesunate suppositories: an effective treatment for severe falciparum malaria in rural areas.
Topics: Acute Disease; Antimalarials; Artemisinins; Artesunate; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Parasitemia; Rural Health; Sesquiterpenes; Suppositories | 1997 |
How Chinese scientists discovered qinghaosu (artemisinin) and developed its derivatives? What are the future perspectives?
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Drug Evaluation; Drug Resistance; Forecasting; Humans; Malaria, Falciparum; Medicine, Chinese Traditional; Sesquiterpenes | 1998 |
The rational use of qinghaosu and its derivatives: what is the future of new compounds?
Topics: Administration, Oral; Administration, Rectal; Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Drug and Narcotic Control; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Registries; Sesquiterpenes; Suppositories; Thailand | 1998 |
Adverse effects in patients with acute falciparum malaria treated with artemisinin derivatives.
Topics: Acute Disease; Antimalarials; Artemether; Artemisinins; Artesunate; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Sesquiterpenes | 1999 |
Drug resistant malaria on the Thai-Myanmar and Thai-Cambodian borders.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Cambodia; Drug Resistance; Humans; Malaria, Falciparum; Mefloquine; Myanmar; Plasmodium falciparum; Sesquiterpenes; Thailand | 2001 |
A new look at an old drug: artemesinin and qinghaosu.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Humans; Malaria, Cerebral; Malaria, Falciparum; Sesquiterpenes | 1992 |
288 trial(s) available for artesunic acid and Malaria, Falciparum
| Article | Year |
|---|---|
Effectiveness and safety of artesunate-amodiaquine versus artemether-lumefantrine for home-based treatment of uncomplicated Plasmodium falciparum malaria among children 6-120 months in Yaoundé, Cameroon: a randomized trial.
Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Cameroon; Child; Drug Combinations; Ethanolamines; Humans; Infant; Malaria, Falciparum; Plasmodium falciparum; Treatment Outcome | 2022 |
Overall and Gender-Specific Effects of Intermittent Preventive Treatment of Malaria with Artemisinin-Based Combination Therapies among Schoolchildren in Mali: A Three-Group Open Label Randomized Controlled Trial.
Topics: Amodiaquine; Anemia; Antimalarials; Artemisinins; Artesunate; Child; Drug Combinations; Drug Therapy, Combination; Female; Hemoglobins; Humans; Malaria; Malaria, Falciparum; Mali; Pyrimethamine; Sulfadoxine | 2022 |
Effectiveness of antimalarial drug combinations in treating concomitant urogenital schistosomiasis in malaria patients in Lambaréné, Gabon: A non-randomised event-monitoring study.
Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artesunate; Drug Combinations; Ethanolamines; Gabon; Humans; Malaria; Malaria, Falciparum; Schistosomiasis haematobia | 2022 |
Comparative effect of artemether-lumefantrine and artesunate-amodiaquine on gametocyte clearance in children with uncomplicated Plasmodium falciparum malaria in Madagascar.
Topics: Adolescent; Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artesunate; Child; Child, Preschool; Drug Combinations; Ethanolamines; Humans; Infant; Madagascar; Malaria, Falciparum; Plasmodium falciparum | 2022 |
Artesunate versus quinine: the controlled trials watershed.
Topics: Antimalarials; Artemisinins; Artesunate; Humans; Malaria, Falciparum; Quinine | 2023 |
Effectiveness and safety of intermittent preventive treatment with dihydroartemisinin-piperaquine or artesunate-amodiaquine for reducing malaria and related morbidities in schoolchildren in Tanzania: a randomised controlled trial.
Topics: Amodiaquine; Antimalarials; Artesunate; Child; COVID-19; Drug Combinations; Hemoglobins; Humans; Incidence; Malaria; Malaria, Falciparum; Quinolines; Tanzania | 2023 |
Therapeutic efficacy and safety of artesunate + amodiaquine and artemether + lumefantrine in treating uncomplicated Plasmodium falciparum malaria in children on the rainy south-east coast of Madagascar.
Topics: Amodiaquine; Artemether, Lumefantrine Drug Combination; Artesunate; Child; Humans; Madagascar; Malaria, Falciparum | 2023 |
Safety and efficacy of artesunate-amodiaquine combined with either methylene blue or primaquine in children with falciparum malaria in Burkina Faso: A randomized controlled trial.
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Burkina Faso; Child, Preschool; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Methylene Blue; Plasmodium falciparum; Primaquine; Treatment Outcome | 2019 |
Piperaquine concentration and malaria treatment outcomes in Ugandan children treated for severe malaria with intravenous Artesunate or quinine plus Dihydroartemisinin-Piperaquine.
Topics: Administration, Intravenous; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Female; Follow-Up Studies; Humans; Infant; Malaria, Falciparum; Male; Osmolar Concentration; Plasmodium falciparum; Quinine; Quinolines; Recurrence; Treatment Outcome; Uganda | 2019 |
In vivo/ex vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine as first-line treatment for uncomplicated falciparum malaria in children: an open label randomized controlled trial in Burkina Faso.
Topics: Adolescent; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Burkina Faso; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Humans; Infant; Inhibitory Concentration 50; Lumefantrine; Malaria, Falciparum; Male; Mass Drug Administration; Plasmodium falciparum; Treatment Failure; Treatment Outcome | 2020 |
Safety and parasite clearance of artemisinin-resistant Plasmodium falciparum infection: A pilot and a randomised volunteer infection study in Australia.
Topics: Adolescent; Adult; Animals; Anti-Infective Agents; Antimalarials; Artemisinins; Artesunate; Australia; Female; Headache; Healthy Volunteers; Humans; Malaria, Falciparum; Male; Nausea; Parasites; Pilot Projects; Plasmodium falciparum; Young Adult | 2020 |
Efficacy, Safety and Tolerability of Pyronaridine-artesunate in Asymptomatic Malaria-infected Individuals: a Randomized Controlled Trial.
Topics: Antimalarials; Artesunate; Drug Combinations; Humans; Malaria; Malaria, Falciparum; Naphthyridines; Plasmodium falciparum; Treatment Outcome | 2022 |
A randomized controlled trial of dihydroartemisinin-piperaquine, artesunate-mefloquine and extended artemether-lumefantrine treatments for malaria in pregnancy on the Thailand-Myanmar border.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Malaria; Malaria, Falciparum; Mefloquine; Myanmar; Pregnancy; Premature Birth; Quinolines; Thailand | 2021 |
Phase 2a, Open-Label, 4-Escalating-Dose, Randomized Multicenter Study Evaluating the Safety and Activity of Ferroquine (SSR97193) Plus Artesunate, versus Amodiaquine Plus Artesunate, in African Adult Men with Uncomplicated
Topics: Adult; Aged; Aged, 80 and over; Aminoquinolines; Amodiaquine; Antimalarials; Artemisinins; Artesunate; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ferrous Compounds; Gabon; Humans; Kenya; Malaria, Falciparum; Male; Metallocenes; Middle Aged | 2017 |
Post-treatment haemolysis in African children with hyperparasitaemic falciparum malaria; a randomized comparison of artesunate and quinine.
Topics: Administration, Intravenous; Adolescent; Anemia, Hemolytic; Antimalarials; Artemisinins; Artesunate; Blood Transfusion; Child; Child, Preschool; Democratic Republic of the Congo; Erythrocytes; Female; Hemolysis; Hospitalization; Humans; Infant; Malaria, Falciparum; Male; Quinine; Sepsis | 2017 |
Acetaminophen as a Renoprotective Adjunctive Treatment in Patients With Severe and Moderately Severe Falciparum Malaria: A Randomized, Controlled, Open-Label Trial.
Topics: Acetaminophen; Acute Kidney Injury; Adolescent; Adult; Analgesics, Non-Narcotic; Antimalarials; Area Under Curve; Artesunate; Female; Humans; Malaria, Falciparum; Male; Young Adult | 2018 |
Population pharmacokinetic and pharmacodynamic properties of artesunate in patients with artemisinin sensitive and resistant infections in Southern Myanmar.
Topics: Antimalarials; Artemisinins; Artesunate; Drug Resistance; Humans; Malaria, Falciparum; Myanmar; Plasmodium falciparum | 2018 |
Pyronaridine-artesunate and artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children: a randomized controlled non-inferiority trial.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artesunate; Child; Child, Preschool; Female; Humans; Infant; Kenya; Malaria, Falciparum; Male; Naphthyridines | 2018 |
Plasmodium falciparum gametocyte dynamics after pyronaridine-artesunate or artemether-lumefantrine treatment.
Topics: Adolescent; Antimalarials; Artemether, Lumefantrine Drug Combination; Artesunate; Child; Child, Preschool; Female; Humans; Infant; Kenya; Malaria, Falciparum; Male; Naphthyridines; Plasmodium falciparum; Reverse Transcriptase Polymerase Chain Reaction; Self-Sustained Sequence Replication | 2018 |
Efficacy of two artemisinin-based combinations for the treatment of malaria in pregnancy in India: a randomized controlled trial.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Drug Combinations; Female; Humans; Incidence; India; Intention to Treat Analysis; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Prevalence; Pyrimethamine; Sulfadoxine; Treatment Outcome; Young Adult | 2018 |
Assessment of parasite clearance following treatment of severe malaria with intravenous artesunate in Ugandan children enrolled in a randomized controlled clinical trial.
Topics: Administration, Intravenous; Antimalarials; Artesunate; Child, Preschool; Female; Humans; Infant; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum; Uganda | 2018 |
Population pharmacokinetics and pharmacodynamics of the artesunate-mefloquine fixed dose combination for the treatment of uncomplicated falciparum malaria in African children.
Topics: Antimalarials; Artesunate; Child, Preschool; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Infant; Kenya; Malaria, Falciparum; Male; Mefloquine; Prospective Studies; Recurrence | 2019 |
Contribution of Functional Antimalarial Immunity to Measures of Parasite Clearance in Therapeutic Efficacy Studies of Artemisinin Derivatives.
Topics: Adolescent; Adult; Aged; Antibodies, Protozoan; Antigens, Protozoan; Antimalarials; Artesunate; Child; Child, Preschool; Drug Resistance, Microbial; Erythrocytes; Female; Humans; Immunity, Innate; Immunoglobulin G; Infant; Malaria, Falciparum; Male; Merozoites; Middle Aged; Parasitemia; Phagocytosis; Plasmodium falciparum; Protozoan Proteins; Seroepidemiologic Studies; Treatment Outcome; Young Adult | 2019 |
Pyronaridine-artesunate Efficacy and Safety in Uncomplicated Plasmodium falciparum Malaria in Areas of Artemisinin-resistant Falciparum in Viet Nam (2017-2018).
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Child; Drug Combinations; Humans; Malaria, Falciparum; Naphthyridines; Plasmodium falciparum; Prospective Studies; Vietnam | 2020 |
Comparative evaluation of efficacy and safety of artesunate-lumefantrine vs. artemether-lumefantrine fixed-dose combination in the treatment of uncomplicated Plasmodium falciparum malaria.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Double-Blind Method; Drug Combinations; Ethanolamines; Female; Fever; Fluorenes; Humans; India; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Parasite Load; Plasmodium falciparum; Time Factors; Treatment Outcome; Young Adult | 2013 |
Reduced susceptibility of Plasmodium falciparum to artesunate in southern Myanmar.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Cambodia; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Myanmar; Plasmodium falciparum | 2013 |
A clinical and molecular study of artesunate + sulphadoxine-pyrimethamine in three districts of central and eastern India.
Topics: Adolescent; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Endemic Diseases; Female; Humans; Malaria, Falciparum; Male; Plasmodium falciparum; Point Mutation; Prevalence; Prospective Studies; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Outcome | 2013 |
Safety, efficacy and population pharmacokinetics of fixed-dose combination of artesunate-mefloquine in the treatment of acute uncomplicated Plasmodium falciparum malaria in India.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Demography; Drug Therapy, Combination; Endemic Diseases; Female; Humans; India; Kaplan-Meier Estimate; Malaria, Falciparum; Male; Mefloquine; Parasitemia; Plasmodium falciparum; Treatment Outcome; Young Adult | 2013 |
Pharmacokinetics of artesunate alone and in combination with sulfadoxine/pyrimethamine in healthy Sudanese volunteers.
Topics: Administration, Oral; Adult; Antimalarials; Artemisinins; Artesunate; Cross-Over Studies; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Plasmodium falciparum; Pyrimethamine; Sudan; Sulfadoxine; Volunteers; Young Adult | 2014 |
Comparison of artesunate and quinine in the treatment of severe Plasmodium falciparum malaria at Kassala hospital, Sudan.
Topics: Administration, Intravenous; Adolescent; Adult; Anemia; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Coma; Female; Hospitals; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Male; Middle Aged; Parasitemia; Quinine; Sudan; Treatment Outcome; Young Adult | 2014 |
Population pharmacokinetics of mefloquine, administered as a fixed-dose combination of artesunate-mefloquine in Indian patients for the treatment of acute uncomplicated Plasmodium falciparum malaria.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Drug Combinations; Female; Humans; India; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Treatment Outcome; Young Adult | 2014 |
Pharmacokinetics of co-formulated mefloquine and artesunate in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum infection in Burkina Faso.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Burkina Faso; Drug Combinations; Female; Humans; Malaria, Falciparum; Mefloquine; Plasma; Pregnancy; Pregnancy Complications, Infectious; Young Adult | 2014 |
Pharmacokinetic evaluation of intravenous artesunate in adults with uncomplicated falciparum malaria in Kenya: a phase II study.
Topics: Activation, Metabolic; Adult; Aged; Antimalarials; Artemisinins; Artesunate; Atovaquone; Chromatography, Liquid; Drug Combinations; Drug Compounding; Drug Monitoring; Female; Half-Life; Humans; Infusions, Intravenous; Kenya; Malaria, Falciparum; Male; Mass Spectrometry; Middle Aged; Proguanil; Reticulocytes; Young Adult | 2014 |
Efficacy and safety of triple combination therapy with artesunate-amodiaquine-methylene blue for falciparum malaria in children: a randomized controlled trial in Burkina Faso.
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Burkina Faso; Child, Preschool; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Infant; Malaria, Falciparum; Male; Methylene Blue; Microscopy; Plasmodium falciparum; Polymerase Chain Reaction; Treatment Outcome | 2015 |
Population pharmacokinetics of orally administered mefloquine in healthy volunteers and patients with uncomplicated Plasmodium falciparum malaria.
Topics: Administration, Oral; Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Cross-Over Studies; Female; Healthy Volunteers; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Monte Carlo Method; Plasma; Young Adult | 2015 |
Pharmacokinetic interactions between primaquine and pyronaridine-artesunate in healthy adult Thai subjects.
Topics: Administration, Oral; Adult; Antimalarials; Artemisinins; Artesunate; Cross-Over Studies; Drug Interactions; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Malaria, Vivax; Male; Middle Aged; Naphthyridines; Primaquine; Thailand; Young Adult | 2015 |
Fixed dose artesunate amodiaquine - a phase IIb, randomized comparative trial with non-fixed artesunate amodiaquine.
Topics: Adolescent; Adult; Amodiaquine; Antimalarials; Artemisinins; Artesunate; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Kenya; Malaria, Falciparum; Male; Middle Aged; Treatment Outcome; Young Adult | 2014 |
Validation and pharmacokinetic application of a high-performance liquid chromatographic technique for determining the concentrations of amodiaquine and its metabolite in plasma of patients treated with oral fixed-dose amodiaquine-artesunate combination in
Topics: Administration, Oral; Adult; Amodiaquine; Antimalarials; Artemisinins; Artesunate; Chromatography, High Pressure Liquid; Drug Combinations; Female; Humans; Malaria; Malaria, Falciparum; Male; Nigeria; Young Adult | 2015 |
An operational comparative study of quinine and artesunate for the treatment of severe malaria in hospitals and health centres in the Democratic Republic of Congo: the MATIAS study.
Topics: Adolescent; Adult; Ambulatory Care Facilities; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Democratic Republic of the Congo; Female; Hospitals; Humans; Infant; Injections, Intravenous; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Quinine; Young Adult | 2015 |
Ferroquine and artesunate in African adults and children with Plasmodium falciparum malaria: a phase 2, multicentre, randomised, double-blind, dose-ranging, non-inferiority study.
Topics: Adolescent; Adult; Aged; Aminoquinolines; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Ferrous Compounds; Humans; Malaria, Falciparum; Male; Metallocenes; Middle Aged; Plasmodium falciparum; Treatment Outcome | 2015 |
A randomized trial of the efficacy of artesunate and three quinine regimens in the treatment of severe malaria in children at the Ebolowa Regional Hospital, Cameroon.
Topics: Administration, Intravenous; Administration, Oral; Adolescent; Antimalarials; Artemisinins; Artesunate; Cameroon; Child; Child, Preschool; Female; Hospitals; Humans; Infant; Malaria, Falciparum; Male; Quinine; Treatment Outcome | 2015 |
Population Pharmacokinetics of Pyronaridine in Pediatric Malaria Patients.
Topics: Adolescent; Antimalarials; Area Under Curve; Artemisinins; Artesunate; Child; Child, Preschool; Female; Humans; Infant; Malaria; Malaria, Falciparum; Malaria, Vivax; Male; Models, Theoretical; Naphthyridines | 2015 |
Intramuscular Artesunate for Severe Malaria in African Children: A Multicenter Randomized Controlled Trial.
Topics: Africa; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Infant; Injections, Intramuscular; Malaria, Falciparum; Male; Severity of Illness Index | 2016 |
Gametocyte clearance dynamics following oral artesunate treatment of uncomplicated falciparum malaria in Malian children.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Carrier State; Child; Child, Preschool; Drug Resistance; Female; Germ Cells; Humans; Infant; Malaria, Falciparum; Male; Mali; Parasitemia; Plasmodium falciparum; Prospective Studies; Single-Blind Method | 2016 |
Clinical trials of artesunate plus sulfadoxine-pyrimethamine for Plasmodium falciparum malaria in Afghanistan: maintained efficacy a decade after introduction.
Topics: Adolescent; Adult; Afghanistan; Aged; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Clinical Trials as Topic; Drug Resistance; Female; Humans; Infant; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome; Young Adult | 2016 |
No Clinical or Molecular Evidence of Plasmodium falciparum Resistance to Artesunate-Mefloquine in Northwestern Brazil.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; Artesunate; Brazil; Child; Child, Preschool; DNA, Protozoan; Dose-Response Relationship, Drug; Drug Combinations; Fever; Follow-Up Studies; Humans; Malaria, Falciparum; Mefloquine; Middle Aged; Multidrug Resistance-Associated Proteins; Parasitemia; Plasmodium falciparum; Treatment Outcome; Young Adult | 2016 |
In Vivo Efficacy and Tolerability of Artesunate-Azithromycin for the Treatment of Falciparum Malaria in Vietnam.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; Artesunate; Azithromycin; Child; Child, Preschool; Drug Combinations; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Pilot Projects; Plasmodium falciparum; Pregnancy; Vietnam; Young Adult | 2016 |
No Reduction in Hemoglobin Level in Severe Plasmodium falciparum Malaria Treated with Artesunate in Central Sudan.
Topics: Anemia; Antimalarials; Artemisinins; Artesunate; Biomarkers; Child; Child, Preschool; Drug Administration Schedule; Female; Follow-Up Studies; Hemoglobins; Humans; Infant; Injections, Intravenous; Malaria, Falciparum; Male; Quinine; Severity of Illness Index; Sudan; Treatment Outcome | 2017 |
Comparison of artesunate-mefloquine and artemether-lumefantrine fixed-dose combinations for treatment of uncomplicated Plasmodium falciparum malaria in children younger than 5 years in sub-Saharan Africa: a randomised, multicentre, phase 4 trial.
Topics: Africa South of the Sahara; Antimalarials; Artemether; Artemisinins; Artesunate; Child, Preschool; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Mefloquine; Patient Safety; Polymerase Chain Reaction | 2016 |
Dysregulation of angiopoietin-1 plays a mechanistic role in the pathogenesis of cerebral malaria.
Topics: Adenoviridae; Angiopoietin-1; Animals; Antimalarials; Artemisinins; Artesunate; Blood-Brain Barrier; Child, Preschool; Disease Models, Animal; Disease Susceptibility; Endothelial Cells; Female; Gene Deletion; Humans; Infant; Kaplan-Meier Estimate; Kinetics; Malaria, Cerebral; Malaria, Falciparum; Male; Mice, Inbred C57BL; Phenotype; Plasmodium falciparum; Receptor, TIE-2; Recombinant Proteins; Survival Analysis; Treatment Outcome; Uganda | 2016 |
Economic evaluation of artesunate and three quinine regimens in the treatment of severe malaria in children at the Ebolowa Regional Hospital-Cameroon: a cost analysis.
Topics: Adolescent; Antimalarials; Artemisinins; Artesunate; Cameroon; Child; Child, Preschool; Costs and Cost Analysis; Female; Health Expenditures; Hospitals; Humans; Infant; Malaria, Falciparum; Male; Quinine | 2016 |
Safety and tolerability of combination antimalarial therapies for uncomplicated falciparum malaria in Ugandan children.
Topics: Amodiaquine; Anorexia; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Infant; Longitudinal Studies; Malaria, Falciparum; Muscle Weakness; Pyrimethamine; Single-Blind Method; Sulfadoxine; Uganda | 2008 |
Gametocyte clearance in uncomplicated and severe Plasmodium falciparum malaria after artesunate-mefloquine treatment in Thailand.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Drug Evaluation; Drug Therapy, Combination; Female; Follow-Up Studies; Germ Cells; Humans; Malaria, Falciparum; Male; Mefloquine; Plasmodium falciparum; Severity of Illness Index; Thailand; Treatment Outcome | 2008 |
Efficacy of Artequick versus artesunate-mefloquine in the treatment of acute uncomplicated falciparum malaria in Thailand.
Topics: Acute Disease; Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Drug Combinations; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Primaquine; Prospective Studies; Quinolines; Thailand; Treatment Outcome | 2008 |
Effects of artesunate-cotrimoxazole and amodiaquine-artesunate against asexual and sexual stages of Plasmodium falciparum malaria in Nigerian children.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Humans; Infant; Life Cycle Stages; Malaria, Falciparum; Male; Nigeria; Plasmodium falciparum; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 2008 |
[Gametocytemia in falciparum malaria treated with amodiaquine or artesunate].
Topics: Adolescent; Adult; Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Colombia; Drug Combinations; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Parasitemia; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Failure; Treatment Outcome | 2008 |
Effect of concomitant artesunate administration and cytochrome P4502C8 polymorphisms on the pharmacokinetics of amodiaquine in Ghanaian children with uncomplicated malaria.
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Aryl Hydrocarbon Hydroxylases; Child; Child, Preschool; Cytochrome P-450 CYP2C8; Drug Therapy, Combination; Female; Ghana; Humans; Malaria, Falciparum; Male; Polymorphism, Genetic; Treatment Outcome | 2008 |
A randomized, comparative study of supervised and unsupervised artesunate-amodiaquine, for the treatment of uncomplicated malaria in Ghana.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Therapy, Combination; Female; Ghana; Humans; Infant; Malaria, Falciparum; Male; Plasmodium falciparum; Statistics as Topic; Treatment Outcome | 2008 |
A randomized trial of artesunate-mefloquine versus artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Mali.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Base Sequence; DNA Primers; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Mali; Mefloquine; Plasmodium falciparum; Polymerase Chain Reaction; Treatment Outcome | 2008 |
Effects of amodiaquine, artesunate, and artesunate-amodiaquine on Plasmodium falciparum malaria-associated anaemia in children.
Topics: Amodiaquine; Anemia; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Nigeria; Treatment Outcome | 2009 |
Dosing accuracy of artesunate and amodiaquine as treatment for falciparum malaria in Casamance, Senegal.
Topics: Adolescent; Adult; Amodiaquine; Antimalarials; Artemisinins; Artesunate; Body Weight; Child; Child, Preschool; Drug Administration Schedule; Drug Combinations; Female; Humans; Malaria, Falciparum; Male; Severity of Illness Index; Treatment Outcome | 2009 |
dhfr and dhps genotype and sulfadoxine-pyrimethamine treatment failure in children with falciparum malaria in the Democratic Republic of Congo.
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Democratic Republic of the Congo; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Genetic Markers; Genotype; Humans; Infant; Malaria, Falciparum; Male; Point Mutation; Pyrimethamine; Rural Health; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Failure | 2008 |
Pre-referral rectal artesunate to prevent death and disability in severe malaria: a placebo-controlled trial.
Topics: Administration, Rectal; Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Disabled Persons; Female; Humans; Infant; Malaria, Falciparum; Malaria, Vivax; Male; Placebos; Rural Health Services; Suppositories; Young Adult | 2009 |
A trial of combination antimalarial therapies in children from Papua New Guinea.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Child, Preschool; Chloroquine; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Kaplan-Meier Estimate; Lumefantrine; Malaria, Falciparum; Malaria, Vivax; Male; Proportional Hazards Models; Pyrimethamine; Quinolines; Recurrence; Sulfadoxine | 2008 |
High risk of severe anaemia after chlorproguanil-dapsone+artesunate antimalarial treatment in patients with G6PD (A-) deficiency.
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Dapsone; Drug Combinations; Drug Therapy, Combination; Female; Glucosephosphate Dehydrogenase Deficiency; Humans; Infant; Malaria, Falciparum; Male; Oxidants; Polymorphism, Genetic; Proguanil; Pyrimethamine; Sulfadoxine | 2008 |
N-acetylcysteine as adjunctive treatment in severe malaria: a randomized, double-blinded placebo-controlled clinical trial.
Topics: Acetylcysteine; Adult; Antimalarials; Artemisinins; Artesunate; Bangladesh; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Placebos; Thailand; Treatment Outcome | 2009 |
[Artesunate in interrupting the transmission of Plasmodium falciparum].
Topics: Adolescent; Adult; Animals; Anopheles; Antimalarials; Artemisinins; Artesunate; Child; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Young Adult | 2008 |
Submicroscopic gametocytes and the transmission of antifolate-resistant Plasmodium falciparum in Western Kenya.
Topics: Animals; Artemisinins; Artesunate; Carrier State; Child, Preschool; Drug Combinations; Drug Resistance; Folic Acid Antagonists; Genotype; Germ Cells; Humans; Infant; Kenya; Malaria, Falciparum; Mutation; Parasitemia; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2009 |
Extended high efficacy of the combination sulphadoxine-pyrimethamine with artesunate in children with uncomplicated falciparum malaria on the Benin coast, West Africa.
Topics: Analysis of Variance; Animals; Antimalarials; Artemisinins; Artesunate; Benin; Child, Preschool; Cohort Studies; Drug Combinations; Female; Fever; Follow-Up Studies; Genotype; Humans; Infant; Kaplan-Meier Estimate; Malaria, Falciparum; Male; Plasmodium falciparum; Polymerase Chain Reaction; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2009 |
A randomised controlled trial of artemether-lumefantrine versus artesunate for uncomplicated plasmodium falciparum treatment in pregnancy.
Topics: Adult; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Infant, Newborn; Lumefantrine; Malaria, Falciparum; Parasitic Sensitivity Tests; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Thailand; Young Adult | 2008 |
Mefloquine pharmacokinetics and mefloquine-artesunate effectiveness in Peruvian patients with uncomplicated Plasmodium falciparum malaria.
Topics: Administration, Oral; Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Chromatography, High Pressure Liquid; Drug Administration Schedule; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitemia; Peru; Plasmodium falciparum; Time Factors; Treatment Outcome; Young Adult | 2009 |
Efficacy and safety of a fixed dose artesunate-sulphamethoxypyrazine-pyrimethamine compared to artemether-lumefantrine for the treatment of uncomplicated falciparum malaria across Africa: a randomized multi-centre trial.
Topics: Animals; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child; Child, Preschool; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Malaria, Falciparum; Male; Plasmodium falciparum; Pregnancy; Prospective Studies; Pyrimethamine; Sulfalene; Tablets; Treatment Outcome | 2009 |
Strong gametocytocidal effect of methylene blue-based combination therapy against falciparum malaria: a randomised controlled trial.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Burkina Faso; Child; Drug Therapy, Combination; Germ Cells; Humans; Malaria, Falciparum; Methylene Blue; Plasmodium falciparum; Treatment Outcome | 2009 |
Comparison of sulfadoxine-pyrimethamine, unsupervised artemether-lumefantrine, and unsupervised artesunate-amodiaquine fixed-dose formulation for uncomplicated plasmodium falciparum malaria in Benin: a randomized effectiveness noninferiority trial.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Benin; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Polymerase Chain Reaction; Pyrimethamine; Sulfadoxine | 2009 |
Intermittent preventive treatment using artemisinin-based combination therapy reduces malaria morbidity among school-aged children in Mali.
Topics: Adolescent; Anemia; Artemisinins; Artesunate; Child; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mali; Parasitemia; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2009 |
Pharmacokinetics of chlorproguanil, dapsone, artesunate and their major metabolites in patients during treatment of acute uncomplicated Plasmodium falciparum malaria.
Topics: Adult; Antimalarials; Area Under Curve; Artemisinins; Artesunate; Dapsone; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Drug Therapy, Combination; Female; Gambia; Humans; Malaria, Falciparum; Malawi; Male; Middle Aged; Parasitic Sensitivity Tests; Proguanil; Time Factors | 2009 |
Efficacy of sulphadoxine-pyrimethamine with or without artesunate for the treatment of uncomplicated Plasmodium falciparum malaria in southern Mozambique: a randomized controlled trial.
Topics: Antimalarials; Artemisinins; Artesunate; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Malaria, Falciparum; Male; Mozambique; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Genetic; Proportional Hazards Models; Pyrimethamine; Sulfadoxine; Time Factors; Treatment Outcome | 2009 |
Artemisinin resistance in Plasmodium falciparum malaria.
Topics: Administration, Oral; Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Drug Resistance; Drug Therapy, Combination; Follow-Up Studies; Humans; Hypoxanthine; Inhibitory Concentration 50; Malaria, Falciparum; Mefloquine; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymorphism, Genetic; Recurrence; Young Adult | 2009 |
Varying efficacy of artesunate+amodiaquine and artesunate+sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in the Democratic Republic of Congo: a report of two in-vivo studies.
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Democratic Republic of the Congo; Drug Combinations; Female; Humans; Infant; Malaria, Falciparum; Male; Pyrimethamine; Sulfadoxine; Treatment Failure; Treatment Outcome | 2009 |
Chlorproguanil-dapsone-artesunate versus artemether-lumefantrine: a randomized, double-blind phase III trial in African children and adolescents with uncomplicated Plasmodium falciparum malaria.
Topics: Adolescent; Africa; Antimalarials; Artemisinins; Artesunate; Child; Dapsone; Double-Blind Method; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Patient Compliance; Proguanil; Treatment Outcome | 2009 |
The neurological assessment in young children treated with artesunate monotherapy or artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Asia; Asia, Southeastern; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Nervous System Diseases; Neurologic Examination | 2009 |
Ursodeoxycholic acid and artesunate in the treatment of severe falciparum malaria patients with jaundice.
Topics: Administration, Oral; Adult; Alanine Transaminase; Alkaline Phosphatase; Antimalarials; Artemisinins; Artesunate; Aspartate Aminotransferases; Bilirubin; Biomarkers; Cholagogues and Choleretics; Drug Therapy, Combination; Female; Humans; Jaundice; Liver Function Tests; Malaria, Falciparum; Male; Prospective Studies; Severity of Illness Index; Treatment Outcome; Ursodeoxycholic Acid; Young Adult | 2010 |
Selection of parasites with diminished drug susceptibility by amodiaquine-containing antimalarial regimens in Uganda.
Topics: Amino Acid Sequence; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child; Child, Preschool; Cohort Studies; Drug Combinations; Drug Resistance; Ethanolamines; Fluorenes; Humans; Infant; Malaria, Falciparum; Molecular Sequence Data; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymorphism, Genetic; Pyrimethamine; Sequence Alignment; Sulfadoxine; Uganda | 2009 |
Chlorproguanil-dapsone-artesunate versus chlorproguanil-dapsone: a randomized, double-blind, phase III trial in African children, adolescents, and adults with uncomplicated Plasmodium falciparum malaria.
Topics: Adolescent; Adult; Africa South of the Sahara; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Dapsone; Double-Blind Method; Drug Therapy, Combination; Female; Glycogen Storage Disease Type I; Hemolysis; Humans; Malaria, Falciparum; Male; Plasmodium falciparum; Proguanil; Time Factors | 2009 |
Therapeutic efficacy and effects of artesunate-mefloquine and mefloquine alone on malaria-associated anemia in children with uncomplicated Plasmodium falciparum malaria in southwest Nigeria.
Topics: Anemia; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Therapy, Combination; Hematocrit; Humans; Infant; Malaria, Falciparum; Mefloquine; Nigeria; Treatment Failure | 2009 |
A randomized trial of artesunate mefloquine versus artemether lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Senegalese children.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Base Sequence; Child; Child, Preschool; DNA Primers; Female; Humans; Malaria, Falciparum; Male; Polymerase Chain Reaction | 2010 |
[Therapeutic efficacy of a regimen of artesunate-mefloquine-primaquine treatment for Plasmodium falciparum malaria and treatment effects on gametocytic development].
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Child; Drug Resistance; Drug Therapy, Combination; Female; Fever; Germ Cells; Humans; Malaria, Falciparum; Male; Mefloquine; Parasitemia; Patient Compliance; Pilot Projects; Plasmodium falciparum; Primaquine; Treatment Outcome; Young Adult | 2009 |
In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individuals.
Topics: Anemia; Anti-Infective Agents; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Follow-Up Studies; Glucosephosphate Dehydrogenase; Glucosephosphate Dehydrogenase Deficiency; Hemoglobins; Hemolysis; Humans; Infant; Malaria, Falciparum; Multivariate Analysis; Prevalence; Primaquine; Pyrimethamine; Regression Analysis; Risk Factors; Sulfadoxine; Tanzania | 2010 |
The effect of point mutations in dihydrofolate reductase genes and multidrug resistance gene 1-86 on treatment of falciparum malaria in Sudan.
Topics: Alleles; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Genes, MDR; Humans; Infant; Malaria, Falciparum; Male; Point Mutation; Prevalence; Pyrimethamine; Sudan; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Outcome | 2010 |
Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, and praziquantel against Schistosoma haematobium: randomized, exploratory open-label trial.
Topics: Abdominal Pain; Animals; Anthelmintics; Artemisinins; Artesunate; Child; Drug Therapy, Combination; Female; Humans; Incidence; Malaria, Falciparum; Male; Mefloquine; Parasite Egg Count; Plasmodium falciparum; Praziquantel; Schistosoma haematobium; Schistosomiasis haematobia; Treatment Outcome | 2010 |
Efficacy and safety of a new pediatric artesunate-mefloquine drug formulation for the treatment of uncomplicated falciparum malaria in Gabon.
Topics: Administration, Oral; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Developing Countries; Drug Combinations; Female; Gabon; Humans; Malaria, Falciparum; Male; Mefloquine | 2010 |
Randomized controlled trial of artesunate or artemether in Vietnamese adults with severe falciparum malaria.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemether; Artemisinins; Artesunate; Cause of Death; Double-Blind Method; Female; Humans; Injections, Intramuscular; Kaplan-Meier Estimate; Logistic Models; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Severity of Illness Index; Treatment Outcome; Vietnam; Young Adult | 2010 |
Efficacy and safety of a fixed-dose oral combination of pyronaridine-artesunate compared with artemether-lumefantrine in children and adults with uncomplicated Plasmodium falciparum malaria: a randomised non-inferiority trial.
Topics: Adolescent; Adult; Africa; Antimalarials; Artemether; Artemisinins; Artesunate; Asia; Child; Child, Preschool; Double-Blind Method; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Naphthyridines; Treatment Outcome; Young Adult | 2010 |
Tolerability and efficacy of a pediatric granule formulation of artesunate-mefloquine in young children from Cameroon with uncomplicated falciparum malaria.
Topics: Antimalarials; Artemisinins; Artesunate; Cameroon; Child; Child, Preschool; Dosage Forms; Drug Combinations; Female; Humans; Infant; Malaria, Falciparum; Male; Mefloquine | 2010 |
New fixed-dose artesunate-mefloquine formulation against multidrug-resistant Plasmodium falciparum in adults: a comparative phase IIb safety and pharmacokinetic study with standard-dose nonfixed artesunate plus mefloquine.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; Artesunate; Drug Resistance, Multiple; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Treatment Outcome; Young Adult | 2010 |
Azithromycin combination therapy for the treatment of uncomplicated falciparum malaria in Bangladesh: an open-label randomized, controlled clinical trial.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Azithromycin; Bangladesh; Child; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Parasitemia; Time Factors; Treatment Outcome; Young Adult | 2010 |
Intravenous ibuprofen (IV-ibuprofen) controls fever effectively in adults with acute uncomplicated Plasmodium falciparum malaria but prolongs parasitemia.
Topics: Acute Disease; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Double-Blind Method; Drug Therapy, Combination; Fever; Humans; Ibuprofen; Injections, Intravenous; Malaria, Falciparum; Mefloquine; Parasitemia; Plasmodium falciparum; Treatment Outcome | 2010 |
Use of area under the curve to evaluate the effects of antimalarial drugs on malaria-associated anemia after treatment.
Topics: Amodiaquine; Anemia; Antimalarials; Area Under Curve; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Ethanolamines; Female; Fluorenes; Hematocrit; Humans; Infant; Malaria; Malaria, Falciparum; Male; Mefloquine; Nigeria; Plasmodium falciparum | 2011 |
An open-label, randomised study of dihydroartemisinin-piperaquine versus artesunate-mefloquine for falciparum malaria in Asia.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; Artesunate; Asia; Child; Child, Preschool; Female; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Quinolines; Young Adult | 2010 |
Comparative study of efficacy of artesunate plus cotrimoxazole and artesunate plus chloroquine in the treatment of malaria in Nigerian children: a preliminary report.
Topics: Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Nigeria; Plasmodium falciparum; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 2010 |
Comparison of artesunate and quinine in the treatment of Sudanese children with severe Plasmodium falciparum malaria.
Topics: Antimalarials; Artemisinins; Artesunate; Child, Preschool; Female; Fever; Humans; Infusions, Intravenous; Malaria, Falciparum; Male; Plasmodium falciparum; Quinine; Sudan; Treatment Outcome | 2010 |
Artesunate-mefloquine combination therapy in acute Plasmodium falciparum malaria in young children: a field study regarding neurological and neuropsychiatric safety.
Topics: Africa; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Mental Disorders; Nervous System Diseases; Plasmodium falciparum | 2010 |
Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial.
Topics: Africa South of the Sahara; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Female; Humans; Infant; Kaplan-Meier Estimate; Malaria, Falciparum; Male; Quinine; Survival Rate | 2010 |
A phase III, randomized, non-inferiority trial to assess the efficacy and safety of dihydroartemisinin-piperaquine in comparison with artesunate-mefloquine in patients with uncomplicated Plasmodium falciparum malaria in southern Laos.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Laos; Malaria, Falciparum; Male; Mefloquine; Quinolines; Young Adult | 2010 |
An open randomized clinical trial in comparing two artesunate-based combination treatments on Plasmodium falciparum malaria in Nigerian children: artesunate/sulphamethoxypyrazine/pyrimethamine (fixed dose over 24 hours) versus artesunate/amodiaquine (fixe
Topics: Adolescent; Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Nigeria; Pyrimethamine; Sulfalene; Time Factors; Treatment Outcome | 2010 |
Artesunate/mefloquine paediatric formulation vs. artemether/lumefantrine for the treatment of uncomplicated Plasmodium falciparum in Anonkoua kouté, Côte d'Ivoire.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child, Preschool; Drug Combinations; Epidemiologic Methods; Ethanolamines; Female; Fever; Fluorenes; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Plasmodium falciparum; Treatment Outcome | 2011 |
Effect of artesunate and mefloquine in combination on the Fridericia corrected QT intervals in Plasmodium falciparum infected adults from Thailand.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Drug Combinations; Drug Therapy, Combination; Electrocardiography; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Torsades de Pointes; Young Adult | 2011 |
Population pharmacokinetics of artesunate and dihydroartemisinin in pregnant and non-pregnant women with malaria.
Topics: Administration, Oral; Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Case-Control Studies; Democratic Republic of the Congo; Female; Humans; Malaria, Falciparum; Models, Biological; Models, Statistical; Pregnancy; Pregnancy Complications, Parasitic; Young Adult | 2011 |
Frequency of glucose-6-phosphate dehydrogenase deficiency in malaria patients from six African countries enrolled in two randomized anti-malarial clinical trials.
Topics: Adolescent; Africa; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Dapsone; Drug Combinations; Female; Genotype; Glucosephosphate Dehydrogenase; Glucosephosphate Dehydrogenase Deficiency; Humans; Infant; Malaria, Falciparum; Male; Phenotype; Proguanil; Treatment Outcome | 2011 |
A simple dose regimen of artesunate and amodiaquine based on arm span- or age range for childhood falciparum malaria: a preliminary evaluation.
Topics: Adolescent; Age Distribution; Amodiaquine; Antimalarials; Area Under Curve; Arm; Artemisinins; Artesunate; Body Weight; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Humans; Malaria, Falciparum; Male; Plasmodium falciparum; Program Evaluation; Treatment Outcome | 2012 |
Impact of combining intermittent preventive treatment with home management of malaria in children less than 10 years in a rural area of Senegal: a cluster randomized trial.
Topics: Amodiaquine; Anemia; Animals; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child; Child, Preschool; Community Health Workers; Disease Management; Drug Combinations; Ethanolamines; Female; Fluorenes; Follow-Up Studies; Health Promotion; Humans; Infant; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum; Prevalence; Preventive Health Services; Pyrimethamine; Rural Population; Seasons; Senegal; Sulfadoxine | 2011 |
A simplified intravenous artesunate regimen for severe malaria.
Topics: Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Double-Blind Method; Female; Humans; Kaplan-Meier Estimate; Malaria, Falciparum; Male; Parasite Load; Parasitemia; Time Factors; Treatment Outcome | 2012 |
Randomized, prospective, three-arm study to confirm the auditory safety and efficacy of artemether-lumefantrine in Colombian patients with uncomplicated Plasmodium falciparum malaria.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Atovaquone; Audiometry; Child; Colombia; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Evoked Potentials, Auditory, Brain Stem; Female; Fluorenes; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Proguanil; Prospective Studies; Treatment Outcome; Young Adult | 2012 |
Efficacy of different primaquine-based antimalarial regimens against Plasmodium falciparum gametocytemia.
Topics: Adolescent; Adult; Aged; Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Colombia; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Germ Cells; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitemia; Plasmodium falciparum; Primaquine; Pyrimethamine; Sulfadoxine; Treatment Outcome; Young Adult | 2012 |
Defining Plasmodium falciparum treatment in South West Asia: a randomized trial comparing artesunate or primaquine combined with chloroquine or SP.
Topics: Adolescent; Antimalarials; Artemisinins; Artesunate; Child; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Malaria, Falciparum; Male; Pakistan; Patient Selection; Plasmodium falciparum; Polymerase Chain Reaction; Primaquine; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2012 |
Comparative efficacies of artemisinin combination therapies in Plasmodium falciparum malaria and polymorphism of pfATPase6, pfcrt, pfdhfr, and pfdhps genes in tea gardens of Jalpaiguri District, India.
Topics: Adolescent; Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Biomarkers; Calcium-Transporting ATPases; Child; Child, Preschool; Dihydropteroate Synthase; Drug Combinations; Ethanolamines; Female; Fluorenes; Follow-Up Studies; Humans; India; Malaria, Falciparum; Male; Mefloquine; Membrane Transport Proteins; Mutation; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Outcome | 2012 |
No evidence for spread of Plasmodium falciparum artemisinin resistance to Savannakhet Province, Southern Laos.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Follow-Up Studies; Humans; Laos; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Treatment Outcome; Young Adult | 2012 |
Predicting the clinical outcome of severe falciparum malaria in african children: findings from a large randomized trial.
Topics: Africa; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Female; Humans; Infant; Injections, Intravenous; Malaria, Falciparum; Male; Prognosis; Quinine; Severity of Illness Index; Treatment Outcome | 2012 |
Pyronaridine-artesunate versus mefloquine plus artesunate for malaria.
Topics: Adolescent; Adult; Africa; Antimalarials; Artemisinins; Artesunate; Asia; Child; Child, Preschool; Drug Combinations; Drug Resistance; Female; Humans; Intention to Treat Analysis; Kaplan-Meier Estimate; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Naphthyridines; Proportional Hazards Models; Young Adult | 2012 |
Therapeutic efficacy and safety of dihydroartemisinin-piperaquine versus artesunate-mefloquine in uncomplicated Plasmodium falciparum malaria in India.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; Artesunate; Asia; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Humans; India; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Quinolines; Treatment Outcome; Young Adult | 2012 |
Pharmacokinetics and pharmacodynamics of oral artesunate monotherapy in patients with uncomplicated Plasmodium falciparum malaria in western Cambodia.
Topics: Administration, Oral; Adult; Antimalarials; Artemisinins; Artesunate; Cambodia; Drug Administration Schedule; Female; Humans; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum; Severity of Illness Index | 2012 |
Diagnosing severe falciparum malaria in parasitaemic African children: a prospective evaluation of plasma PfHRP2 measurement.
Topics: Adolescent; Africa; Antigens, Protozoan; Artemisinins; Artesunate; Child; Child, Preschool; Demography; Female; Humans; Infant; Malaria, Falciparum; Male; Models, Biological; Odds Ratio; Parasitemia; Prospective Studies; Protozoan Proteins; Quinine; Risk Factors; Severity of Illness Index | 2012 |
Relapses contribute significantly to the risk of Plasmodium vivax infection and disease in Papua New Guinean children 1-5 years of age.
Topics: Antimalarials; Artemisinins; Artesunate; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Malaria, Vivax; Male; Papua New Guinea; Primaquine; Recurrence; Risk Factors; Time Factors | 2012 |
In vivo susceptibility of Plasmodium falciparum to artesunate in Binh Phuoc Province, Vietnam.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Child; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Plasmodium falciparum; Quinolines; Treatment Outcome; Vietnam; Young Adult | 2012 |
Pyronaridine-artesunate granules versus artemether-lumefantrine crushed tablets in children with Plasmodium falciparum malaria: a randomized controlled trial.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child; Child, Preschool; Dosage Forms; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Infant; Malaria, Falciparum; Male; Naphthyridines; Parasite Load; Recurrence; Tablets; Treatment Outcome | 2012 |
Effect of high-dose or split-dose artesunate on parasite clearance in artemisinin-resistant falciparum malaria.
Topics: Administration, Oral; Adolescent; Adult; Antibodies, Protozoan; Antimalarials; Artemisinins; Artesunate; Cambodia; Child; Drug Resistance; Female; Half-Life; Humans; Immunoglobulin G; Malaria, Falciparum; Male; Parasite Load; Parasitemia; Plasmodium falciparum; Thailand; Treatment Outcome; Young Adult | 2013 |
Efficacy and tolerability of a new formulation of artesunate-mefloquine for the treatment of uncomplicated malaria in adult in Senegal: open randomized trial.
Topics: Adolescent; Adult; Antigens, Protozoan; Antimalarials; Artemisinins; Artesunate; Base Sequence; Chemistry, Pharmaceutical; DNA, Protozoan; Drug Combinations; Female; Genes, Protozoan; Humans; Malaria, Falciparum; Male; Mefloquine; Merozoite Surface Protein 1; Parasite Load; Plasmodium falciparum; Polymerase Chain Reaction; Protozoan Proteins; Senegal; Treatment Outcome; Young Adult | 2012 |
Intramuscular bioavailability and clinical efficacy of artesunate in gabonese children with severe malaria.
Topics: Antimalarials; Area Under Curve; Artemisinins; Artesunate; Biological Availability; Child, Preschool; Cross-Over Studies; Female; Gabon; Half-Life; Humans; Infant; Injections, Intramuscular; Injections, Intravenous; Malaria, Falciparum; Male; Metabolic Clearance Rate; Sesquiterpenes; Treatment Outcome | 2002 |
Treatment of uncomplicated multidrug-resistant falciparum malaria with artesunate-atovaquone-proguanil.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Artemisinins; Artesunate; Atovaquone; Child; Child, Preschool; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Naphthoquinones; Plasmodium falciparum; Proguanil; Sesquiterpenes; Treatment Failure | 2002 |
Artesunate and mefloquine given simultaneously for three days via a prepacked blister is equally effective and tolerated as a standard sequential treatment of uncomplicated acute Plasmodium falciparum malaria: randomized, double-blind study in Thailand.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Central Nervous System Diseases; Child; Double-Blind Method; Drug Administration Schedule; Drug Packaging; Drug Resistance; Drug Therapy, Combination; Female; Fever; Humans; Malaria, Falciparum; Male; Mefloquine; Nausea; Plasmodium falciparum; Sesquiterpenes; Thailand; Treatment Outcome | 2002 |
Penetration of dihydroartemisinin into cerebrospinal fluid after administration of intravenous artesunate in severe falciparum malaria.
Topics: Adolescent; Adult; Artemisinins; Artesunate; Chromatography, High Pressure Liquid; Female; Half-Life; Humans; Injections, Intravenous; Malaria, Cerebral; Malaria, Falciparum; Male; Middle Aged; Sesquiterpenes | 2003 |
Lack of prediction of mefloquine and mefloquine-artesunate treatment outcome by mutations in the Plasmodium falciparum multidrug resistance 1 (pfmdr1) gene for P. falciparum malaria in Peru.
Topics: Adult; Animals; Antimalarials; Artemisinins; Artesunate; ATP-Binding Cassette Transporters; Base Sequence; Cohort Studies; DNA, Protozoan; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Molecular Sequence Data; Mutation; Peru; Plasmodium falciparum; Predictive Value of Tests; Protozoan Proteins; Sequence Alignment; Sesquiterpenes | 2003 |
An open randomized clinical trial of Artecom vs artesunate-mefloquine in the treatment of acute uncomplicated falciparum malaria in Thailand.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; Artesunate; Child; Drug Combinations; Drug Resistance, Multiple; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Quinolines; Sesquiterpenes; Thailand; Trimethoprim | 2002 |
Efficacy of mefloquine and a mefloquine-artesunate combination therapy for the treatment of uncomplicated Plasmodium falciparum malaria in the Amazon Basin of Peru.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitemia; Peru; Recurrence; Sesquiterpenes; Treatment Outcome; Vomiting | 2003 |
The efficacy of combined mefloquine-artesunate versus mefloquine-primaquine on subsequent development of Plasmodium falciparum gametocytemia.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Carrier State; Child; Drug Resistance; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Parasitemia; Plasmodium falciparum; Primaquine; Secondary Prevention; Sesquiterpenes | 2003 |
Randomized comparison of artesunate and quinine in the treatment of severe falciparum malaria.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; Artesunate; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Quinine; Sesquiterpenes; Survival Analysis; Thailand; Treatment Outcome | 2003 |
The addition of artesunate to chloroquine for treatment of Plasmodium falciparum malaria in Gambian children delays, but does not prevent treatment failure.
Topics: Age Factors; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Therapy, Combination; Female; Gambia; Humans; Infant; Malaria, Falciparum; Male; Plasmodium falciparum; Sesquiterpenes; Treatment Failure | 2003 |
The pharmacokinetics of atovaquone and proguanil in pregnant women with acute falciparum malaria.
Topics: Acute Disease; Antimalarials; Artemisinins; Artesunate; Atovaquone; Drug Combinations; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Naphthoquinones; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Proguanil; Sesquiterpenes; Thailand | 2003 |
N-acetylcysteine in severe falciparum malaria in Thailand.
Topics: Acetylcysteine; Administration, Oral; Adolescent; Adult; Aged; Antimalarials; Artemisinins; Artesunate; Female; Humans; Injections, Intravenous; Malaria, Falciparum; Male; Middle Aged; Sesquiterpenes; Survival Rate; Thailand; Treatment Outcome | 2003 |
[A randomized comparative study of naphtoquine, mefloquine and artsunate in the treatment of falciparum malaria].
Topics: Adolescent; Adult; Aminoquinolines; Antimalarials; Artemisinins; Artesunate; Child; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Sesquiterpenes | 2003 |
Treatment of uncomplicated falciparum malaria in southern Vietnam: can chloroquine or sulfadoxine-pyrimethamine be reintroduced in combination with artesunate?
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Child; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Genotype; Humans; Malaria, Falciparum; Male; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Outcome; Vietnam | 2003 |
Randomised efficacy and safety study of two 3-day artesunate rectal capsule/mefloquine regimens versus artesunate alone for uncomplicated malaria in Ecuadorian children.
Topics: Administration, Rectal; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Resistance, Multiple; Ecuador; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Plasmodium falciparum; Sesquiterpenes; Treatment Outcome | 2003 |
Addition of artesunate to chloroquine for treatment of Plasmodium falciparum malaria in Gambian children causes a significant but short-lived reduction in infectiousness for mosquitoes.
Topics: Acute Disease; Age Factors; Animals; Anopheles; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Resistance; Drug Therapy, Combination; Female; Gambia; Humans; Infant; Malaria, Falciparum; Parasitemia; Plasmodium falciparum; Prevalence; Sesquiterpenes; Treatment Failure | 2004 |
Adherence to the combination of sulphadoxine-pyrimethamine and artesunate in the Maheba refugee settlement, Zambia.
Topics: Antimalarials; Artemisinins; Artesunate; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Family; Female; Health Education; Humans; Infant; Malaria, Falciparum; Male; Patient Compliance; Pyrimethamine; Refugees; Sesquiterpenes; Sulfadoxine; Surveys and Questionnaires; Treatment Refusal; Zambia | 2004 |
Optimising operational use of artesunate-mefloquine: a randomised comparison of four treatment regimens.
Topics: Adolescent; Adult; Aged; Anemia; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Female; Hemoglobins; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Middle Aged; Rural Health; Sesquiterpenes | 2004 |
Efficacy of mefloquine and mefloquine-artesunate for the treatment of uncomplicated Plasmodium falciparum malaria in the Amazon region of Bolivia.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Bolivia; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitemia; Sesquiterpenes; Treatment Outcome | 2004 |
Activities of artesunate and primaquine against asexual- and sexual-stage parasites in falciparum malaria.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Drug Therapy, Combination; Erythrocytes; Humans; Malaria, Falciparum; Male; Middle Aged; Parasite Egg Count; Plasmodium falciparum; Primaquine; Prospective Studies; Sesquiterpenes; Tetracycline; Treatment Outcome | 2004 |
A randomized trial of amodiaquine and artesunate alone and in combination for the treatment of uncomplicated falciparum malaria in children from Burkina Faso.
Topics: Adolescent; Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Double-Blind Method; Drug Therapy, Combination; Humans; Infant; Malaria, Falciparum; Parasitemia; Sesquiterpenes; Treatment Outcome | 2004 |
Randomized control trial of quinine and artesunate in complicated malaria.
Topics: Adolescent; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Female; Headache; Humans; Malaria, Falciparum; Male; Nausea; Quinine; Sesquiterpenes; Treatment Outcome; Vomiting | 2004 |
Monitoring the therapeutic efficacy of antimalarials against uncomplicated falciparum malaria in Thailand.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Fluorenes; Health Policy; Humans; Lumefantrine; Malaria, Falciparum; Mefloquine; Middle Aged; Primaquine; Sesquiterpenes; Statistics, Nonparametric; Thailand; Treatment Outcome | 2003 |
Six-years monitoring the efficacy of the combination of artesunate and mefloquine for the treatment of uncomplicated falciparum malaria.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Drug Resistance, Multiple; Drug Therapy, Combination; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Sesquiterpenes; Thailand | 2003 |
Efficacy of rectal artesunate compared with parenteral quinine in initial treatment of moderately severe malaria in African children and adults: a randomised study.
Topics: Administration, Rectal; Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Humans; Infant; Infusions, Intravenous; Injections, Intramuscular; Malaria, Falciparum; Male; Middle Aged; Pyrimethamine; Quinine; Sesquiterpenes; Sulfadoxine; Suppositories | 2004 |
Artesunate with mefloquine at various intervals for non-severe Plasmodium falciparum malaria.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Child; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Sesquiterpenes; Treatment Outcome; Vietnam | 2004 |
Is amodiaquine failing in Rwanda? Efficacy of amodiaquine alone and combined with artesunate in children with uncomplicated malaria.
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Drug Resistance; Drug Therapy, Combination; Humans; Infant; Malaria, Falciparum; Rwanda; Sesquiterpenes; Survival Analysis; Treatment Failure; Treatment Outcome | 2004 |
Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic.
Topics: Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Laos; Lumefantrine; Malaria, Falciparum; Male; Mefloquine; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 2004 |
Randomized, controlled dose-optimization studies of dihydroartemisinin-piperaquine for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Quinolines; Sesquiterpenes; Thailand | 2004 |
Comparative pharmacokinetics of intramuscular artesunate and artemether in patients with severe falciparum malaria.
Topics: Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Artesunate; Chromatography, High Pressure Liquid; Gas Chromatography-Mass Spectrometry; Half-Life; Humans; Injections, Intramuscular; Malaria, Falciparum; Middle Aged; Sesquiterpenes; Vietnam | 2004 |
Therapeutic efficacy of artemether-lumefantrine and artesunate-mefloquine for treatment of uncomplicated Plasmodium falciparum malaria in Luang Namtha Province, Lao People's Democratic Republic.
Topics: Acute Disease; Adolescent; Adult; Aged; Antimalarials; Artemether; Artemisinins; Artesunate; Biological Availability; Child; Child, Preschool; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Korea; Lumefantrine; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitemia; Sesquiterpenes; Treatment Outcome | 2004 |
Comparison of chloroquine, sulfadoxine/pyrimethamine, mefloquine and mefloquine-artesunate for the treatment of falciparum malaria in Kachin State, North Myanmar.
Topics: Adolescent; Adult; Age Distribution; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Hemoglobins; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Myanmar; Pyrimethamine; Recurrence; Sesquiterpenes; Sulfadoxine; Treatment Failure | 2004 |
Efficacy and effectiveness of the combination of sulfadoxine/pyrimethamine and a 3-day course of artesunate for the treatment of uncomplicated falciparum malaria in a refugee settlement in Zambia.
Topics: Antimalarials; Artemisinins; Artesunate; Child, Preschool; Developing Countries; Drug Administration Schedule; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Genetic Markers; Genomics; Humans; Infant; Malaria, Falciparum; Male; Patient Compliance; Pyrimethamine; Refugees; Sesquiterpenes; Sulfadoxine; Treatment Outcome; Zambia | 2005 |
Efficacy of two artemisinin combination therapies for uncomplicated falciparum malaria in children under 5 years, Malakal, Upper Nile, Sudan.
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Pyrimethamine; Sesquiterpenes; Sudan; Sulfadoxine | 2005 |
Curdlan sulphate in human severe/cerebral Plasmodium falciparum malaria.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; beta-Glucans; Child; Double-Blind Method; Drug Therapy, Combination; Female; Fever; Humans; Malaria, Cerebral; Malaria, Falciparum; Male; Middle Aged; Parasitemia; Sesquiterpenes; Treatment Outcome | 2005 |
Pharmacokinetics of oral doxycycline during combination treatment of severe falciparum malaria.
Topics: Administration, Oral; Adolescent; Adult; Aged; Animals; Antimalarials; Artemisinins; Artesunate; Doxycycline; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Sesquiterpenes; Severity of Illness Index | 2005 |
Efficacies of mefloquine alone and of artesunate followed by mefloquine, for the treatment of uncomplicated, Plasmodium falciparum malaria in eastern Sudan.
Topics: Administration, Oral; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Therapy, Combination; Genotype; Humans; Malaria, Falciparum; Mefloquine; Parasitemia; Plasmodium falciparum; Sesquiterpenes; Sudan; Treatment Outcome | 2005 |
Malaria in the Nuba Mountains of Sudan: baseline genotypic resistance and efficacy of the artesunate plus sulfadoxine-pyrimethamine and artesunate plus amodiaquine combinations.
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Membrane Proteins; Membrane Transport Proteins; Protozoan Proteins; Pyrimethamine; Sesquiterpenes; Sudan; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Outcome | 2005 |
Antimalarial efficacy of chloroquine, amodiaquine, sulfadoxine-pyrimethamine, and the combinations of amodiaquine + artesunate and sulfadoxine-pyrimethamine + artesunate in Huambo and Bie provinces, central Angola.
Topics: Amodiaquine; Angola; Animals; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Plasmodium falciparum; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Failure | 2005 |
Efficacy and tolerability of artesunate plus sulfadoxine-pyrimethamine and sulfadoxine-pyrimethamine alone for the treatment of uncomplicated Plasmodium falciparum malaria in Peru.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Child; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Peru; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 2005 |
Artesunate-clindamycin versus quinine-clindamycin in the treatment of Plasmodium falciparum malaria: a randomized controlled trial.
Topics: Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Clindamycin; Drug Therapy, Combination; Female; Gabon; Humans; Malaria, Falciparum; Male; Quinine; Sesquiterpenes | 2005 |
A randomized, placebo-controlled, double-blind trial on sulfadoxine-pyrimethamine alone or combined with artesunate or amodiaquine in uncomplicated malaria.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Genotype; Humans; Infant; Malaria, Falciparum; Male; Parasite Egg Count; Plasmodium falciparum; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2005 |
Efficacy of combination therapy with artesunate plus amodiaquine compared to monotherapy with chloroquine, amodiaquine or sulfadoxine-pyrimethamine for treatment of uncomplicated Plasmodium falciparum in Afghanistan.
Topics: Adolescent; Adult; Afghanistan; Aged; Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Parasite Egg Count; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Failure; Treatment Outcome | 2005 |
A comparison of the efficacy of artesunate plus sulfadoxine-pyrimethamine with that of sulfadoxine-pyrimethamine alone, in the treatment of uncomplicated, Plasmodium falciparum malaria in eastern Sudan.
Topics: Adolescent; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Parasitemia; Pyrimethamine; Recurrence; Sesquiterpenes; Sudan; Sulfadoxine; Treatment Failure; Treatment Outcome | 2005 |
A randomized, controlled study of a simple, once-daily regimen of dihydroartemisinin-piperaquine for the treatment of uncomplicated, multidrug-resistant falciparum malaria.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Resistance, Multiple; Female; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Quinolines; Sesquiterpenes | 2005 |
Comparative efficacy of antimalarial drugs including ACTs in the treatment of uncomplicated malaria among children under 5 years in Ghana.
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Ghana; Humans; Infant; Malaria, Falciparum; Male; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2005 |
A randomized comparison of artesunate-atovaquone-proguanil versus quinine in treatment for uncomplicated falciparum malaria during pregnancy.
Topics: Adolescent; Adult; Anemia; Animals; Antimalarials; Artemisinins; Artesunate; Atovaquone; Female; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Naphthoquinones; Parasitemia; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Proguanil; Quinine; Sesquiterpenes; Thailand | 2005 |
Efficacy of chloroquine + sulfadoxine--pyrimethamine, mefloquine + artesunate and artemether + lumefantrine combination therapies to treat Plasmodium falciparum malaria in the Chittagong Hill Tracts, Bangladesh.
Topics: Adolescent; Antimalarials; Artemether; Artemisinins; Artesunate; Bangladesh; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Mefloquine; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2005 |
Short report: no evidence of cardiotoxicity of atovaquone-proguanil alone or in combination with artesunate.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Atovaquone; Child; Drug Therapy, Combination; Electrocardiography; Female; Heart Diseases; Humans; Long QT Syndrome; Malaria, Falciparum; Male; Middle Aged; Myanmar; Myocardium; Naphthoquinones; Plasmodium falciparum; Proguanil; Sesquiterpenes; Thailand; Treatment Outcome | 2005 |
An open, randomized trial of three-day treatment with artesunate combined with a standard dose of mefloquine divided over either two or three days, for acute, uncomplicated falciparum malaria.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Sesquiterpenes; Time Factors; Treatment Outcome | 2005 |
Life-saving rectal artesunate for complicated malaria in children.
Topics: Administration, Rectal; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child Welfare; Child, Preschool; Drug Resistance, Multiple; Drug Therapy, Combination; Humans; Malaria, Cerebral; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Sesquiterpenes; Suppositories; Thailand; Treatment Outcome | 2005 |
Short-course regimens of artesunate-fosmidomycin in treatment of uncomplicated Plasmodium falciparum malaria.
Topics: Antimalarials; Artemisinins; Artesunate; Chemistry, Pharmaceutical; Child; Cohort Studies; Dose-Response Relationship, Drug; Drug Combinations; Endpoint Determination; Female; Fosfomycin; Humans; Malaria, Falciparum; Male; Reverse Transcriptase Polymerase Chain Reaction; Sesquiterpenes | 2005 |
Efficacy of artesunate plus amodiaquine versus that of artemether-lumefantrine for the treatment of uncomplicated childhood Plasmodium falciparum malaria in Zanzibar, Tanzania.
Topics: Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Odds Ratio; Plasmodium falciparum; Sesquiterpenes; Tanzania | 2005 |
A randomized trial of artemether-lumefantrine versus mefloquine-artesunate for the treatment of uncomplicated multi-drug resistant Plasmodium falciparum on the western border of Thailand.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Drug Resistance, Multiple; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Sesquiterpenes; Thailand | 2005 |
Efficacy of sulfadoxin pyrimethamine for uncomplicated Plasmodium falciparum malaria in a small sample of Sudanese children.
Topics: Adolescent; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Endemic Diseases; Female; Genotype; Humans; Infant; Malaria, Falciparum; Male; Parasite Egg Count; Parasitic Sensitivity Tests; Plasmodium falciparum; Prospective Studies; Pyrimethamine; Recurrence; Seasons; Sesquiterpenes; Sudan; Sulfadoxine; Treatment Failure | 2004 |
5-day nonobserved artesunate monotherapy for treating uncomplicated Falciparum malaria in young Gabonese children.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Female; Gabon; Humans; Infant; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum; Sesquiterpenes; Treatment Outcome | 2005 |
Open randomized study of artesunate-amodiaquine vs. chloroquine-pyrimethamine-sulfadoxine for the treatment of uncomplicated Plasmodium falciparum malaria in Nigerian children.
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Fever; Humans; Infant; Malaria, Falciparum; Male; Nigeria; Parasitemia; Polymerase Chain Reaction; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Failure; Treatment Outcome | 2005 |
A randomized trial comparing the efficacy of four treatment regimens for uncomplicated falciparum malaria in Assam state, India.
Topics: Adolescent; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Humans; India; Infant; Malaria, Falciparum; Male; Mefloquine; Prospective Studies; Pyrimethamine; Quinolines; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2006 |
An open randomized clinical trial of Artekin vs artesunate-mefloquine in the treatment of acute uncomplicated falciparum malaria.
Topics: Acute Disease; Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Drug Combinations; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Quinolines; Sesquiterpenes; Thailand; Treatment Outcome | 2005 |
Artesunate suppositories versus intramuscular artemether for treatment of severe malaria in children in Papua New Guinea.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Body Weight; Child; Child, Preschool; Clinical Trials as Topic; Developing Countries; Endemic Diseases; Female; Humans; Infant; Injections, Intramuscular; Malaria, Falciparum; Male; Papua New Guinea; Parasitemia; Retrospective Studies; Sesquiterpenes; Severity of Illness Index; Suppositories | 2006 |
(Sub)microscopic Plasmodium falciparum gametocytaemia in Kenyan children after treatment with sulphadoxine-pyrimethamine monotherapy or in combination with artesunate.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Carrier State; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Nucleic Acid Amplification Techniques; Parasitemia; Plasmodium falciparum; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 2006 |
Seasonal intermittent preventive treatment with artesunate and sulfadoxine-pyrimethamine for prevention of malaria in Senegalese children: a randomised, placebo-controlled, double-blind trial.
Topics: Antimalarials; Artemisinins; Artesunate; Bedding and Linens; Child, Preschool; Double-Blind Method; Drug Combinations; Drug Resistance; Humans; Infant; Malaria, Falciparum; Prevalence; Pyrimethamine; Seasons; Senegal; Sesquiterpenes; Sulfadoxine | 2006 |
Artemether-lumefantrine versus artesunate plus amodiaquine for treating uncomplicated childhood malaria in Nigeria: randomized controlled trial.
Topics: Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Child, Preschool; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Nigeria; Plasmodium falciparum; Sesquiterpenes; Treatment Outcome | 2006 |
Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison.
Topics: Adolescent; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Myanmar; Plasmodium falciparum; Quinolines; Recurrence; Sesquiterpenes; Treatment Outcome | 2006 |
Population pharmacokinetic assessment of a new regimen of mefloquine used in combination treatment of uncomplicated falciparum malaria.
Topics: Adolescent; Adult; Animals; Antimalarials; Area Under Curve; Artemisinins; Artesunate; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Sesquiterpenes; Treatment Outcome | 2006 |
High efficacy of two artemisinin-based combinations (artesunate + amodiaquine and artemether + lumefantrine) in Caala, Central Angola.
Topics: Amodiaquine; Angola; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Child, Preschool; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Sesquiterpenes; Treatment Outcome | 2006 |
Efficacy and safety of an artesunate/mefloquine combination, (artequin) in the treatment of uncomplicated P. falciparum malaria in Kenya.
Topics: Adult; Animals; Antimalarials; Artemisinins; Artesunate; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Kenya; Malaria, Falciparum; Male; Mefloquine; Plasmodium falciparum; Remission Induction; Sesquiterpenes | 2006 |
An open, randomized comparison of artesunate plus mefloquine vs. dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in the Lao People's Democratic Republic (Laos).
Topics: Administration, Oral; Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Child; Drug Therapy, Combination; Female; Humans; Laos; Malaria, Falciparum; Male; Mefloquine; Parasitemia; Quinolines; Recurrence; Sesquiterpenes; Treatment Failure; Treatment Outcome | 2006 |
A fixed-dose 24-hour regimen of artesunate plus sulfamethoxypyrazine-pyrimethamine for the treatment of uncomplicated Plasmodium falciparum malaria in eastern Sudan.
Topics: Adult; Animals; Antimalarials; Artemisinins; Artesunate; Child; Drug Administration Schedule; Drug Therapy, Combination; Genotype; Humans; Malaria, Falciparum; Patient Selection; Plasmodium falciparum; Pyrimethamine; Recurrence; Sesquiterpenes; Sudan; Sulfalene; Treatment Failure; Treatment Outcome | 2006 |
Artesunate + amodiaquine and artesunate + sulphadoxine-pyrimethamine for treatment of uncomplicated malaria in Democratic Republic of Congo: a clinical trial with determination of sulphadoxine and pyrimethamine-resistant haplotypes.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Democratic Republic of the Congo; DNA, Protozoan; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Haplotypes; Humans; Infant; Malaria; Malaria, Falciparum; Male; Plasmodium; Polymerase Chain Reaction; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2006 |
A randomized trial of artesunate-sulfamethoxypyrazine-pyrimethamine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Mali.
Topics: Adolescent; Adult; Anemia; Antimalarials; Artemether; Artemisinins; Artesunate; Carrier State; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Pyrimethamine; Sesquiterpenes; Sulfalene; Treatment Outcome | 2006 |
Azithromycin combination therapy with artesunate or quinine for the treatment of uncomplicated Plasmodium falciparum malaria in adults: a randomized, phase 2 clinical trial in Thailand.
Topics: Adult; Animals; Antimalarials; Artemisinins; Artesunate; Azithromycin; Child; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Pregnancy; Quinine; Sesquiterpenes | 2006 |
An open label randomized comparison of mefloquine-artesunate as separate tablets vs. a new co-formulated combination for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Middle Aged; Quality Control; Sesquiterpenes; Tablets; Thailand; Treatment Outcome | 2006 |
The pharmacokinetics of intravenous artesunate in adults with severe falciparum malaria.
Topics: Administration, Oral; Adolescent; Adult; Age Factors; Antimalarials; Area Under Curve; Artemisinins; Artesunate; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electrochemistry; Female; Half-Life; Humans; Injections, Intravenous; Malaria, Falciparum; Male; Metabolic Clearance Rate; Middle Aged; Pilot Projects; Quinine; Sesquiterpenes; Severity of Illness Index; Thailand | 2006 |
Efficacy of three artemisinin combination therapies for the treatment of uncomplicated Plasmodium falciparum malaria in the Republic of Congo.
Topics: Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Child, Preschool; Democratic Republic of the Congo; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Plasmodium falciparum; Sesquiterpenes; Treatment Outcome | 2006 |
Efficacy of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in northwest Cambodia.
Topics: Acute Disease; Adolescent; Adult; Animals; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child; Dietary Supplements; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Mefloquine; Parasitic Sensitivity Tests; Plasmodium falciparum; Sesquiterpenes; Treatment Failure; Treatment Outcome | 2006 |
Efficacies of artesunate plus either sulfadoxine-pyrimethamine or amodiaquine, for the treatment of uncomplicated, Plasmodium falciparum malaria in eastern Sudan.
Topics: Adolescent; Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Humans; Malaria, Falciparum; Parasitemia; Pyrimethamine; Sesquiterpenes; Sudan; Sulfadoxine; Treatment Outcome | 2007 |
Molecular genotyping in a malaria treatment trial in Uganda - unexpected high rate of new infections within 2 weeks after treatment.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Child; Drug Combinations; Drug Therapy, Combination; Endemic Diseases; Genes, Protozoan; Genotype; Humans; Malaria, Falciparum; Merozoite Surface Protein 1; Parasitemia; Plasmodium falciparum; Polymerase Chain Reaction; Protozoan Proteins; Pyrimethamine; Recurrence; Sesquiterpenes; Sulfadoxine; Uganda | 2007 |
A randomized open study to assess the efficacy and tolerability of dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Cambodia.
Topics: Adolescent; Adult; Aged; Anemia; Antimalarials; Artemisinins; Artesunate; Cambodia; Child; Child, Preschool; Drug Therapy, Combination; Female; Genome, Protozoan; Humans; Infant; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Middle Aged; Quinolines; Recurrence; Sesquiterpenes; Treatment Outcome | 2007 |
Thiamin deficiency and uncomplicated falciparum malaria in Laos.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Artemisinins; Artesunate; Beriberi; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Enzyme Activation; Erythrocytes; Female; Humans; Infant; Laos; Malaria, Falciparum; Male; Middle Aged; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Thiamine Deficiency; Transketolase; Treatment Outcome | 2007 |
Activities of amodiaquine, artesunate, and artesunate-amodiaquine against asexual- and sexual-stage parasites in falciparum malaria in children.
Topics: Adolescent; Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Plasmodium falciparum; Sesquiterpenes; Sex Ratio | 2007 |
Artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Colombia.
Topics: Adolescent; Adult; Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Bone Marrow Diseases; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Colombia; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Humans; Kaplan-Meier Estimate; Malaria, Falciparum; Male; Middle Aged; Parasitemia; Plasmodium falciparum; Sesquiterpenes; Treatment Outcome | 2007 |
Lack of impact of artesunate on the disposition kinetics of sulfadoxine/pyrimethamine when the two drugs are concomitantly administered.
Topics: Adult; Antimalarials; Area Under Curve; Artemisinins; Artesunate; Chromatography, High Pressure Liquid; Cross-Over Studies; Drug Combinations; Drug Interactions; Half-Life; Humans; Malaria, Falciparum; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 2007 |
Artesunate--amodiaquine combination therapy for falciparum malaria in young Gabonese children.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Drug Therapy, Combination; Gabon; Humans; Infant; Malaria, Falciparum; Plasmodium falciparum; Sesquiterpenes; Treatment Outcome | 2007 |
Dihydroartemisinin-piperaquine versus artesunate-amodiaquine: superior efficacy and posttreatment prophylaxis against multidrug-resistant Plasmodium falciparum and Plasmodium vivax malaria.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Drug Resistance, Multiple; Drug Tolerance; Humans; Indonesia; Malaria, Falciparum; Malaria, Vivax; Plasmodium falciparum; Quinolines; Sesquiterpenes; Treatment Outcome | 2007 |
Artesunate, artemether or quinine in severe Plasmodium falciparum malaria?
Topics: Animals; Artemether; Artemisinins; Artesunate; Humans; Malaria, Falciparum; Quinine; Sesquiterpenes | 2007 |
Pfmdr1 and in vivo resistance to artesunate-mefloquine in falciparum malaria on the Cambodian-Thai border.
Topics: Adolescent; Adult; Aged; Animals; Artemisinins; Artesunate; Cambodia; Child; Drug Resistance; Female; Genotype; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Recurrence; Sesquiterpenes; Thailand | 2007 |
Comparative study of the effectiveness and pharmacokinetics of two rectal artesunate/oral mefloquine combination regimens for the treatment of uncomplicated childhood falciparum malaria.
Topics: Administration, Oral; Administration, Rectal; Adolescent; Antimalarials; Artemisinins; Artesunate; Body Weight; Child; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Sesquiterpenes; Single-Blind Method; Treatment Outcome | 2007 |
Efficacy of antimalarial treatment in Guinea: in vivo study of two artemisinin combination therapies in Dabola and molecular markers of resistance to sulphadoxine-pyrimethamine in N'Zérékoré.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Genes, Protozoan; Genetic Markers; Genotype; Guinea; Humans; Infant; Malaria, Falciparum; Male; Plasmodium falciparum; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Outcome | 2007 |
Randomized clinical trial of artemisinin versus non-artemisinin combination therapy for uncomplicated falciparum malaria in Madagascar.
Topics: Adolescent; Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Humans; Infant; Madagascar; Malaria, Falciparum; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2007 |
Combination therapy for uncomplicated falciparum malaria in Ugandan children: a randomized trial.
Topics: Amodiaquine; Animals; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Infant; Longitudinal Studies; Malaria, Falciparum; Parasitemia; Plasmodium falciparum; Pyrimethamine; Sesquiterpenes; Single-Blind Method; Sulfadoxine; Treatment Outcome; Uganda; Urban Population | 2007 |
Effect of artesunate plus sulfadoxine-pyrimethamine on haematological recovery and anaemia, in Kenyan children with uncomplicated, Plasmodium falciparum malaria.
Topics: Anemia; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Drug Combinations; Female; Humans; Infant; Kenya; Malaria, Falciparum; Male; Prevalence; Pyrimethamine; Risk Factors; Sesquiterpenes; Sulfadoxine | 2007 |
Resistance-mediating Plasmodium falciparum pfcrt and pfmdr1 alleles after treatment with artesunate-amodiaquine in Uganda.
Topics: Alleles; Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Mutation; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Sesquiterpenes; Treatment Outcome; Uganda | 2007 |
Efficacy of artesunate plus amodiaquine, artesunate plus sulfadoxine-pyrimethamine, and chloroquine plus sulfadoxine-pyrimethamine in patients with uncomplicated Plasmodium falciparum in the Comoros Union.
Topics: Adolescent; Adult; Aged; Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Comoros; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 2007 |
Efficacy and tolerability of four antimalarial combinations in the treatment of uncomplicated Plasmodium falciparum malaria in Senegal.
Topics: Adolescent; Adult; Aged; Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Fluorenes; Follow-Up Studies; Humans; Infant; Lumefantrine; Malaria, Falciparum; Mefloquine; Middle Aged; Plasmodium falciparum; Pyrimethamine; Senegal; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2007 |
Sulfadoxine-pyrimethamine plus artesunate compared with chloroquine for the treatment of vivax malaria in areas co-endemic for Plasmodium falciparum and P. vivax: a randomised non-inferiority trial in eastern Afghanistan.
Topics: Adolescent; Afghanistan; Antimalarials; Artemisinins; Artesunate; Child; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Endemic Diseases; Humans; Malaria, Falciparum; Malaria, Vivax; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2007 |
Amodiaquine in future combination treatment of malaria in Ghana.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Drug Therapy, Combination; Female; Ghana; Humans; Infant; Malaria, Falciparum; Male; Sesquiterpenes; Treatment Outcome | 2007 |
Pharmacokinetics of two paediatric artesunate mefloquine drug formulations in the treatment of uncomplicated falciparum malaria in Gabon.
Topics: Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Gabon; Humans; Malaria, Falciparum; Male; Mefloquine; Sesquiterpenes; Tablets | 2007 |
Primaquine clears submicroscopic Plasmodium falciparum gametocytes that persist after treatment with sulphadoxine-pyrimethamine and artesunate.
Topics: Adolescent; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Female; Humans; Malaria; Malaria, Falciparum; Male; Plasmodium falciparum; Primaquine; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Tanzania; Treatment Outcome | 2007 |
A randomised controlled trial to assess the efficacy of dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Peru.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Peru; Quinolines; Sesquiterpenes | 2007 |
Comparison of different artemisinin-based combinations for the treatment of Plasmodium falciparum malaria in children in Kigali, Rwanda, an area of resistance to sulfadoxine-pyrimethamine: artesunate plus sulfadoxine/pyrimethamine versus artesunate plus s
Topics: Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Resistance, Multiple; Female; Hemoglobins; Humans; Infant; Malaria, Falciparum; Male; Pyrimethamine; Rwanda; Sesquiterpenes; Sulfadoxine; Sulfalene | 2007 |
A randomized controlled pilot trial of azithromycin or artesunate added to sulfadoxine-pyrimethamine as treatment for malaria in pregnant women.
Topics: Adolescent; Adult; Artemisinins; Artesunate; Azithromycin; Female; Humans; Malaria, Falciparum; Middle Aged; Pilot Projects; Pregnancy; Pregnancy Complications, Parasitic | 2007 |
A randomized open-label trial of artesunate- sulfadoxine-pyrimethamine with or without primaquine for elimination of sub-microscopic P. falciparum parasitaemia and gametocyte carriage in eastern Sudan.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Artemisinins; Artesunate; Carrier State; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Primaquine; Pyrimethamine; Sudan; Sulfadoxine | 2007 |
Adding artesunate to sulphadoxine-pyrimethamine greatly improves the treatment efficacy in children with uncomplicated falciparum malaria on the coast of Benin, West Africa.
Topics: Analysis of Variance; Anemia; Animals; Antimalarials; Artemisinins; Artesunate; Benin; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Fever; Follow-Up Studies; Humans; Infant; Kaplan-Meier Estimate; Malaria, Falciparum; Male; Plasmodium falciparum; Pyrimethamine; Respiratory Tract Infections; Sesquiterpenes; Sulfadoxine; Time Factors; Treatment Outcome | 2007 |
The antischistosomal efficacies of artesunate-sulfamethoxypyrazine-pyrimethamine and artemether-lumefantrine administered as treatment for uncomplicated, Plasmodium falciparum malaria.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child; Drug Combinations; Drug Therapy, Combination; Endemic Diseases; Ethanolamines; Feces; Fluorenes; Humans; Malaria, Falciparum; Parasite Egg Count; Pyrimethamine; Schistosoma mansoni; Schistosomiasis mansoni; Schistosomicides; Sesquiterpenes; Sudan; Sulfalene | 2008 |
Randomized, comparative study of the efficacy and safety of artesunate plus amodiaquine, administered as a single daily intake versus two daily intakes in the treatment of uncomplicated falciparum malaria.
Topics: Adolescent; Adult; Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Cameroon; Child; Child, Preschool; Female; Gastrointestinal Diseases; Humans; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum; Polymerase Chain Reaction; Pruritus; Senegal; Sesquiterpenes | 2008 |
Sulphadoxine/pyrimethamine versus amodiaquine for treating uncomplicated childhood malaria in Gabon: a randomized trial to guide national policy.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Dihydropteroate Synthase; Drug Resistance; Drug Therapy, Combination; Female; Follow-Up Studies; Gabon; Health Policy; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Male; Mutation; Plasmodium falciparum; Polymerase Chain Reaction; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2008 |
Safety and efficacy of methylene blue combined with artesunate or amodiaquine for uncomplicated falciparum malaria: a randomized controlled trial from Burkina Faso.
Topics: Amodiaquine; Artemisinins; Artesunate; Burkina Faso; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Dysuria; Humans; Malaria, Falciparum; Methylene Blue; Sesquiterpenes; Treatment Outcome; Vomiting | 2008 |
Open-label comparative clinical study of chlorproguanil-dapsone fixed dose combination (Lapdap) alone or with three different doses of artesunate for uncomplicated Plasmodium falciparum malaria.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisia; Artemisinins; Artesunate; Child; Child, Preschool; Dapsone; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Female; Gambia; Humans; Infant; Malaria, Falciparum; Malawi; Male; Middle Aged; Parasitic Sensitivity Tests; Plasmodium falciparum; Proguanil; Sample Size; Sesquiterpenes; Treatment Outcome | 2008 |
A randomised trial to assess the efficacy and safety of chlorproguanil/dapsone + artesunate for the treatment of uncomplicated Plasmodium falciparum malaria.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Dapsone; Drug Administration Schedule; Drug Therapy, Combination; Female; Genotype; Humans; Infant; Malaria, Falciparum; Male; Proguanil; Rural Health; Rwanda; Treatment Outcome | 2008 |
Efficacy, safety, and selection of molecular markers of drug resistance by two ACTs in Mali.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Biomarkers; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mali; Plasmodium falciparum; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Time Factors; Vomiting | 2008 |
High efficacy of two artemisinin-based combinations (artemether-lumefantrine and artesunate plus amodiaquine) for acute uncomplicated malaria in Ibadan, Nigeria.
Topics: Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Nigeria; Plasmodium falciparum; Treatment Outcome | 2008 |
Oral artesunate in the treatment of uncomplicated hyperparasitemic falciparum malaria.
Topics: Administration, Oral; Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Malaria, Falciparum; Male; Mefloquine; Parasitemia; Quinine; Sesquiterpenes; Time Factors; Treatment Outcome | 1995 |
Treatment of multidrug-resistant Plasmodium falciparum malaria with 3-day artesunate-mefloquine combination.
Topics: Adult; Animals; Antimalarials; Artemisinins; Artesunate; Child; Disease-Free Survival; Drug Administration Schedule; Drug Resistance, Multiple; Drug Therapy, Combination; Follow-Up Studies; Humans; Malaria, Falciparum; Mefloquine; Myanmar; Plasmodium falciparum; Recurrence; Sesquiterpenes; Thailand; Time Factors | 1994 |
Randomized trial of mefloquine-doxycycline, and artesunate-doxycycline for treatment of acute uncomplicated falciparum malaria.
Topics: Acute Disease; Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Doxycycline; Drug Resistance; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Recurrence; Sesquiterpenes | 1994 |
Artemisinin: large community studies.
Topics: Administration, Oral; Antimalarials; Antiprotozoal Agents; Artemether; Artemisinins; Artesunate; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Mefloquine; Prospective Studies; Sesquiterpenes; Suppositories | 1994 |
Randomized trial of mefloquine alone and artesunate followed by mefloquine for the treatment of acute uncomplicated falciparum malaria.
Topics: Acute Disease; Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Sesquiterpenes | 1994 |
Pharmacokinetics of mefloquine alone or in combination with artesunate.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Drug Therapy, Combination; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Sesquiterpenes | 1994 |
Comparison of oral artesunate and quinine plus tetracycline in acute uncomplicated falciparum malaria.
Topics: Administration, Oral; Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Drug Therapy, Combination; Humans; Malaria, Falciparum; Male; Quinine; Sesquiterpenes; Tetracycline; Thailand | 1994 |
Efficacy of oral and intravenous artesunate in male Tanzanian adults with Plasmodium falciparum malaria and in vitro susceptibility to artemisinin, chloroquine, and mefloquine.
Topics: Administration, Oral; Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Chloroquine; Drugs, Chinese Herbal; Erythrocytes; Humans; Injections, Intravenous; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitemia; Plasmodium falciparum; Recurrence; Sesquiterpenes; Tanzania | 1995 |
Randomized controlled trial of artesunate plus tetracycline versus standard treatment (quinine plus tetracycline) for uncomplicated Plasmodium falciparum malaria in Brazil.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Antimalarials; Artemisinins; Artesunate; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Quinine; Sesquiterpenes; Tetracycline | 1996 |
Comparative clinical trial of artesunate followed by mefloquine in the treatment of acute uncomplicated falciparum malaria: two- and three-day regimens.
Topics: Acute Disease; Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Sesquiterpenes | 1996 |
In vivo efficacy of chloroquine, halofantrine, pyrimethamine-sulfadoxine and qinghaosu (artesunate) in the treatment of malaria in Calabar, Nigeria.
Topics: Adolescent; Antimalarials; Artemisinins; Artesunate; Child; Chloroquine; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Nigeria; Phenanthrenes; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Time Factors; Urban Health | 1996 |
Co-administration of desferrioxamine B with artesunate in malaria: an assessment of safety and tolerance.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Deferoxamine; Drug Therapy, Combination; Female; Humans; Malaria, Cerebral; Malaria, Falciparum; Male; Prospective Studies; Sesquiterpenes; Single-Blind Method | 1996 |
Monotherapy with sodium artesunate for uncomplicated falciparum malaria in Thailand: a comparison of 5- and 7-day regimens.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Drug Administration Schedule; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Sesquiterpenes; Thailand | 1997 |
Randomized comparison of artemether-benflumetol and artesunate-mefloquine in treatment of multidrug-resistant falciparum malaria.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Double-Blind Method; Drug Resistance, Multiple; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Prospective Studies; Sesquiterpenes; Treatment Outcome | 1998 |
Comparative clinical trial of artesunate suppositories and oral artesunate in combination with mefloquine in the treatment of children with acute falciparum malaria.
Topics: Administration, Oral; Antimalarials; Artemisinins; Artesunate; Child; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Parasitemia; Pilot Projects; Recurrence; Sesquiterpenes; Suppositories; Thailand | 1998 |
A pharmacokinetic and pharmacodynamic study of intravenous vs oral artesunate in uncomplicated falciparum malaria.
Topics: Administration, Oral; Adult; Antimalarials; Artemisinins; Artesunate; Female; Humans; Injections, Intravenous; Malaria, Falciparum; Male; Reference Values; Sesquiterpenes; Time Factors; Vietnam | 1998 |
Effect of pentoxifylline on cytokine patterns in the therapy of complicated Plasmodium falciparum malaria.
Topics: Antimalarials; Artemisinins; Artesunate; Cytokines; Drug Therapy, Combination; Fever; Humans; Interleukin-6; Malaria, Falciparum; Parasitemia; Pentoxifylline; Phosphodiesterase Inhibitors; Receptors, Interleukin-6; Receptors, Tumor Necrosis Factor; Sesquiterpenes; Tumor Necrosis Factor-alpha | 1998 |
Pentoxifylline as an ancillary treatment for severe falciparum malaria in Thailand.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Pentoxifylline; Phosphodiesterase Inhibitors; Sesquiterpenes; Thailand | 1998 |
A comparative study of artesunate and artemether in combination with mefloquine on multidrug resistant falciparum malaria in eastern Thailand.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antimalarials; Artemether; Artemisinins; Artesunate; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Sesquiterpenes; Thailand; Treatment Outcome | 1997 |
Two doses of artemether/mefloquine or artesunate/mefloquine combination for multidrug resistant falciparum Malaria.
Topics: Acute Disease; Adult; Antimalarials; Artemether; Artemisinins; Artesunate; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Sesquiterpenes; Thailand; Treatment Outcome | 1997 |
Influence of blister packaging on the efficacy of artesunate + mefloquine over artesunate alone in community-based treatment of non-severe falciparum malaria in Myanmar.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Double-Blind Method; Drug Packaging; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Myanmar; Patient Compliance; Sesquiterpenes | 1998 |
Compliance with artesunate and quinine + tetracycline treatment of uncomplicated falciparum malaria in Thailand.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Antimalarials; Artemisinins; Artesunate; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Patient Compliance; Quinine; Sesquiterpenes; Statistics, Nonparametric; Tetracycline; Thailand | 1998 |
[Comparison on treatment of falciparum malaria with different courses of artesunate tablet].
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; Artesunate; Child; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Recurrence; Sesquiterpenes; Tablets | 1997 |
Artesunate versus artemether for the treatment of recrudescent multidrug-resistant falciparum malaria.
Topics: Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Drug Resistance, Multiple; Female; Humans; Infant; Malaria, Falciparum; Male; Recurrence; Sesquiterpenes; Treatment Failure | 1998 |
Pharmacokinetics of mefloquine combined with artesunate in children with acute falciparum malaria.
Topics: Acute Disease; Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Sesquiterpenes | 1999 |
Declining concentrations of dihydroartemisinin in plasma during 5-day oral treatment with artesunate for Falciparum malaria.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Chromatography, High Pressure Liquid; Electrochemistry; Humans; Malaria, Falciparum; Male; Sesquiterpenes | 1999 |
Cost-effectiveness analysis of artesunate and quinine + tetracycline for the treatment of uncomplicated falciparum malaria in Chanthaburi, Thailand.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Antimalarials; Artemisinins; Artesunate; Cost-Benefit Analysis; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Quinine; Sesquiterpenes; Statistics, Nonparametric; Tetracycline; Thailand | 1999 |
Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trial.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Gambia; Humans; Infant; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 2000 |
Efficacy and effectiveness of five day treatment of uncomplicated falciparum with artemisinin or artesunate in Vietnam.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Child; Drug Monitoring; Female; Fever; Follow-Up Studies; Humans; Lactones; Malaria, Falciparum; Male; Sesquiterpenes; Treatment Outcome; Vietnam | 1999 |
The effects of quinine and artesunate treatment on plasma tumor necrosis factor levels in malaria-infected patients.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Cell Adhesion; Drug Monitoring; Female; Humans; Infusions, Intravenous; Malaria, Falciparum; Male; Middle Aged; Quinine; Sesquiterpenes; Time Factors; Treatment Outcome; Tumor Necrosis Factor-alpha | 1999 |
Antimalarial bioavailability and disposition of artesunate in acute falciparum malaria.
Topics: Administration, Oral; Adolescent; Adult; Antimalarials; Area Under Curve; Artemisinins; Artesunate; Biological Availability; Chromatography, High Pressure Liquid; Electrochemistry; Female; Half-Life; Humans; Injections, Intravenous; Intestinal Absorption; Malaria, Falciparum; Male; Models, Biological; Sesquiterpenes | 2000 |
Glucose and lactate kinetics in children with severe malaria.
Topics: Acidosis, Lactic; Antimalarials; Artemisinins; Artesunate; Blood Glucose; Child; Child, Preschool; Dichloroacetic Acid; Female; Humans; Infant; Insulin; Kinetics; Lactic Acid; Malaria, Falciparum; Male; Quinine; Sesquiterpenes | 2000 |
A clinical trial of combination of artesunate and mefloquine in the treatment of acute uncomplicated falciparum malaria: a short and practical regimen.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Drug Resistance; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Sesquiterpenes; Thailand; Time Factors; Treatment Outcome | 1998 |
Effect of artemisinin on lipid peroxidation and fluidity of the erythrocyte membrane in malaria.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Cyclic N-Oxides; Deferoxamine; Double-Blind Method; Erythrocyte Membrane; Humans; Lipid Peroxidation; Malaria; Malaria, Falciparum; Membrane Fluidity; Plasmodium falciparum; Sesquiterpenes; Thiobarbituric Acid Reactive Substances | 2000 |
Pharmacokinetics and pharmacodynamics of intravenous artesunate in severe falciparum malaria.
Topics: Adult; Antimalarials; Area Under Curve; Artemisinins; Artesunate; Female; Half-Life; Humans; Infusions, Intravenous; Malaria, Falciparum; Male; Sesquiterpenes | 2001 |
Artesunate reduces but does not prevent posttreatment transmission of Plasmodium falciparum to Anopheles gambiae.
Topics: Adolescent; Animals; Anopheles; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Gambia; Humans; Infant; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 2001 |
A randomized clinical trial of combinations of artesunate and azithromycin for treatment of uncomplicated Plasmodium falciparum malaria in Thailand.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Azithromycin; Child; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Sesquiterpenes; Thailand; Treatment Outcome | 2000 |
Therapy of uncomplicated falciparum malaria: a randomized trial comparing artesunate plus sulfadoxine-pyrimethamine versus sulfadoxine-pyrimethamine alone in Irian Jaya, Indonesia.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Fever; Humans; Indonesia; Infant; Malaria, Falciparum; Male; Middle Aged; Parasite Egg Count; Parasitemia; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrimethamine; Risk; Sesquiterpenes; Sulfadoxine; Time Factors; Treatment Failure; Treatment Outcome | 2001 |
Treatment of falciparum malaria in Vietnamese children: the need for combination therapy and optimized dosage regimens.
Topics: Adolescent; Adult; Age Factors; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Directly Observed Therapy; Drug Resistance; Drug Therapy, Combination; Endemic Diseases; Female; Humans; Linear Models; Malaria, Falciparum; Male; Mefloquine; Parasitemia; Parasitic Sensitivity Tests; Recurrence; Regression Analysis; Sesquiterpenes; Statistics, Nonparametric; Vietnam | 2001 |
A comparison of oral artesunate and artemether antimalarial bioactivities in acute falciparum malaria.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Antimalarials; Area Under Curve; Artemether; Artemisinins; Artesunate; Biological Availability; Cross-Over Studies; Female; Humans; Malaria, Falciparum; Male; Models, Biological; Sesquiterpenes; Thailand; Time Factors | 2001 |
Randomized trial of artesunate and mefloquine in comparison with quinine sulfate to treat P. falciparum malaria pregnant women.
Topics: Adult; Analysis of Variance; Antimalarials; Artemisinins; Artesunate; Female; Gestational Age; Humans; Malaria, Falciparum; Mefloquine; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Probability; Prospective Studies; Quinine; Sesquiterpenes; Thailand; Treatment Outcome | 2001 |
The pharmacokinetic properties of intramuscular artesunate and rectal dihydroartemisinin in uncomplicated falciparum malaria.
Topics: Administration, Rectal; Adult; Antimalarials; Area Under Curve; Artemisinins; Artesunate; Confidence Intervals; Cross-Over Studies; Female; Humans; Injections, Intramuscular; Injections, Intravenous; Malaria, Falciparum; Male; Sesquiterpenes; Statistics, Nonparametric | 2002 |
Oral artesunate dose-response relationship in acute falciparum malaria.
Topics: Acute Disease; Adolescent; Adult; Aged; Antimalarials; Area Under Curve; Artemisinins; Artesunate; Biotransformation; Dose-Response Relationship, Drug; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Sesquiterpenes; Treatment Outcome | 2002 |
Comparison of oral artesunate and dihydroartemisinin antimalarial bioavailabilities in acute falciparum malaria.
Topics: Acute Disease; Adolescent; Adult; Aged; Antimalarials; Area Under Curve; Artemisinins; Artesunate; Biological Availability; Chromatography, High Pressure Liquid; Cross-Over Studies; Double-Blind Method; Female; Half-Life; Humans; Malaria, Falciparum; Male; Middle Aged; Sesquiterpenes; Spectrophotometry, Ultraviolet; Vietnam | 2002 |
Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combination; Female; Gabon; Humans; Infant; Kenya; Malaria, Falciparum; Male; Plasmodium falciparum; Senegal; Sesquiterpenes; Treatment Outcome | 2002 |
Randomised trial of artesunate and mefloquine alone and in sequence for acute uncomplicated falciparum malaria.
Topics: Acute Disease; Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Sesquiterpenes | 1992 |
Clinical trial of artesunate and artemether on multidrug resistant falciparum malaria in Thailand. A preliminary report.
Topics: Administration, Oral; Adolescent; Adult; Artemether; Artemisinins; Artesunate; Drug Administration Schedule; Drug Resistance; Hospitals, University; Humans; Injections, Intramuscular; Injections, Intravenous; Leukopenia; Malaria, Falciparum; Male; Microbial Sensitivity Tests; Recurrence; Sesquiterpenes; Thailand | 1991 |
Double blind randomised clinical trial of two different regimens of oral artesunate in falciparum malaria.
Topics: Administration, Oral; Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Dose-Response Relationship, Drug; Double-Blind Method; Follow-Up Studies; Humans; Malaria, Falciparum; Middle Aged; Randomized Controlled Trials as Topic; Recurrence; Sesquiterpenes; Time Factors | 1991 |
Double blind randomised clinical trial of oral artesunate at once or twice daily dose in falciparum malaria.
Topics: Administration, Oral; Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Double-Blind Method; Follow-Up Studies; Humans; Malaria, Falciparum; Middle Aged; Randomized Controlled Trials as Topic; Recurrence; Sesquiterpenes; Time Factors | 1991 |
391 other study(ies) available for artesunic acid and Malaria, Falciparum
| Article | Year |
|---|---|
Characteristics of severe malaria in hospitalized children in Ho Chi Minh City from 2012 to 2019.
Topics: Adolescent; Anemia; Artesunate; Child; Child, Hospitalized; Child, Preschool; Female; Fever; Hepatomegaly; Humans; Infant; Malaria, Falciparum; Male; Splenomegaly; Vietnam | 2021 |
Dimeric artesunate-choline conjugate micelles coated with hyaluronic acid as a stable, safe and potent alternative anti-malarial injection of artesunate.
Topics: Antimalarials; Artesunate; Choline; Humans; Hyaluronic Acid; Malaria, Falciparum; Micelles | 2021 |
MEFAS, a hybrid of artesunate-mefloquine active against asexual stages of Plasmodium vivax in field isolates, inhibits malaria transmission.
Topics: Animals; Antimalarials; Artesunate; Humans; Malaria; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Plasmodium falciparum; Plasmodium vivax | 2021 |
Plasmodium falciparum clearance time in Malawian children with cerebral malaria: a retrospective cohort study.
Topics: Adolescent; Antimalarials; Artesunate; Child; Child, Preschool; Cohort Studies; Female; Humans; Infant; Malaria, Cerebral; Malaria, Falciparum; Malawi; Male; Plasmodium falciparum; Quinine; Retrospective Studies; Time Factors | 2021 |
Returned traveller presenting with anaemia: clinical challenge of post-artesunate delayed haemolysis.
Topics: Anemia; Antimalarials; Artemisinins; Artesunate; Hemolysis; Humans; Malaria, Falciparum | 2021 |
Delayed autoimmune haemolytic anaemia after artesunate therapy for severe malaria.
Topics: Anemia, Hemolytic, Autoimmune; Antimalarials; Artesunate; Humans; Malaria; Malaria, Falciparum; Male; Middle Aged | 2022 |
Circulation of an Artemisinin-Resistant Malaria Lineage in a Traveler Returning from East Africa to France.
Topics: Antimalarials; Artemisinins; Artesunate; Drug Resistance; Humans; Malaria, Falciparum; Plasmodium falciparum; Protozoan Proteins; Uganda | 2022 |
Artesunate monotherapy versus artesunate plus quinine combination therapy for treatment of imported severe malaria: a TropNet retrospective cohort study.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Child; Drug Therapy, Combination; Fever; Humans; Malaria; Malaria, Falciparum; Quinine; Retrospective Studies | 2022 |
Parvovirus B19-associated transient aplastic crisis following P. falciparum malaria and post-artesunate delayed haemolysis in a returning traveller.
Topics: Artesunate; Hemolysis; Humans; Malaria; Malaria, Falciparum; Parvovirus B19, Human | 2022 |
Assessment of quantitative and semi-quantitative biological test methods of artesunate in vitro.
Topics: Antimalarials; Artesunate; Humans; Malaria, Falciparum; Plasmodium falciparum | 2022 |
Dimeric Artesunate Glycerophosphocholine Conjugate Nano-Assemblies as Slow-Release Antimalarials to Overcome Kelch 13 Mutant Artemisinin Resistance.
Topics: Antimalarials; Artemisinins; Artesunate; Cryoelectron Microscopy; Drug Resistance; Humans; Liposomes; Malaria; Malaria, Falciparum; Plasmodium falciparum | 2022 |
Artesunate Resistance - An Emerging Threat.
Topics: Adult; Antimalarials; Artesunate; Drug Resistance; Female; Humans; Malaria; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Pregnancy; Vomiting | 2022 |
Artesunate-amodiaquine and artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in Liberia: in vivo efficacy and frequency of molecular markers.
Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artesunate; Child; Chloroquine; DNA Copy Number Variations; Female; Humans; Liberia; Malaria; Malaria, Falciparum; Membrane Transport Proteins; Plasmodium falciparum; Pregnancy | 2022 |
[Malaria and its importance in travel medicine].
Topics: Antimalarials; Artesunate; Humans; Malaria; Malaria, Falciparum; Severity of Illness Index; Travel; Travel Medicine | 2022 |
Artesunate and dihydroartemisinin-piperaquine treatment failure in a severe Plasmodium falciparum malaria case imported from Republic of Côte d'Ivoire.
Topics: Aged; Antimalarials; Artemisinins; Artesunate; Cote d'Ivoire; Drug Combinations; Humans; Malaria; Malaria, Falciparum; Male; Piperazines; Plasmodium falciparum; Quinolines; Treatment Failure | 2022 |
Parasite Viability as a Measure of
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Australia; Humans; Malaria, Falciparum; Mice; Parasitemia; Parasites; Plasmodium falciparum | 2022 |
Stakeholder perceptions on the deployment of multiple first-line therapies for uncomplicated malaria: a qualitative study in the health district of Kaya, Burkina Faso.
Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Burkina Faso; Drug Combinations; Drug Therapy, Combination; Humans; Malaria; Malaria, Falciparum; Naphthyridines | 2022 |
[Pcr-rflp genotyping of
Topics: Amodiaquine; Artesunate; Child; Chloroquine; Drug Resistance; Genotype; Humans; Madagascar; Malaria, Falciparum; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Protozoan Proteins | 2022 |
Post-artesunate Delayed Hemolysis in Patients With Severe Malaria in the United States-April 2019 Through July 2021.
Topics: Antimalarials; Artemisinins; Artesunate; Hemolysis; Humans; Malaria; Malaria, Falciparum; United States | 2023 |
Naturally Acquired Kelch13 Mutations in Plasmodium falciparum Strains Modulate
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Drug Resistance; Drug Tolerance; Hyperoxia; Malaria, Falciparum; Mutation; Parasites; Plasmodium falciparum; Protozoan Proteins | 2022 |
Prevalence and characterization of piperaquine, mefloquine and artemisinin derivatives triple-resistant Plasmodium falciparum in Cambodia.
Topics: Antimalarials; Artemisinins; Artesunate; Cambodia; Drug Resistance; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Prevalence; Quinolines | 2023 |
Rectal artesunate as pre-referral treatment for severe malaria in sub-Saharan Africa: still a long way to go.
Topics: Africa South of the Sahara; Antimalarials; Artesunate; Humans; Malaria; Malaria, Falciparum; Referral and Consultation | 2023 |
Molecular surveillance of anti-malarial drug resistance genes in Plasmodium falciparum isolates in Odisha, India.
Topics: Antimalarials; Artesunate; Chloroquine; Drug Combinations; Drug Resistance; Humans; India; Malaria, Falciparum; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Sulfadoxine | 2022 |
Return to Travel in the Coronavirus Disease 2019 Pandemic Recovery Period and Implications for Imported Malaria: Reinforcing Prevention, Early Diagnosis, and Appropriate Treatment of Malaria.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artesunate; COVID-19; COVID-19 Testing; Early Diagnosis; Humans; Malaria; Malaria, Falciparum; Pandemics; Travel; United States | 2023 |
Congenital severe malaria: Artesunate for successful and safe treatment in neonates: A case report.
Topics: Antimalarials; Artesunate; Humans; Infant, Newborn; Infant, Newborn, Diseases; Malaria; Malaria, Falciparum | 2023 |
Prediction of improved antimalarial chemotherapy of artesunate-mefloquine in combination with mefloquine sensitive and resistant Plasmodium falciparum malaria.
Topics: Antimalarials; Artemisinins; Artesunate; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Sesquiterpenes | 2023 |
Use of artesunate in the treatment of severe imported malaria in France: review of the effectiveness and real-life safety in two French university hospitals.
Topics: Antimalarials; Artemisinins; Artesunate; France; Hospitals, University; Humans; Malaria; Malaria, Falciparum; Retrospective Studies | 2023 |
An artesunate pharmacometric model to explain therapeutic responses in falciparum malaria.
Topics: Antimalarials; Artemisinins; Artesunate; Bayes Theorem; Drug Resistance; Humans; Malaria, Falciparum; Plasmodium falciparum | 2023 |
Therapeutic efficacy of artesunate-amodiaquine and artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in Chad: clinical and genetic surveillance.
Topics: Adult; Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Chad; Female; Humans; Malaria, Falciparum; Pregnancy; Prospective Studies | 2023 |
Evidence Based Optimal Dosing of Intravenous Artesunate in Children with Severe Falciparum Malaria.
Topics: Administration, Intravenous; Adolescent; Antimalarials; Artesunate; Bayes Theorem; Child; Humans; Malaria; Malaria, Falciparum | 2023 |
Investigation of new ferrocenyl-artesunate derivatives as antiparasitics.
Topics: Amides; Antimalarials; Antiparasitic Agents; Artesunate; Humans; Malaria; Malaria, Falciparum; Plasmodium falciparum | 2023 |
Antimalarial Agents Targeting Plasmodium falciparum Carbonic Anhydrase: Towards Artesunate Hybrid Compounds with Dual Mechanism of Action.
Topics: Animals; Antimalarials; Artesunate; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Humans; Malaria; Malaria, Falciparum; Mice; Plasmodium falciparum; Protein Isoforms | 2023 |
Variation in neutrophil levels and artemisinin-based combination therapy efficacy in West-Africa.
Topics: Africa; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Drug Combinations; Ethanolamines; Humans; Malaria; Malaria, Falciparum; Neutropenia; Neutrophils; Parasitemia; Plasmodium falciparum; Prospective Studies | 2023 |
[Extracorporeal support treatment in severe malaria].
Topics: Adult; Antimalarials; Artesunate; Brain Diseases; Humans; Malaria; Malaria, Falciparum; Male | 2023 |
Favorable outcome without corticosteroids during post-artesunate delayed hemolysis with positive direct antiglobulin test in severe imported Plasmodium falciparum malaria, France.
Topics: Adrenal Cortex Hormones; Antimalarials; Artemisinins; Artesunate; Coombs Test; France; Hemolysis; Humans; Malaria; Malaria, Falciparum; Retrospective Studies | 2023 |
Severe Malaria Treatment in the United States at the Precipice.
Topics: Antimalarials; Artesunate; Drug Approval; Humans; Malaria, Falciparum; Male; Patient Care Planning; Quinidine; Severity of Illness Index; United States; United States Food and Drug Administration; Young Adult | 2019 |
Adherence to antimalarial drug policy among doctors in Delta State, Nigeria: implications for malaria control.
Topics: Adult; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artesunate; Chloroquine; Drug Resistance, Microbial; Female; Guideline Adherence; Health Policy; Humans; Malaria, Falciparum; Male; Middle Aged; Nigeria; Plasmodium falciparum; Practice Guidelines as Topic; Practice Patterns, Physicians'; Quinine; Surveys and Questionnaires; Young Adult | 2019 |
Safety and tolerability of artesunate-amodiaquine, artemether-lumefantrine and quinine plus clindamycin in the treatment of uncomplicated Plasmodium falciparum malaria in Kinshasa, the Democratic Republic of the Congo.
Topics: Amodiaquine; Anti-Bacterial Agents; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child, Preschool; Clindamycin; Democratic Republic of the Congo; Drug Combinations; Female; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Plasmodium falciparum; Quinine | 2019 |
Comment on "A. annua and A. afra infusions vs. Artesunate-amodiaquine (ASAQ) in treating Plasmodium falciparum malaria in a large scale, double blind, randomized clinical trial" Munyangi et al., 2019.
Topics: Amodiaquine; Artemisinins; Artesunate; Double-Blind Method; Humans; Malaria, Falciparum | 2022 |
Intravenous Artesunate for Imported Severe Malaria in Children Treated in Four Tertiary Care Centers in Germany: A Retrospective Study.
Topics: Acute Disease; Administration, Intravenous; Adolescent; Antimalarials; Artesunate; Child; Child, Preschool; Communicable Diseases, Imported; Female; Germany; Humans; Infant; Malaria, Falciparum; Malaria, Vivax; Male; Parasitemia; Retrospective Studies; Tertiary Care Centers | 2019 |
Regulated rutin co-administration reverses mitochondrial-mediated apoptosis in Plasmodium berghei-infected mice.
Topics: Animals; Apoptosis; Artemisinins; Artesunate; Drug Therapy, Combination; Malaria, Falciparum; Male; Mefloquine; Mice; Mitochondria; Plasmodium berghei; Rutin | 2020 |
Two cases of airport-associated falciparum malaria in Frankfurt am Main, Germany, October 2019.
Topics: Adult; Airports; Antimalarials; Artesunate; Atovaquone; Fever; Genotype; Germany; Humans; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Polymerase Chain Reaction; Proguanil; Travel; Treatment Outcome | 2019 |
Association of Lipid Levels with Mefloquine and Carboxy-Mefloquine Concentrations in Patients with Uncomplicated Falciparum Malaria.
Topics: Adult; Antimalarials; Artesunate; Biotransformation; Brazil; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Drug Therapy, Combination; Erythrocytes; Humans; Malaria, Falciparum; Male; Mefloquine; Plasmodium falciparum; Severity of Illness Index; Triglycerides | 2020 |
Antiplasmodial profile of selected compounds from Malaria Box: in vitro evaluation, speed of action and drug combination studies.
Topics: Antimalarials; Artesunate; Drug Combinations; Hep G2 Cells; Humans; Malaria, Falciparum; Plasmodium berghei; Plasmodium falciparum; Toxicity Tests | 2019 |
A Computer Modelling Approach To Evaluate the Accuracy of Microsatellite Markers for Classification of Recurrent Infections during Routine Monitoring of Antimalarial Drug Efficacy.
Topics: Algorithms; Antimalarials; Artemether, Lumefantrine Drug Combination; Artesunate; Computational Biology; Computer Simulation; Data Interpretation, Statistical; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Microsatellite Repeats; Plasmodium falciparum; Reinfection; Treatment Failure | 2020 |
Machine learning analysis plans for randomised controlled trials: detecting treatment effect heterogeneity with strict control of type I error.
Topics: Adult; Algorithms; Antimalarials; Artesunate; Asia; Humans; Machine Learning; Malaria, Falciparum; Plasmodium falciparum; Quinine; Randomized Controlled Trials as Topic; Retrospective Studies; Treatment Outcome | 2020 |
Different Plasmodium falciparum clearance times in two Malian villages following artesunate monotherapy.
Topics: Antimalarials; Artesunate; Child; Female; Humans; Malaria, Falciparum; Male; Mali; Microscopy; Parasitemia; Plasmodium falciparum; Real-Time Polymerase Chain Reaction | 2020 |
Increase hemoglobin level in severe malarial anemia while controlling parasitemia: A mathematical model.
Topics: Anemia; Animals; Antimalarials; Artesunate; Computer Simulation; Dendritic Cells; Drug Therapy, Combination; Erythrocytes; Hemoglobins; Humans; Intramolecular Oxidoreductases; Limonins; Macrophage Activation; Macrophage Migration-Inhibitory Factors; Malaria, Falciparum; Mathematical Concepts; Mice; Models, Biological; Models, Immunological; Parasitemia; Th1 Cells | 2020 |
Efficacy of dihydroartemisinin/piperaquine and artesunate monotherapy for the treatment of uncomplicated Plasmodium falciparum malaria in Central Vietnam.
Topics: Antimalarials; Artemisinins; Artesunate; Humans; Malaria, Falciparum; Plasmodium falciparum; Quinolines; Vietnam | 2020 |
Clinical and In Vitro Resistance of Plasmodium falciparum to Artesunate-Amodiaquine in Cambodia.
Topics: Adult; Amodiaquine; Antimalarials; Artemisinins; Artesunate; Asia; Cambodia; Child; Humans; Malaria; Malaria, Falciparum; Plasmodium falciparum; Prospective Studies | 2021 |
Non-synonymous amino acid alterations in PfEBA-175 modulate the merozoite ligand's ability to interact with host's Glycophorin A receptor.
Topics: Amino Acid Substitution; Animals; Antimalarials; Artemisinins; Artesunate; Erythrocytes; Glycophorins; Host-Parasite Interactions; Humans; Intracellular Signaling Peptides and Proteins; Malaria, Falciparum; Molecular Docking Simulation; Plasmodium falciparum; Polymorphism, Genetic; Protein Binding; Protein Domains; Protein Folding; Protozoan Proteins; Recombinant Proteins | 2020 |
Spontaneous Bilateral Subdural Hematoma in a Patient with Falciparum Malaria.
Topics: Aged; Artesunate; Female; Hematoma, Subdural; Humans; Malaria, Falciparum | 2020 |
Increased Sensitivity of Plasmodium falciparum to Artesunate/Amodiaquine Despite 14 Years as First-Line Malaria Treatment, Zanzibar.
Topics: Amodiaquine; Antimalarials; Artesunate; Asia; Drug Combinations; Drug Resistance; Humans; Malaria; Malaria, Falciparum; Plasmodium falciparum; Protozoan Proteins; Tanzania | 2020 |
Stable high frequencies of sulfadoxine-pyrimethamine resistance associated mutations and absence of K13 mutations in Plasmodium falciparum 3 and 4 years after the introduction of artesunate plus sulfadoxine-pyrimethamine in Ujjain, Madhya Pradesh, India.
Topics: Adolescent; Adult; Aged; Antimalarials; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Resistance; Humans; India; Infant; Malaria, Falciparum; Middle Aged; Mutation; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Young Adult | 2020 |
Dormant Plasmodium falciparum Parasites in Human Infections Following Artesunate Therapy.
Topics: Antimalarials; Artesunate; Drug Resistance; Humans; Malaria, Falciparum; Plasmodium falciparum; Protozoan Proteins | 2021 |
Plasmodium falciparum replication factor C subunit 1 is involved in genotoxic stress response.
Topics: Antimalarials; Artesunate; Cell Death; Chloroquine; DNA Damage; DNA Repair; DNA Replication; DNA, Protozoan; Erythrocytes; Gene Expression Regulation; Host-Parasite Interactions; Humans; Malaria, Falciparum; Plasmodium falciparum; Protozoan Proteins; Reactive Oxygen Species; Replication Protein C | 2021 |
Parasite Viability as a Superior Measure of Antimalarial Drug Activity in Humans.
Topics: Antimalarials; Artemisinins; Artesunate; Drug Resistance; Humans; Malaria, Falciparum; Models, Theoretical; Plasmodium falciparum | 2021 |
Delayed haemolysis following artesunate in a child with profound anaemia and Coca-Cola-coloured urine.
Topics: Anemia; Antimalarials; Artesunate; Blood Transfusion; Child; Female; Hemolysis; Humans; Malaria, Falciparum; Time Factors; Treatment Outcome | 2020 |
A Case of Plasmodium falciparum Malaria Treated with Artesunate in a 55-Year-Old Woman on Return to Florida from a Visit to Ghana.
Topics: Adult; Antimalarials; Artesunate; Child; Female; Florida; Ghana; Humans; Malaria, Falciparum; Middle Aged; United States | 2020 |
Maintaining focus on administering effective malaria treatment during the COVID-19 pandemic.
Topics: Administration, Intravenous; Antigens, Protozoan; Antimalarials; Artemether, Lumefantrine Drug Combination; Artesunate; COVID-19; Early Diagnosis; Early Medical Intervention; Humans; Malaria; Malaria, Falciparum; Microscopy; Point-of-Care Testing; Primaquine; Protozoan Proteins; SARS-CoV-2; Severity of Illness Index; South Africa | 2020 |
Acute kidney injury secondary to severe delayed haemolysis in intravenous artesunate use for severe malaria.
Topics: Acute Kidney Injury; Administration, Intravenous; Anemia, Hemolytic; Antimalarials; Artesunate; Australia; Erythrocyte Transfusion; Fluid Therapy; Hemolysis; Humans; Malaria, Falciparum; Male; Middle Aged; Severity of Illness Index; Travel-Related Illness | 2021 |
Hepatic safety of repeated treatment with pyronaridine-artesunate versus artemether-lumefantrine in patients with uncomplicated malaria: a secondary analysis of the WANECAM 1 data from Bobo-Dioulasso, Burkina Faso.
Topics: Adolescent; Antimalarials; Artemether, Lumefantrine Drug Combination; Artesunate; Burkina Faso; Child; Child, Preschool; Drug Combinations; Female; Humans; Infant; Infant, Newborn; Liver; Malaria, Falciparum; Male; Naphthyridines; Plasmodium falciparum | 2021 |
4-chloro eugenol interacts synergistically with artesunate against drug resistant P. falciparum inducing oxidative stress.
Topics: Animals; Antimalarials; Artesunate; Calcium; DNA Damage; Drug Resistance; Drug Synergism; Eugenol; Lipid Peroxidation; Malaria, Falciparum; Membrane Potential, Mitochondrial; Mice; Oxidative Stress; Plasmodium falciparum; Protein Carbonylation; Reactive Nitrogen Species; Reactive Oxygen Species | 2021 |
Dolutegravir pharmacokinetics during co-administration with either artemether/lumefantrine or artesunate/amodiaquine.
Topics: Africa; Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artesunate; Drug Combinations; Ethanolamines; Fluorenes; Heterocyclic Compounds, 3-Ring; Humans; Malaria, Falciparum; Oxazines; Piperazines; Pyridones | 2021 |
Malaria in an asylum seeker paediatric liver transplant recipient: diagnostic challenges for migrant population.
Topics: Antimalarials; Artemether; Artesunate; Child, Preschool; Humans; Liver Transplantation; Lumefantrine; Malaria, Falciparum; Male; Plasmodium falciparum; Transients and Migrants; Transplant Recipients; Treatment Outcome | 2021 |
Intravenous Artesunate for the Treatment of Severe Imported Malaria: Implementation, Efficacy, and Safety in 1391 Patients.
Topics: Antimalarials; Artemisinins; Artesunate; Female; Hemolysis; Humans; Malaria; Malaria, Falciparum; Pregnancy | 2021 |
Effect of Body Weight and Age on the Pharmacokinetics of Dihydroartemisinin: Food and Drug Administration Basis for Dose Determination of Artesunate for Injection in Pediatric Patients With Severe Malaria.
Topics: Antimalarials; Artemisinins; Artesunate; Body Weight; Child; Humans; Malaria; Malaria, Falciparum; United States; United States Food and Drug Administration | 2021 |
Recrudescence of a high parasitaemia, severe Plasmodium falciparum malaria episode, treated by artesunate monotherapy.
Topics: Aged; Antimalarials; Artesunate; Humans; Malaria, Falciparum; Male; Parasitemia; Recurrence | 2021 |
Development and Validation of an
Topics: Adult; Africa; Antimalarials; Artesunate; Asia, Southeastern; Bayes Theorem; Child; Computer Simulation; Humans; Malaria; Malaria, Falciparum; Plasmodium falciparum | 2021 |
Atovaquone/Proguanil Resistance in an Imported Malaria Case in Chile.
Topics: Adult; Antimalarials; Artesunate; Atovaquone; Chile; Cytochromes b; Drug Combinations; Drug Resistance; Female; Gene Expression; Humans; Malaria, Falciparum; Male; Mefloquine; Mutation; Nigeria; Parasitemia; Plasmodium falciparum; Proguanil; Protozoan Proteins; Recurrence; Tetrahydrofolate Dehydrogenase; Travel | 2021 |
Association between ABCB1 Polymorphisms and Artesunate-Mefloquine Treatment Responses of Patients with Falciparum Malaria on the Thailand-Myanmar Border.
Topics: Adolescent; Adult; Antimalarials; Artesunate; ATP Binding Cassette Transporter, Subfamily B; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Myanmar; Plasmodium falciparum; Polymorphism, Genetic; Thailand; Young Adult | 2021 |
Suspected
Topics: Antimalarials; Artemisinins; Artesunate; Cameroon; Female; Humans; Malaria, Falciparum; Plasmodium falciparum; Pregnancy | 2021 |
Safety and Effectiveness of Intravenous Artesunate for Treatment of Severe Malaria in the United States-April 2019 Through December 2020.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Female; Humans; Malaria; Malaria, Falciparum; Male; Middle Aged; United States; Young Adult | 2021 |
Quality of artemisinin-based antimalarial drugs marketed in Nigeria.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Drug and Narcotic Control; Drug Combinations; Drug Evaluation; Ethanolamines; Fluorenes; Humans; Malaria, Falciparum; Nigeria; Quality Control | 2017 |
Antibody Responses to
Topics: Adaptive Immunity; Antibodies, Protozoan; Antimalarials; Artemisinins; Artesunate; Chloroquine; Cohort Studies; Disease Resistance; Disease Susceptibility; Female; Humans; Immunoglobulin G; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Merozoite Surface Protein 1; Parasitemia; Parturition; Plasmodium falciparum; Plasmodium vivax; Pregnancy; Proportional Hazards Models; Risk; Time Factors | 2017 |
Clinical and molecular monitoring of Plasmodium falciparum resistance to antimalarial drug (artesunate+sulphadoxine-pyrimethamine) in two highly malarious district of Madhya Pradesh, Central India from 2012-2014.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Resistance; Epidemiological Monitoring; Female; Genes, Protozoan; Genotype; Genotyping Techniques; Humans; India; Infant; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome; Young Adult | 2017 |
Malaria: diagnosis, treatment and management of a critically ill patient.
Topics: Adolescent; Antimalarials; Artemisinins; Artesunate; Critical Care Nursing; Critical Illness; Fatal Outcome; Female; Humans; Malaria, Cerebral; Malaria, Falciparum | 2017 |
Severe delayed haemolytic anaemia associated with artemether-lumefantrine treatment of malaria in a Japanese traveller.
Topics: Administration, Intravenous; Administration, Oral; Anemia, Hemolytic; Antimalarials; Artemether; Artemisinins; Artesunate; Blackwater Fever; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Plasmodium falciparum; Plasmodium vivax; Recurrence; Young Adult | 2018 |
Cellular mechanisms of action and resistance of Plasmodium falciparum to artemisinin.
Topics: Antimalarials; Antioxidants; Artemisinins; Artesunate; Drug Resistance; Hemeproteins; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Polymorphism, Genetic; Thailand | 2017 |
Antimalarial activity of Malaria Box Compounds against Plasmodium falciparum clinical isolates.
Topics: Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Evaluation, Preclinical; Drug Resistance; Erythrocytes; Ghana; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Parasitic Sensitivity Tests; Plasmodium falciparum | 2017 |
Plasmodium falciparum Kelch 13 mutations and treatment response in patients in Hpa-Pun District, Northern Kayin State, Myanmar.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Middle Aged; Mutation; Myanmar; Phenotype; Plasmodium falciparum; Polymorphism, Genetic; Prevalence; Protozoan Proteins; Young Adult | 2017 |
Poor response to artesunate treatment in two patients with severe malaria on the Thai-Myanmar border.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Drug Resistance; Fatal Outcome; Humans; Malaria, Falciparum; Male; Myanmar; Plasmodium falciparum; Quinine; Thailand; Treatment Outcome | 2018 |
Severe post-artesunate delayed onset anaemia responding to corticotherapy: a case report.
Topics: Administration, Intravenous; Adrenal Cortex Hormones; Adult; Anemia, Hemolytic; Artemisinins; Artesunate; Coombs Test; Hemolysis; Humans; Malaria, Falciparum; Male; Parasitemia; Travel | 2018 |
Blackwater fever in a non-immune patient with Plasmodium falciparum malaria after intravenous artesunate.
Topics: Administration, Intravenous; Antimalarials; Artesunate; Blackwater Fever; Hemolysis; Humans; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Travel | 2018 |
Transfusion-Transmitted Plasmodium falciparum in a Patient With Sickle Cell Hemoglobinopathy.
Topics: Adolescent; Anemia, Sickle Cell; Antimalarials; Artesunate; Erythrocyte Transfusion; Humans; Malaria, Falciparum; Male; Multiple Organ Failure; Transfusion Reaction | 2018 |
Severe
Topics: Adult; Antimalarials; Artesunate; Critical Care; Drugs, Investigational; Humans; Malaria, Falciparum; Male; Severity of Illness Index; United States; United States Food and Drug Administration | 2020 |
Suspected quinine resistant P. falciparum severe malaria possibly acquired in Ivory Coast.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Clindamycin; Cote d'Ivoire; Drug Therapy, Combination; Humans; Malaria, Falciparum; Male; Parasitemia; Quinine; Spain; Treatment Failure; Treatment Outcome | 2018 |
The Impact of Artesunate-Amodiaquine on Schistosoma mansoni Infection among Children Infected by Plasmodium in Rural Area of Lemfu, Kongo Central, Democratic Republic of the Congo.
Topics: Adolescent; Amodiaquine; Animals; Antimalarials; Artesunate; Child; Child, Preschool; Democratic Republic of the Congo; Female; Humans; Malaria, Falciparum; Male; Plasmodium; Prospective Studies; Rural Population; Schistosoma mansoni; Schistosomiasis mansoni | 2018 |
Population pharmacokinetics of mefloquine given as a 3-day artesunate-mefloquine in patients with acute uncomplicated Plasmodium falciparum malaria in a multidrug-resistant area along the Thai-Myanmar border.
Topics: Acute Disease; Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Drug Combinations; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Myanmar; Plasmodium falciparum; Thailand; Young Adult | 2018 |
Topics: Antimalarials; Artemisinins; Artesunate; Computer Simulation; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Models, Biological; Plasmodium falciparum; Quinolines; Treatment Failure | 2018 |
Absence of
Topics: Antimalarials; Artemether; Artesunate; Brazil; Drug Combinations; Drug Resistance; Epidemiological Monitoring; Gene Expression; Genetic Markers; Genotyping Techniques; Humans; Kelch Repeat; Malaria, Falciparum; Mefloquine; Molecular Epidemiology; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Quinine | 2018 |
Cryptic severe
Topics: Administration, Intravenous; Administration, Oral; Antimalarials; Artemisinins; Artesunate; Humans; Italy; Malaria, Falciparum; Male; Middle Aged; Morocco; Plasmodium falciparum; Quinolines; Transients and Migrants; Treatment Outcome | 2018 |
Molecular Evidence for
Topics: Adolescent; Adult; Aged; Alleles; Antimalarials; Artemisinins; Artesunate; Child; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Epidemiological Monitoring; Female; Gene Expression; Humans; India; Kelch Repeat; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Molecular Epidemiology; Multidrug Resistance-Associated Proteins; Mutation; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2018 |
Optimal Treatments for Severe Malaria and the Threat Posed by Artemisinin Resistance.
Topics: Acute Disease; Antimalarials; Artemisinins; Artesunate; Drug Resistance; Humans; Malaria, Falciparum; Models, Biological; Parasitemia; Plasmodium falciparum; Treatment Outcome | 2019 |
Viability Screen of LOPAC
Topics: Antimalarials; Artesunate; Drug Resistance; Genotype; Humans; Malaria, Falciparum; Mutation; Plasmodium falciparum; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Protozoan Proteins; Tyrphostins | 2019 |
Relationship between weight status and anti-malarial drug efficacy and safety in children in Mali.
Topics: Adolescent; Amodiaquine; Antimalarials; Artesunate; Body Weight; Child; Child, Preschool; Clinical Trials as Topic; Female; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Male; Mali; Sulfadoxine; Treatment Outcome; Young Adult | 2019 |
Acute interstitial nephritis with podocyte foot-process effacement complicating Plasmodium falciparum infection.
Topics: Adult; Antimalarials; Artesunate; Biopsy; Histocytochemistry; Humans; Ireland; Malaria, Falciparum; Male; Nephritis, Interstitial; Nigeria; Podocytes; Renal Dialysis; Travel-Related Illness | 2019 |
Propensity Score Analysis of Artesunate Versus Quinine for Severe Imported Plasmodium falciparum Malaria in France.
Topics: Antimalarials; Artemisinins; Artesunate; France; Humans; Malaria, Falciparum; Propensity Score; Quinine | 2020 |
Plasmodium falciparum Clearance Is Pitting-Dependent With Artemisinin-Based Drugs but Pitting-Independent With Atovaquone-Proguanil or Mefloquine.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Atovaquone; Child; Drug Combinations; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Proguanil; Young Adult | 2019 |
Expanded Availability of Intravenous Artesunate for the Treatment of Severe Malaria in the United States.
Topics: Administration, Intravenous; Antimalarials; Artesunate; Centers for Disease Control and Prevention, U.S.; Drug Administration Schedule; Drug Approval; Humans; Malaria, Falciparum; Quinidine; Quinine; United States; United States Food and Drug Administration | 2019 |
Level of knowledge among health care providers on preparation of injectable artesunate for treatment of severe malaria in public health facilities in Tanzania.
Topics: Adult; Antimalarials; Artesunate; Cross-Sectional Studies; Female; Health Facilities; Health Knowledge, Attitudes, Practice; Health Personnel; Humans; Injections; Malaria, Falciparum; Male; Middle Aged; Professional Competence; Public Health; Tanzania | 2019 |
Artesunate Versus Quinine: Keeping Our Options Open.
Topics: Artesunate; France; Humans; Malaria, Falciparum; Propensity Score; Quinine | 2020 |
Pyronaridine-artesunate Shows Promise as an Effective and Well-tolerated Treatment for Artemisinin-resistant Plasmodium falciparum Malaria.
Topics: Artemisinins; Artesunate; Humans; Malaria, Falciparum; Naphthyridines; Vietnam | 2020 |
The effect of dose on the antimalarial efficacy of artesunate-mefloquine against
Topics: Antimalarials; Artesunate; Clinical Protocols; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Meta-Analysis as Topic; Research Design; Systematic Reviews as Topic; Treatment Outcome | 2019 |
Pre-clinical study of iron oxide nanoparticles fortified artesunate for efficient targeting of malarial parasite.
Topics: Animals; Antimalarials; Artesunate; Ferric Compounds; Humans; Malaria, Falciparum; Metal Nanoparticles; Mice; Plasmodium falciparum | 2019 |
Evolution of Plasmodium falciparum drug resistance genes following artemisinin combination therapy in Sudan.
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Artesunate; Chloroquine; DNA, Protozoan; Drug Resistance; Drug Therapy, Combination; Genetic Markers; Genotype; Humans; Lumefantrine; Malaria, Falciparum; Mutation; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Pyrimethamine; Sudan; Sulfadoxine | 2019 |
Tetany with Plasmodium falciparum infection.
Topics: Administration, Intravenous; Adult; Antimalarials; Artemisinins; Artesunate; Calcium; Calcium Gluconate; Humans; Hypocalcemia; Magnesium; Malaria, Falciparum; Male; Phosphates; Plasmodium falciparum; Tetany; Treatment Outcome | 2012 |
Safety and efficacy of pyronaridine-artesunate in uncomplicated acute malaria: an integrated analysis of individual patient data from six randomized clinical trials.
Topics: Adolescent; Adult; Africa; Antimalarials; Artemisinins; Artesunate; Asia; Child; Child, Preschool; Clinical Trials, Phase III as Topic; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Infant; Malaria; Malaria, Falciparum; Malaria, Vivax; Male; Middle Aged; Naphthyridines; Randomized Controlled Trials as Topic; Treatment Outcome; Young Adult | 2013 |
Plasmodium falciparum clearance rates in response to artesunate in Malian children with malaria: effect of acquired immunity.
Topics: Adaptive Immunity; Adolescent; Amodiaquine; Antibodies, Protozoan; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Cohort Studies; Erythrocytes; Female; Humans; Immunoglobulin G; Infant; Malaria, Falciparum; Male; Mali; Parasite Load; Parasitemia; Plasmodium falciparum | 2013 |
Prevalence of antifolate resistance mutations in Plasmodium falciparum isolates in Afghanistan.
Topics: Adult; Afghanistan; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; DNA, Protozoan; Drug Combinations; Drug Resistance; Folic Acid Antagonists; Humans; Malaria, Falciparum; Mutation, Missense; Plasmodium falciparum; Polymerase Chain Reaction; Prevalence; Protozoan Proteins; Pyrimethamine; Sulfadoxine | 2013 |
Population pharmacokinetics of intramuscular artesunate in African children with severe malaria: implications for a practical dosing regimen.
Topics: Antimalarials; Artemisinins; Artesunate; Body Weight; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Infant; Injections, Intramuscular; Malaria, Falciparum; Models, Biological; Nonlinear Dynamics; Severity of Illness Index; Tanzania; Time Factors; Tissue Distribution | 2013 |
Manual blood exchange transfusion does not significantly contribute to parasite clearance in artesunate-treated individuals with imported severe Plasmodium falciparum malaria.
Topics: Adult; Animals; Antimalarials; Artemisinins; Artesunate; Blood; Exchange Transfusion, Whole Blood; Female; Follow-Up Studies; Humans; Malaria, Falciparum; Male; Middle Aged; Netherlands; Plasmodium falciparum; Quinine; Retrospective Studies; Treatment Outcome | 2013 |
Selection of antimalarial drug resistance after intermittent preventive treatment of infants and children (IPTi/c) in Senegal.
Topics: Antimalarials; Artemisinins; Artesunate; Child, Preschool; Cross-Sectional Studies; DNA, Protozoan; Drug Resistance; Follow-Up Studies; Haplotypes; Humans; Infant; Malaria, Falciparum; Mutation; Pilot Projects; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Protozoan Proteins; Pyrimethamine; Senegal; Sequence Analysis, DNA; Sulfadoxine | 2013 |
Prognostic indicators in adults hospitalized with falciparum malaria in Western Thailand.
Topics: Adolescent; Adult; Aged; Artemisinins; Artesunate; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Prognosis; Quinine; Severity of Illness Index; Survival Analysis; Thailand; Young Adult | 2013 |
Pharmacokinetic modelling of the anti-malarial drug artesunate and its active metabolite dihydroartemisinin.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Computer Simulation; Humans; Malaria, Falciparum; Mathematical Concepts; Models, Biological | 2013 |
Identification of resistance of Plasmodium falciparum to artesunate-mefloquine combination in an area along the Thai-Myanmar border: integration of clinico-parasitological response, systemic drug exposure, and in vitro parasite sensitivity.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; DNA, Protozoan; Drug Combinations; Female; Gene Dosage; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Multidrug Resistance-Associated Proteins; Myanmar; Parasitic Sensitivity Tests; Plasmodium falciparum; Thailand; Treatment Outcome; Young Adult | 2013 |
Artesunate v. quinine for severe malaria.
Topics: Antimalarials; Artemisinins; Artesunate; Humans; Malaria, Falciparum; Quinine; Severity of Illness Index; South Africa | 2013 |
Effects of body size and gender on the population pharmacokinetics of artesunate and its active metabolite dihydroartemisinin in pediatric malaria patients.
Topics: Administration, Oral; Adult; Age Factors; Antimalarials; Artemisinins; Artesunate; Body Size; Body Weight; Child; Child, Preschool; Computer Simulation; Drug Administration Schedule; Drug Dosage Calculations; Female; Half-Life; Humans; Malaria, Falciparum; Male; Microbial Sensitivity Tests; Models, Statistical; Plasmodium falciparum; Sex Factors | 2013 |
Therapeutic efficacy of fixed dose artesunate-mefloquine for the treatment of acute, uncomplicated Plasmodium falciparum malaria in Kampong Speu, Cambodia.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Cambodia; Child; Child, Preschool; Drug Combinations; Female; Genotype; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymerase Chain Reaction; Recurrence; Treatment Outcome; Young Adult | 2013 |
[Treatment of severe and uncomplicated falciparum malaria in children in France].
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Atovaquone; Child; Drug Combinations; Ethanolamines; Fluorenes; France; Humans; Malaria, Falciparum; Proguanil; Quinolines | 2013 |
Evidence for pyronaridine as a highly effective partner drug for treatment of artemisinin-resistant malaria in a rodent model.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Drug Combinations; Drug Resistance; Female; Flow Cytometry; Malaria, Falciparum; Mefloquine; Mice; Naphthyridines | 2014 |
Evaluation of parasite subpopulations and genetic diversity of the msp1, msp2 and glurp genes during and following artesunate monotherapy treatment of Plasmodium falciparum malaria in Western Cambodia.
Topics: Adolescent; Adult; Aged; Animals; Antigens, Protozoan; Antimalarials; Artemisinins; Artesunate; Cambodia; Female; Genetic Variation; Genotype; Humans; Malaria, Falciparum; Male; Merozoite Surface Protein 1; Middle Aged; Plasmodium falciparum; Polymerase Chain Reaction; Protozoan Proteins; Young Adult | 2013 |
[Evaluation of imported Plasmodium falciparum malaria cases: the use of polymerase chain reaction in diagnosis].
Topics: Adolescent; Adult; Africa; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Doxycycline; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Polymerase Chain Reaction; Travel; Turkey; Young Adult | 2013 |
Schizontemia as an indicator of severe malaria.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Blood Chemical Analysis; Body Mass Index; Female; Hematologic Tests; Humans; Malaria, Falciparum; Male; Mefloquine; Schizonts; Severity of Illness Index | 2013 |
Rapid clinical assessment to facilitate the triage of adults with falciparum malaria, a retrospective analysis.
Topics: Acute Disease; Adult; Algorithms; Antimalarials; Artemisinins; Artesunate; Early Diagnosis; Female; Humans; Hyperglycemia; Hypoglycemia; Malaria, Falciparum; Male; Middle Aged; Oliguria; Patient Selection; Plasmodium falciparum; Respiratory Rate; Severity of Illness Index; Shock | 2014 |
Laboratory detection of artemisinin-resistant Plasmodium falciparum.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Drug Resistance; Half-Life; Malaria, Falciparum; Parasitic Sensitivity Tests; Phenotype; Plasmodium falciparum | 2014 |
Postartesunate delayed hemolysis is a predictable event related to the lifesaving effect of artemisinins.
Topics: Adult; Anemia, Hemolytic; Antimalarials; Artemisinins; Artesunate; Erythrocytes; Female; Follow-Up Studies; Hemolysis; Humans; Malaria, Falciparum; Male; Middle Aged; Prognosis; Treatment Outcome; Young Adult | 2014 |
Bilateral subhyaloid haemorrhage in a conscious patient: a new spectrum of ocular involvement by Plasmodium falciparum.
Topics: Antimalarials; Artemisinins; Artesunate; Eye Hemorrhage; Female; Fundus Oculi; Humans; Malaria, Falciparum; Mefloquine; Patient Positioning; Plasmodium falciparum; Young Adult | 2014 |
Preliminary investigation of the contribution of CYP2A6, CYP2B6, and UGT1A9 polymorphisms on artesunate-mefloquine treatment response in Burmese patients with Plasmodium falciparum malaria.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Aryl Hydrocarbon Hydroxylases; Asian People; Cytochrome P-450 CYP2A6; Cytochrome P-450 CYP2B6; Drug Therapy, Combination; Female; Gene Expression; Genotype; Glucuronosyltransferase; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Polymorphism, Genetic; Treatment Outcome; UDP-Glucuronosyltransferase 1A9 | 2014 |
Genetic polymorphisms of candidate markers and in vitro susceptibility of Plasmodium falciparum isolates from Thai-Myanmar border in relation to clinical response to artesunate-mefloquine combination.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Drug Resistance; Drug Therapy, Combination; Female; Gene Dosage; Haplotypes; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Multidrug Resistance-Associated Proteins; Mutation; Myanmar; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Thailand; Young Adult | 2014 |
Case definition: postartemisinin delayed hemolysis.
Topics: Antimalarials; Artemisinins; Artesunate; Female; Hemolysis; Humans; Malaria, Falciparum; Male | 2014 |
Declining efficacy of artesunate plus sulphadoxine-pyrimethamine in northeastern India.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Humans; India; Kaplan-Meier Estimate; Malaria, Falciparum; Male; Plasmodium falciparum; Pyrimethamine; Risk Factors; Sulfadoxine; Treatment Failure | 2014 |
Delayed anemia after treatment with injectable artesunate in the Democratic Republic of the Congo: a manageable issue.
Topics: Anemia, Hemolytic; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Democratic Republic of the Congo; Follow-Up Studies; Hemoglobins; Humans; Infant; Injections, Intravenous; Malaria, Falciparum; Plasmodium falciparum; Time Factors | 2014 |
Antimalarial activity of the myxobacterial macrolide chlorotonil a.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Chloroquine; Hydrocarbons, Chlorinated; Macrolides; Malaria, Falciparum; Mice; Mice, Inbred BALB C; Myxococcales; Parasitemia; Parasitic Sensitivity Tests; Plasmodium berghei; Plasmodium falciparum | 2014 |
Inhibition of metalloproteinase-9 secretion and gene expression by artemisinin derivatives.
Topics: Artemisinins; Artesunate; Cytokines; Gene Expression Regulation; Humans; Inflammation Mediators; Malaria, Cerebral; Malaria, Falciparum; Matrix Metalloproteinase 9; Monocytes; Plasmodium falciparum; Polymerase Chain Reaction; RNA, Messenger | 2014 |
[Imported severe falciparum malaria in France in 2000-2011: epidemiological trends and the need for new treatments].
Topics: Anemia; Antimalarials; Artemisinins; Artesunate; France; Humans; Malaria, Falciparum; Pharmacovigilance; Severity of Illness Index; Travel | 2013 |
Update on cases of delayed hemolysis after parenteral artesunate therapy for malaria - United States, 2008 and 2013.
Topics: Adult; Anemia, Hemolytic; Antimalarials; Artemisinins; Artesunate; Erythrocyte Transfusion; Female; Hemolysis; Humans; Infusions, Parenteral; Malaria, Falciparum; Male; Middle Aged; Retrospective Studies; Time Factors; United States | 2014 |
Plasmodium falciparum clearance is rapid and pitting independent in immune Malian children treated with artesunate for malaria.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Cohort Studies; Female; Humans; Infant; Malaria, Falciparum; Male; Mali; Parasite Load; Parasitemia; Plasmodium falciparum; Retrospective Studies; Treatment Outcome | 2015 |
Effect of fluorescent dyes on in vitro-differentiated, late-stage Plasmodium falciparum gametocytes.
Topics: Antimalarials; Artemisinins; Artesunate; Carbocyanines; Erythrocytes; Fluorescent Dyes; Gametogenesis; Humans; Inhibitory Concentration 50; Life Cycle Stages; Luminescent Measurements; Malaria, Falciparum; Mitochondria; Plasmodium falciparum; Rhodamines | 2014 |
Donor-transmitted malaria after heart transplant managed successfully with artesunate.
Topics: Antimalarials; Artemisinins; Artesunate; Heart Transplantation; Humans; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Tissue Donors | 2014 |
Severe delayed autoimmune haemolytic anaemia following artesunate administration in severe malaria: a case report.
Topics: Adolescent; Anemia, Hemolytic, Autoimmune; Antimalarials; Artemisinins; Artesunate; Cote d'Ivoire; Female; France; Humans; Malaria, Falciparum | 2014 |
Evaluation of antimalarial resistance marker polymorphism in returned migrant workers in China.
Topics: Antimalarials; Artemisinins; Artesunate; China; Drug Resistance; Ghana; Haplotypes; Humans; Malaria, Falciparum; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Mutation; Polymorphism, Genetic; Protozoan Proteins; Transients and Migrants | 2015 |
Cost of treating inpatient falciparum malaria on the Thai-Myanmar border.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Costs and Cost Analysis; Female; Humans; Malaria, Falciparum; Male; Myanmar; Quinine; Thailand; Young Adult | 2014 |
Artemisinin resistance--modelling the potential human and economic costs.
Topics: Antimalarials; Artemisinins; Artesunate; Drug Resistance; Drug Therapy, Combination; Health Care Costs; Humans; Malaria, Falciparum; Quinine | 2014 |
Severe delayed hemolysis associated with regulated parenteral antimalarial drug.
Topics: Adult; Anemia, Hemolytic; Antimalarials; Artemisinins; Artesunate; Drug Administration Routes; Hemolysis; Humans; Malaria; Malaria, Falciparum; Male | 2015 |
An imported case of severe falciparum malaria with prolonged hemolytic anemia clinically mimicking a coinfection with babesiosis.
Topics: Anemia, Hemolytic; Anti-Bacterial Agents; Antimalarials; Artemisinins; Artesunate; Atovaquone; Azithromycin; Babesiosis; Benin; Blood; Coinfection; Drug Combinations; France; Humans; Korea; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Proguanil; Travel; Treatment Outcome | 2014 |
Preparedness for severe malaria.
Topics: Antimalarials; Artemisinins; Artesunate; Clinical Laboratory Techniques; Critical Illness; Hospitals; Humans; Malaria; Malaria, Falciparum; Microscopy; Patient Transfer; Quinine; Reagent Kits, Diagnostic; Surveys and Questionnaires; Time Factors | 2015 |
[Therapeutic effect of 138 imported falciparum malaria patients].
Topics: Adult; Africa; Antimalarials; Artemether; Artemisinins; Artesunate; China; Diagnostic Errors; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Retrospective Studies; Travel; Young Adult | 2014 |
Defining the in vivo phenotype of artemisinin-resistant falciparum malaria: a modelling approach.
Topics: Antimalarials; Artemisinins; Artesunate; Cambodia; Drug Resistance; Humans; Life Cycle Stages; Malaria, Falciparum; Myanmar; Parasite Load; Parasitemia; Phenotype; Phylogeny; Plasmodium falciparum; Reference Values; Thailand | 2015 |
Quality of artemisinin-based combination formulations for malaria treatment: prevalence and risk factors for poor quality medicines in public facilities and private sector drug outlets in Enugu, Nigeria.
Topics: Antimalarials; Artemisinins; Artesunate; Chromatography, High Pressure Liquid; Humans; Malaria, Falciparum; Nigeria; Pharmacies; Private Sector; Public Facilities; Quality Control; Risk Factors; Tablets | 2015 |
Severe falciparum malaria treated with artesunate complicated by delayed onset haemolysis and acute kidney injury.
Topics: Acute Kidney Injury; Administration, Intravenous; Anemia, Hemolytic; Artemisinins; Artesunate; Bangladesh; Humans; Malaria, Falciparum; Male; Middle Aged; Parasitemia; Treatment Outcome | 2015 |
How Robust Are Malaria Parasite Clearance Rates as Indicators of Drug Effectiveness and Resistance?
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Child; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Dosage Calculations; Drug Resistance; Humans; Immunity, Innate; Malaria, Falciparum; Mefloquine; Models, Statistical; Parasitemia; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinolines; Treatment Outcome | 2015 |
Delayed Hemolysis After Parenteral Artesunate Therapy for Severe Malaria in Two Returning Canadian Travelers.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Cameroon; Canada; Democratic Republic of the Congo; Haptoglobins; Hemoglobins; Hemolysis; Humans; Infusions, Intravenous; L-Lactate Dehydrogenase; Malaria, Falciparum; Male; Middle Aged; Travel | 2015 |
Post-artesunate delayed haemolysis in severe imported Plasmodium falciparum malaria.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Female; Hemolysis; Humans; Malaria, Falciparum | 2015 |
Characterizing Types of Human Mobility to Inform Differential and Targeted Malaria Elimination Strategies in Northeast Cambodia.
Topics: Animals; Anopheles; Antimalarials; Artemisinins; Artesunate; Cambodia; Chloroquine; Disease Eradication; Health Surveys; Humans; Insect Vectors; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Plasmodium falciparum; Plasmodium vivax; Transients and Migrants | 2015 |
Delayed haemolysis after artesunate therapy in a cohort of patients with severe imported malaria due to Plasmodium falciparum.
Topics: Adult; Africa South of the Sahara; Anemia, Hemolytic; Antimalarials; Artesunate; Biomarkers; Emigrants and Immigrants; Female; Humans; Incidence; Malaria, Falciparum; Male; Middle Aged; Parasitemia; Retrospective Studies; Senegal; Time Factors; Travel-Related Illness | 2017 |
Potential for reduction of burden and local elimination of malaria by reducing Plasmodium falciparum malaria transmission: a mathematical modelling study.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Culicidae; Female; Geography; Humans; Incidence; Insect Vectors; Insecticide-Treated Bednets; Malaria, Falciparum; Models, Theoretical; Mosquito Control; Prevalence | 2016 |
In Vivo Efficacy and Parasite Clearance of Artesunate + Sulfadoxine-Pyrimethamine Versus Artemether-Lumefantrine in Mali.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Malaria, Falciparum; Male; Mali; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 2016 |
Rapid evaluation of artesunate quality with a specific monoclonal antibody-based lateral flow dipstick.
Topics: Animals; Antibodies, Immobilized; Antibodies, Monoclonal; Antimalarials; Artemisinins; Artesunate; Gold Colloid; Humans; Hybridomas; Immunoassay; Limit of Detection; Malaria, Falciparum; Mice; Point-of-Care Systems; Reagent Strips | 2016 |
UK malaria treatment guidelines 2016.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Breast Feeding; Child; Child, Preschool; Female; Humans; Malaria; Malaria, Falciparum; Malaria, Vivax; Plasmodium falciparum; Plasmodium vivax; Pregnancy; Pregnancy Complications, Parasitic; Primaquine; Travel | 2016 |
Altered drug susceptibility during host adaptation of a Plasmodium falciparum strain in a non-human primate model.
Topics: Adaptation, Biological; Animals; Antimalarials; Aotidae; Artemisinins; Artesunate; Disease Models, Animal; Drug Resistance; Host-Pathogen Interactions; Malaria, Falciparum; Parasitic Sensitivity Tests; Phenotype; Plasmodium falciparum; Primates; Quantitative Trait Loci; Treatment Failure | 2016 |
Transmission-Blocking Potential of MEFAS, a Hybrid Compound Derived from Artesunate and Mefloquine.
Topics: Antimalarials; Artemisinins; Artesunate; Malaria, Falciparum; Mefloquine; Plasmodium falciparum | 2016 |
Efficacy and Safety of Pyronaridine-Artesunate for Treatment of Uncomplicated Plasmodium falciparum Malaria in Western Cambodia.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Cambodia; Child; Female; Humans; Kaplan-Meier Estimate; Malaria, Falciparum; Male; Middle Aged; Naphthyridines; Young Adult | 2016 |
The Community As the Patient in Malaria-Endemic Areas: Preempting Drug Resistance with Multiple First-Line Therapies.
Topics: Antimalarials; Artemisinins; Artesunate; Drug Resistance, Microbial; Drug Therapy, Combination; Endemic Diseases; Health Policy; Humans; Malaria; Malaria, Falciparum; Mefloquine | 2016 |
Rubber workers on the front lines.
Topics: Adolescent; Agricultural Workers' Diseases; Antimalarials; Artemisinins; Artesunate; Cambodia; Drug Combinations; Drug Substitution; Farmers; Hevea; Human Migration; Humans; Malaria, Falciparum; Male; Mefloquine; Mekong Valley; Rubber; Young Adult | 2016 |
High efficacy of artemether-lumefantrine and declining efficacy of artesunate + sulfadoxine-pyrimethamine against Plasmodium falciparum in Sudan (2010-2015): evidence from in vivo and molecular marker studies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child; Child, Preschool; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Ethanolamines; Female; Fluorenes; Genetic Markers; Genotype; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Pyrimethamine; Sudan; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Outcome; Young Adult | 2016 |
Sustained efficacy of artesunate-sulfadoxine-pyrimethamine against Plasmodium falciparum in Yemen and a renewed call for an adjunct single dose primaquine to clear gametocytes.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Female; Gene Frequency; Humans; Infant; Malaria, Falciparum; Male; Middle Aged; Mutation; Plasmodium falciparum; Primaquine; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Treatment Outcome; Yemen; Young Adult | 2016 |
Highly active ozonides selected against drug resistant malaria.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Chloroquine; Disease Models, Animal; Female; Humans; Malaria, Falciparum; Mefloquine; Mice; Parasitemia; Plasmodium falciparum | 2016 |
Molecular markers associated with resistance to commonly used antimalarial drugs among Plasmodium falciparum isolates from a malaria-endemic area in Taiz governorate-Yemen during the transmission season.
Topics: Alleles; Antimalarials; Artemisinins; Artesunate; Chloroquine; Cross-Sectional Studies; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Genotype; Malaria, Falciparum; Membrane Transport Proteins; Mutation; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Pyrimethamine; Sequence Analysis, DNA; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Yemen | 2016 |
Artesunate-mefloquine: a malaria treatment for African children?
Topics: Antimalarials; Artemisinins; Artesunate; Child; Drug Therapy, Combination; Humans; Malaria; Malaria, Falciparum; Mefloquine; Treatment Outcome | 2016 |
Parenteral Artesunate for Severe Imported Plasmodium falciparum Malaria in Children.
Topics: Adolescent; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Plasmodium falciparum; Severity of Illness Index; Travel-Related Illness; Treatment Outcome | 2016 |
Concurrent Infection with Scrub Typhus, Dengue and Malaria in an Immunocompetent Young Male.
Topics: Artemisinins; Artesunate; Clindamycin; Coinfection; Dengue; Doxycycline; Enzyme-Linked Immunosorbent Assay; Fever of Unknown Origin; Humans; Immunocompetence; Immunoglobulin M; Malaria, Falciparum; Male; Plasmodium falciparum; Scrub Typhus; Thrombocytopenia; Treatment Outcome; Young Adult | 2016 |
Plasmodium falciparum Genetic Diversity in Continental Equatorial Guinea before and after Introduction of Artemisinin-Based Combination Therapy.
Topics: Amodiaquine; Antigens, Protozoan; Antimalarials; Artemisinins; Artesunate; Chloroquine; DNA Copy Number Variations; Drug Combinations; Drug Resistance; Equatorial Guinea; Female; Genetic Loci; Genetic Variation; Genotype; Humans; Malaria, Falciparum; Male; Membrane Transport Proteins; Microsatellite Repeats; Plasmodium falciparum; Point Mutation; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2017 |
In vitro sensitivity of antimalarial drugs and correlation with clinico-parasitological response following treatment with a 3-day artesunate-mefloquine combination in patients with falciparum malaria along the Thai-Myanmar border.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Myanmar; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinine; Thailand; Young Adult | 2017 |
Feasibility of Malaria Diagnosis and Management in Burkina Faso, Nigeria, and Uganda: A Community-Based Observational Study.
Topics: Administration, Oral; Antimalarials; Artemisinins; Artesunate; Burkina Faso; Child; Child, Preschool; Community Health Workers; Diagnostic Tests, Routine; Female; Humans; Infant; Malaria; Malaria, Falciparum; Male; Nigeria; Proteins; Referral and Consultation; Uganda | 2016 |
Association between Polymorphisms in the Pf
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Asparagine; ATP-Binding Cassette Transporters; Chloroquine; Doxycycline; Drug Resistance; Ethanolamines; Fluorenes; Gene Expression; Humans; Inhibitory Concentration 50; Lumefantrine; Malaria, Falciparum; Mefloquine; Naphthyridines; Plasmodium falciparum; Polymorphism, Genetic; Protein Isoforms; Protozoan Proteins; Quinine; Quinolines; Repetitive Sequences, Amino Acid; Senegal | 2017 |
Efficacy of artesunate + sulphadoxine/pyrimethamine and artemether + lumefantrine and dhfr and dhps mutations in Somalia: evidence for updating the malaria treatment policy.
Topics: Adolescent; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Dihydropteroate Synthase; Drug Resistance, Multiple; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Mutation; Plasmodium falciparum; Prospective Studies; Protozoan Proteins; Pyrimethamine; Somalia; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Young Adult | 2017 |
A high PCT level correlates with disease severity in Plasmodium falciparum malaria in children.
Topics: Anti-Bacterial Agents; Antimalarials; Artemisinins; Artesunate; Calcitonin; Ceftriaxone; Child, Preschool; Female; Humans; Infant; Malaria, Falciparum; Male; Plasmodium falciparum | 2017 |
Host vascular endothelial growth factor is trophic for Plasmodium falciparum-infected red blood cells.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Cells, Cultured; Erythrocyte Membrane; Erythrocytes; Fluorescent Antibody Technique; Humans; Malaria, Falciparum; Microscopy, Confocal; Plasmodium falciparum; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2 | 2008 |
Lack of multiple copies of pfmdr1 gene in Papua New Guinea.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Drug Resistance; Genes, MDR; Genotype; Humans; Malaria, Falciparum; Mefloquine; Multidrug Resistance-Associated Proteins; Papua New Guinea; Plasmodium falciparum; Polymorphism, Genetic | 2008 |
Surveillance for adverse drug reactions to combination antimalarial therapy with sulfadoxine-pyrimethamine plus artesunate in Peru.
Topics: Antimalarials; Artemisinins; Artesunate; Drug Combinations; Drug Therapy, Combination; Humans; Malaria, Falciparum; Peru; Pyrimethamine; Sulfadoxine | 2008 |
Artesunate for malaria.
Topics: Antimalarials; Artemisinins; Artesunate; Diagnostic Errors; Humans; Malaria, Falciparum; Sesquiterpenes; Travel; United States | 2008 |
Different methodological approaches to the assessment of in vivo efficacy of three artemisinin-based combination antimalarial treatments for the treatment of uncomplicated falciparum malaria in African children.
Topics: Africa; Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Child, Preschool; Databases as Topic; Drug Combinations; Ethanolamines; Fluorenes; Genotype; Humans; Infant; Lumefantrine; Malaria, Falciparum; Plasmodium falciparum; Polymerase Chain Reaction; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2008 |
Fixed-dose pyronaridine-artesunate combination for treatment of uncomplicated falciparum malaria in pediatric patients in Gabon.
Topics: Adolescent; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Therapy, Combination; Drug Tolerance; Female; Gabon; Humans; Malaria, Falciparum; Male; Naphthyridines; Plasmodium falciparum; Polymerase Chain Reaction; Safety; Treatment Outcome | 2008 |
Synthesis, antimalarial activity, and intracellular targets of MEFAS, a new hybrid compound derived from mefloquine and artesunate.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Cell Line; Dose-Response Relationship, Drug; Humans; Magnetic Resonance Spectroscopy; Malaria; Malaria, Falciparum; Mefloquine; Mice; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium berghei; Plasmodium falciparum | 2008 |
Statins alone are ineffective in cerebral malaria but potentiate artesunate.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Atorvastatin; Disease Models, Animal; Drug Synergism; Fatty Acids, Monounsaturated; Fluvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Malaria, Cerebral; Malaria, Falciparum; Mice; Neuroprotective Agents; Pravastatin; Pyrroles; Simvastatin | 2008 |
Purpura fulminans in a complicated Falciparum malaria.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Blood Transfusion; Cephalosporins; Disseminated Intravascular Coagulation; Hand; Humans; IgA Vasculitis; Malaria, Falciparum; Male; Quinine; Renal Dialysis; Treatment Outcome | 2008 |
Molecular surveillance for multidrug-resistant Plasmodium falciparum, Cambodia.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Cambodia; Drug Resistance, Multiple; Female; Gene Dosage; Genes, Protozoan; Humans; Malaria, Falciparum; Male; Mefloquine; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Population Surveillance; Protozoan Proteins | 2008 |
Severe malaria and artesunate treatment, Norway.
Topics: Administration, Oral; Adult; Antimalarials; Artemisinins; Artesunate; Clindamycin; Doxycycline; Drug Administration Schedule; Drug Therapy, Combination; Humans; Injections, Intravenous; Malaria, Falciparum; Medical Records; Middle Aged; Norway; Protein Synthesis Inhibitors; Retrospective Studies; Treatment Outcome | 2008 |
Auditory assessment of patients with acute uncomplicated Plasmodium falciparum malaria treated with three-day mefloquine-artesunate on the north-western border of Thailand.
Topics: Acoustic Impedance Tests; Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Audiometry; Drug Therapy, Combination; Evoked Potentials, Auditory, Brain Stem; Female; Hearing Loss; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Thailand | 2008 |
In vitro and in vivo properties of ellagic acid in malaria treatment.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Atovaquone; Chloroquine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ellagic Acid; Erythrocytes; Female; Inhibitory Concentration 50; Malaria, Falciparum; Mefloquine; Mice; Mice, Inbred Strains; Molecular Structure; Molecular Weight; Parasitemia; Parasitic Sensitivity Tests; Plasmodium; Plasmodium falciparum; Schizonts; Trophozoites | 2009 |
Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern Cambodia.
Topics: Adult; Animals; Antimalarials; Artemisinins; Artesunate; Cambodia; Child; Chloroquine; Drug Therapy, Combination; Female; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Multidrug Resistance-Associated Proteins; Parasitemia; Plasmodium falciparum; Polymerase Chain Reaction; Survival Analysis; Treatment Failure | 2009 |
Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia.
Topics: Adult; Animals; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Cambodia; Child; Clinical Trials as Topic; Drug Combinations; Drug Resistance; Ethanolamines; Fluorenes; Gene Dosage; Genetic Variation; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Mefloquine; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymorphism, Genetic; Survival Analysis; Thailand; Treatment Failure | 2009 |
Immunoglobulin G subclass-specific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illness.
Topics: Adolescent; Age Factors; Animals; Antibodies, Protozoan; Antigens, Protozoan; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Enzyme-Linked Immunosorbent Assay; Humans; Immunoglobulin G; Malaria, Falciparum; Membrane Proteins; Merozoite Surface Protein 1; Merozoites; Parasitemia; Plasmodium falciparum; Protozoan Proteins | 2009 |
[Parenteral combined quinine-artesunate therapy in life-threatening malaria].
Topics: Adult; Anemia; Antimalarials; Artemisinins; Artesunate; Clindamycin; Drug Therapy, Combination; Female; Humans; Infusions, Parenteral; Malaria, Falciparum; Quinine; Treatment Outcome | 2009 |
Changes in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13 years of continuous deployment.
Topics: Adolescent; Antimalarials; Artemisinins; Artesunate; Clinical Trials as Topic; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Retrospective Studies; Thailand; Treatment Outcome | 2009 |
In vitro activity of pyronaridine against Plasmodium falciparum and comparative evaluation of anti-malarial drug susceptibility assays.
Topics: Administration, Oral; Adolescent; Animals; Antigens, Protozoan; Antimalarials; Artemisinins; Artesunate; Biological Assay; Child; Child, Preschool; Chloroquine; Drug Evaluation, Preclinical; Enzyme-Linked Immunosorbent Assay; Female; Gabon; Humans; Infant; Malaria, Falciparum; Male; Naphthyridines; Parasitic Sensitivity Tests; Plasmodium falciparum; Protozoan Proteins; Quinine; Regression Analysis | 2009 |
Anaphylactic reaction to intravenous artesunate.
Topics: Adult; Anaphylaxis; Antimalarials; Artemisinins; Artesunate; Drug Hypersensitivity; Humans; Injections, Intravenous; Malaria, Falciparum; Male | 2009 |
Improved murine model of malaria using Plasmodium falciparum competent strains and non-myelodepleted NOD-scid IL2Rgammanull mice engrafted with human erythrocytes.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Chloroquine; Disease Models, Animal; Erythrocytes; Humans; Interleukin Receptor Common gamma Subunit; Kinetics; Malaria, Falciparum; Mice; Mice, Inbred NOD; Mice, SCID; Pyridones; Pyrimethamine | 2009 |
Monitoring of in vitro susceptibilities and molecular markers of resistance of Plasmodium falciparum isolates from Thai-Myanmar border to chloroquine, quinine, mefloquine and artesunate.
Topics: Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Resistance; Gene Dosage; Genetic Markers; Malaria, Falciparum; Mefloquine; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Myanmar; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Quinine; Thailand | 2010 |
[Availability of antimalarial agents in Dutch hospitals].
Topics: Antimalarials; Artemisinins; Artesunate; Humans; Malaria; Malaria, Falciparum; Netherlands; Pharmacy Service, Hospital; Quinine | 2009 |
Effects of mefloquine and artesunate mefloquine on the emergence, clearance and sex ratio of Plasmodium falciparum gametocytes in malarious children.
Topics: Adolescent; Animals; Artemisinins; Artesunate; Blood; Child; Child, Preschool; Female; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Plasmodium falciparum; Prospective Studies | 2009 |
Plasmodium falciparum: in vitro interaction of quassin and neo-quassin with artesunate, a hemisuccinate derivative of artemisinin.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Chromatography, High Pressure Liquid; Drug Interactions; Humans; Inhibitory Concentration 50; Liver; Malaria, Falciparum; Mice; Mice, Inbred BALB C; Plant Bark; Plant Extracts; Plasmodium falciparum; Quassia; Quassins; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2010 |
Cardiac function and hemodynamics in Kenyan children with severe malaria.
Topics: Acidosis; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Clinical Trials, Phase II as Topic; Developing Countries; Dextrans; Echocardiography; Female; Fluid Therapy; Heart Failure; Hemodynamics; Humans; Hydroxyethyl Starch Derivatives; Infant; Intensive Care Units, Pediatric; Kenya; Malaria, Falciparum; Male; Quinine | 2010 |
Efficacy and safety of quinine-artesunate in an HIV-positive patient with severe falciparum malaria.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Drug Therapy, Combination; HIV Seropositivity; Humans; Malaria, Falciparum; Male; Quinine; Severity of Illness Index | 2010 |
Increased tolerance to artemisinin in Plasmodium falciparum is mediated by a quiescence mechanism.
Topics: Antimalarials; Artemisinins; Artesunate; Cambodia; Drug Resistance, Bacterial; Erythrocytes; Flow Cytometry; Gene Expression Profiling; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Oligonucleotide Array Sequence Analysis; Parasitic Sensitivity Tests; Plasmodium falciparum; Thailand | 2010 |
Decreased in vitro susceptibility of Plasmodium falciparum isolates to artesunate, mefloquine, chloroquine, and quinine in Cambodia from 2001 to 2007.
Topics: Antimalarials; Artemisinins; Artesunate; Cambodia; Chloroquine; Drug Resistance, Bacterial; Geographic Information Systems; In Vitro Techniques; Inhibitory Concentration 50; Malaria, Falciparum; Mefloquine; Oligonucleotide Array Sequence Analysis; Plasmodium falciparum; Point Mutation; Polymorphism, Single Nucleotide; Quinine | 2010 |
Severe congenital malaria acquired in utero.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Female; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Malaria, Falciparum; Pregnancy; Quinolines | 2010 |
Multiple genetic backgrounds of the amplified Plasmodium falciparum multidrug resistance (pfmdr1) gene and selective sweep of 184F mutation in Cambodia.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Cambodia; Drug Resistance; Malaria, Falciparum; Mefloquine; Microsatellite Repeats; Multidrug Resistance-Associated Proteins; Mutation; Plasmodium falciparum | 2010 |
Pyronaridine-artesunate for uncomplicated falciparum malaria.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Drug Combinations; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Naphthyridines | 2010 |
Five years of large-scale dhfr and dhps mutation surveillance following the phased implementation of artesunate plus sulfadoxine-pyrimethamine in Maputo Province, Southern Mozambique.
Topics: Adolescent; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mozambique; Mutation; Plasmodium falciparum; Population Surveillance; Prevalence; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Time Factors | 2010 |
Understanding caretakers' dilemma in deciding whether or not to adhere with referral advice after pre-referral treatment with rectal artesunate.
Topics: Administration, Rectal; Adult; Aged; Antimalarials; Artemisinins; Artesunate; Caregivers; Counseling; Female; Focus Groups; Health Knowledge, Attitudes, Practice; Humans; Malaria, Falciparum; Medication Adherence; Middle Aged; Patient Acceptance of Health Care; Plasmodium falciparum; Referral and Consultation; Severity of Illness Index; Tanzania; Young Adult | 2010 |
Symmetrical peripheral gangrene in childhood falciparum malaria.
Topics: Antimalarials; Artemisinins; Artesunate; Child; Female; Gangrene; Humans; Malaria, Falciparum; Mefloquine; Primaquine | 2010 |
Revisiting the circulation time of Plasmodium falciparum gametocytes: molecular detection methods to estimate the duration of gametocyte carriage and the effect of gametocytocidal drugs.
Topics: Adolescent; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Carrier State; Child; Child, Preschool; Clinical Trials as Topic; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Germ Cells; Humans; Infant; Infant, Newborn; Kenya; Malaria, Falciparum; Male; Models, Biological; Parasitemia; Plasmodium falciparum; Prevalence; Primaquine; Pyrimethamine; Self-Sustained Sequence Replication; Sulfadoxine; Tanzania; Time Factors; Treatment Outcome | 2010 |
[A new antimalarial drug combination].
Topics: Antimalarials; Artemisinins; Artesunate; Drug Combinations; Humans; Malaria, Falciparum; Naphthyridines; Plasmodium falciparum; Treatment Outcome | 2010 |
New perspectives of malaria control in India under World Bank Project.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Disease Outbreaks; Health Policy; Humans; India; Leishmaniasis, Visceral; Malaria, Falciparum; Mosquito Control; Program Development; Program Evaluation; United Nations | 2009 |
Monitoring for Plasmodium falciparum drug resistance to artemisinin and artesunate in Binh Phuoc Province, Vietnam: 1998-2009.
Topics: Adolescent; Adult; Anti-Infective Agents; Antimalarials; Artemisinins; Artesunate; Child; Drug Resistance; Female; Follow-Up Studies; Genotype; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Male; Parasitemia; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymerase Chain Reaction; Recurrence; Sensitivity and Specificity; Time Factors; Vietnam; Young Adult | 2010 |
Early diagnosis and treatment of falciparum malaria in Cambodian trauma patients.
Topics: Adolescent; Adult; Analysis of Variance; Antimalarials; Artemisinins; Artesunate; Cambodia; Child; Child, Preschool; Cohort Studies; Early Diagnosis; Female; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitic Sensitivity Tests; Prevalence; Risk Factors; Surgical Wound Infection; Wounds and Injuries | 2009 |
Dynamics of Plasmodium falciparum parasitemia regarding combined treatment regimens for acute uncomplicated malaria, Antioquia, Colombia.
Topics: Administration, Oral; Animals; Antimalarials; Artemisinins; Artesunate; Clinical Protocols; Colombia; Drug Therapy, Combination; Female; Humans; Malaria; Malaria, Falciparum; Male; Mefloquine; Parasitemia; Patient Compliance; Plasmodium falciparum; Primaquine; Treatment Outcome | 2010 |
Combined intravenous treatment with artesunate and quinine for severe malaria in Italy.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Injections, Intravenous; Italy; Malaria, Falciparum; Male; Parasitemia; Quinine; Retrospective Studies; Travel | 2010 |
Purpura fulminans: a rare presentation of a common disease.
Topics: Anticoagulants; Artemisinins; Artesunate; Disseminated Intravascular Coagulation; Heparin; Humans; India; Lower Extremity; Malaria, Falciparum; Male; Purpura Fulminans; Treatment Outcome; Warfarin; Young Adult | 2010 |
Waking the sleeping beauty.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Humans; Malaria, Falciparum; Microbial Viability; Plasmodium falciparum; Recurrence | 2010 |
Artesunate misuse and Plasmodium falciparum malaria in traveler returning from Africa.
Topics: Adult; Africa; Antimalarials; Artemisinins; Artesunate; Canada; Chemoprevention; Female; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Nigeria; Parasitic Sensitivity Tests; Plasmodium falciparum; Self Medication; Travel | 2010 |
Refractory pancytopenia and megaloblastic anemia due to falciparum malaria.
Topics: Anemia, Megaloblastic; Antimalarials; Artemisinins; Artesunate; Child; Drug Therapy, Combination; Erythrocyte Transfusion; Fatal Outcome; Folic Acid; Humans; Malaria, Falciparum; Male; Nitric Oxide Synthase Type II; Pancytopenia; Plasmodium falciparum; Platelet Transfusion; Vitamin B 12; Vitamin B Complex | 2011 |
Declining in efficacy of a three-day combination regimen of mefloquine-artesunate in a multi-drug resistance area along the Thai-Myanmar border.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Chromatography, High Pressure Liquid; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mass Spectrometry; Mefloquine; Middle Aged; Myanmar; Plasma; Plasmodium falciparum; Thailand; Treatment Failure; Treatment Outcome; Young Adult | 2010 |
Formation and identification of a degradant in chlorproguanil-dapsone-artesunate (Dacart™) tablets.
Topics: Antimalarials; Artemisinins; Artesunate; Chromatography, High Pressure Liquid; Chromatography, Liquid; Dapsone; Drug Combinations; Drug Stability; Drug Therapy, Combination; Hot Temperature; Humans; Humidity; Magnetic Resonance Spectroscopy; Malaria, Falciparum; Mass Spectrometry; Proguanil; Tablets | 2011 |
For severe malaria, artesunate is the answer.
Topics: Adult; Africa South of the Sahara; Antimalarials; Artemisinins; Artesunate; Child; Developing Countries; Humans; Malaria, Falciparum; Quinine | 2010 |
Dose-dependent risk of neutropenia after 7-day courses of artesunate monotherapy in Cambodian patients with acute Plasmodium falciparum malaria.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; Artesunate; Cambodia; Humans; Malaria, Falciparum; Male; Middle Aged; Neutropenia; Young Adult | 2010 |
Alternative visual displays of metaanalysis of malaria treatment trials to facilitate translation of research into policy.
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Computer Graphics; Drug Therapy, Combination; Health Policy; Humans; Malaria, Falciparum; Meta-Analysis as Topic; Models, Biological; Policy Making; Randomized Controlled Trials as Topic; Research; Software; Treatment Outcome | 2010 |
Intrahost modeling of artemisinin resistance in Plasmodium falciparum.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Cambodia; Dose-Response Relationship, Drug; Drug Resistance; Host-Parasite Interactions; Humans; Linear Models; Malaria, Falciparum; Models, Biological; Plasmodium falciparum | 2011 |
Increased prevalence of the Plasmodium falciparum Pfmdr1 86N genotype among field isolates from Franceville, Gabon after replacement of chloroquine by artemether-lumefantrine and artesunate-mefloquine.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Gabon; Genotype; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Parasitemia; Plasmodium falciparum; Polymorphism, Genetic; Prevalence; Protozoan Proteins | 2011 |
Automated erythrocytapheresis for severe falciparum malaria.
Topics: Adult; Antimalarials; Artemether; Artemisinins; Artesunate; Australia; Automation; Blood Component Removal; Cambodia; Combined Modality Therapy; Drug Therapy, Combination; Erythrocyte Transfusion; Erythrocytes; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Parasitemia; Travel | 2011 |
Artemether-Lumefantrin (Coartem) and artesunate with sulfadoxine-pyrimethamine therapeutic efficacy in the treatment of uncomplicated malaria at Gilgel Gibe II (GGII) South-Western Ethiopia.
Topics: Adolescent; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Ethiopia; Female; Fever; Fluorenes; Follow-Up Studies; Humans; Infant; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum; Pyrimethamine; Sentinel Surveillance; Sulfadoxine; Treatment Outcome; Young Adult | 2010 |
Pharmacokinetics and pharmacodynamics of artesunate and dihydroartemisinin following oral treatment in pregnant women with asymptomatic Plasmodium falciparum infections in Kinshasa DRC.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Asymptomatic Infections; Chromatography, Liquid; Democratic Republic of the Congo; Female; Humans; Infant, Newborn; Malaria, Falciparum; Mass Spectrometry; Plasma; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Infectious; Young Adult | 2011 |
Intravenous artesunate for severe malaria in travelers, Europe.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Europe; Female; Humans; Injections, Intravenous; Malaria, Falciparum; Male; Middle Aged; Retrospective Studies; Travel; Treatment Outcome | 2011 |
Distribution of mefloquine in the blood of Thai patients with acute uncomplicated falciparum malaria following administration of therapeutic doses of artesunate.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitemia; Sex Factors; Thailand; Time Factors; Treatment Outcome; Young Adult | 2011 |
Effectiveness of ACTs in cases of resistance to partner drugs.
Topics: Antimalarials; Artemisinins; Artesunate; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Sulfadoxine | 2011 |
Optimal designs for population pharmacokinetic studies of oral artesunate in patients with uncomplicated falciparum malaria.
Topics: Administration, Oral; Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Computer Simulation; Female; Humans; Infant; Malaria, Falciparum; Models, Statistical; Pregnancy; Surveys and Questionnaires; Young Adult | 2011 |
Molecular epidemiology of malaria in Cameroon. XXX. sequence analysis of Plasmodium falciparum ATPase 6, dihydrofolate reductase, and dihydropteroate synthase resistance markers in clinical isolates from children treated with an artesunate-sulfadoxine-pyr
Topics: Antimalarials; Artemisinins; Artesunate; Cameroon; Child; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Mitochondrial Proton-Translocating ATPases; Molecular Epidemiology; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2011 |
Falciparum malaria presenting as subdural hematoma.
Topics: Aged, 80 and over; Antimalarials; Artemisinins; Artesunate; Enzyme-Linked Immunosorbent Assay; Fatal Outcome; Hematoma, Subdural; Humans; Malaria, Falciparum; Male; Plasmodium falciparum; Platelet Transfusion; Thrombocytopenia | 2011 |
Polymorphisms of molecular markers of antimalarial drug resistance and relationship with artesunate-mefloquine combination therapy in patients with uncomplicated Plasmodium falciparum malaria in Thailand.
Topics: Antimalarials; Artemisinins; Artesunate; Drug Resistance, Multiple; Drug Therapy, Combination; Genetic Markers; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Polymorphism, Genetic; Thailand | 2011 |
Ultrastructural and real-time microscopic changes in P. falciparum-infected red blood cells following treatment with antimalarial drugs.
Topics: Antimalarials; Artemisinins; Artesunate; Cells, Cultured; Erythrocytes; Host-Parasite Interactions; Malaria, Falciparum; Microscopy, Electron, Transmission; Plasmodium falciparum; Quinine; Quinolines; Ribosomes; Trophozoites | 2011 |
Artesunate/dihydroartemisinin pharmacokinetics in acute falciparum malaria in pregnancy: absorption, bioavailability, disposition and disease effects.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Biological Availability; Dose-Response Relationship, Drug; Female; Humans; Malaria, Falciparum; Metabolic Clearance Rate; Postpartum Period; Pregnancy; Pregnancy Complications, Parasitic; Severity of Illness Index; Young Adult | 2012 |
Molecular monitoring of Plasmodium falciparum resistance to antimalarial drugs after adoption of sulfadoxine-pyrimethamine plus artesunate as the first line treatment in Iran.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; Artesunate; Child; DNA Fingerprinting; Drug Combinations; Drug Resistance; Gene Frequency; Genotype; Humans; Iran; Malaria, Falciparum; Middle Aged; Mutation, Missense; Plasmodium falciparum; Polymorphism, Restriction Fragment Length; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Young Adult | 2012 |
Rectal artesunates, their utilization, and parental perception in the management of malaria in children from Abeokuta, southwestern Nigeria.
Topics: Administration, Rectal; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Female; Humans; Infant; Malaria, Falciparum; Male; Medication Adherence; Nigeria; Parents; Patient Satisfaction; Plasmodium falciparum; Sex Distribution; Surveys and Questionnaires | 2012 |
The evolution of pyrimethamine resistant dhfr in Plasmodium falciparum of south-eastern Tanzania: comparing selection under SP alone vs SP+artesunate combination.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Resistance; Gene Frequency; Genotype; Humans; Malaria, Falciparum; Microsatellite Repeats; Mutation; Plasmodium falciparum; Pyrimethamine; Selection, Genetic; Sulfadoxine; Tanzania; Tetrahydrofolate Dehydrogenase | 2011 |
Standardizing the measurement of parasite clearance in falciparum malaria: the parasite clearance estimator.
Topics: Antimalarials; Artemisinins; Artesunate; Blood; Cambodia; Humans; Malaria, Falciparum; Parasite Load; Parasitemia; Plasmodium falciparum | 2011 |
High dose artesunate in combination with mefloquine: pharmacovigilance in the Venezuelan Amazon.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Diarrhea; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Pharmacovigilance; Retrospective Studies; Venezuela; Vomiting; Young Adult | 2012 |
Tolerability and safety of primaquine in Papua New Guinean children 1 to 10 years of age.
Topics: Aging; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Cohort Studies; Female; Glucosephosphate Dehydrogenase Deficiency; Hemoglobins; Humans; Infant; Malaria; Malaria, Falciparum; Malaria, Vivax; Male; New Guinea; Primaquine | 2012 |
Spontaneous acute subdural hematoma in malaria: a case report.
Topics: Aged; Antimalarials; Artemisinins; Artesunate; Fatal Outcome; Hematoma, Subdural, Acute; Humans; Malaria, Falciparum; Male; Plasmodium falciparum; Tomography, X-Ray Computed | 2011 |
Artemisinin-based combination therapy does not measurably reduce human infectiousness to vectors in a setting of intense malaria transmission.
Topics: Animals; Antigens, Protozoan; Antimalarials; Artemisinins; Artesunate; Asymptomatic Diseases; Child, Preschool; Culicidae; Disease Vectors; Drug Combinations; Enzyme-Linked Immunosorbent Assay; Female; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Plasmodium falciparum; Pregnancy; Prevalence; Pyrimethamine; Sulfadoxine; Tanzania | 2012 |
Severe malaria, artesunate and haemolysis.
Topics: Antimalarials; Artemisinins; Artesunate; Drug-Related Side Effects and Adverse Reactions; Female; Hemolysis; Humans; Malaria, Falciparum; Young Adult | 2012 |
Post-treatment haemolysis in severe imported malaria after intravenous artesunate: case report of three patients with hyperparasitaemia.
Topics: Antimalarials; Artemisinins; Artesunate; Female; Germany; Hemolysis; Humans; Malaria, Falciparum; Male; Middle Aged; Parasitemia; Travel; Young Adult | 2012 |
Acute pancreatitis in a case of falciparum malaria--a rare presentation.
Topics: Abdominal Pain; Acute Disease; Adult; Anti-Bacterial Agents; Antimalarials; Artemisinins; Artesunate; Fatal Outcome; Humans; Malaria, Falciparum; Male; Multiple Organ Failure; Pancreatitis; Parasitemia; Plasmodium falciparum; Severity of Illness Index; Tomography, X-Ray Computed | 2011 |
No evidence of decreased artemisinin efficacy in a high-transmission malaria setting in Mali.
Topics: Antimalarials; Artemisinins; Artesunate; Female; Humans; Malaria, Falciparum; Male | 2012 |
No evidence of delayed parasite clearance after oral artesunate treatment of uncomplicated falciparum malaria in Mali.
Topics: Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Female; Humans; Infant; Malaria, Falciparum; Male; Mali; Parasitemia | 2012 |
Artesunate for severe acute Plasmodium falciparum infection in a patient with myasthenia gravis.
Topics: Adult; Artemisinins; Artesunate; Humans; Malaria, Falciparum; Male; Myasthenia Gravis; Plasmodium falciparum; Treatment Outcome | 2012 |
Therapeutic efficacy of artesunate in the treatment of uncomplicated Plasmodium falciparum malaria and anti-malarial, drug-resistance marker polymorphisms in populations near the China-Myanmar border.
Topics: Antimalarials; Artemisinins; Artesunate; Blood; China; Drug Resistance; Humans; Malaria, Falciparum; Mutation, Missense; Myanmar; Plasmodium falciparum; Protozoan Proteins; Treatment Outcome | 2012 |
Effect of artesunate-mefloquine fixed-dose combination in malaria transmission in Amazon basin communities.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Artemisinins; Artesunate; Brazil; Child; Child, Preschool; Drug Combinations; Female; Hospitalization; Humans; Incidence; Infant; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Middle Aged; Treatment Outcome; Young Adult | 2012 |
Delayed Plasmodium falciparum clearance following artesunate-mefloquine combination therapy in Thailand, 1997-2007.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Resistance; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitemia; Plasmodium falciparum; Retrospective Studies; Thailand; Time Factors; Treatment Outcome; Young Adult | 2012 |
Artemisinin resistance containment project in Thailand. II: Responses to mefloquine-artesunate combination therapy among falciparum malaria patients in provinces bordering Cambodia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Artemisinins; Artesunate; Cambodia; Child; Child, Preschool; Drug Resistance; Drug Therapy, Combination; Epidemiological Monitoring; Female; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Thailand; Treatment Outcome; Young Adult | 2012 |
Assessing the utility of an anti-malarial pharmacokinetic-pharmacodynamic model for aiding drug clinical development.
Topics: Animals; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Dose-Response Relationship, Drug; Drug Combinations; Drug Discovery; Ethanolamines; Fluorenes; Host-Pathogen Interactions; Humans; Malaria, Falciparum; Mefloquine; Models, Statistical; Plasmodium falciparum; Quinolines | 2012 |
Optimizing the HRP-2 in vitro malaria drug susceptibility assay using a reference clone to improve comparisons of Plasmodium falciparum field isolates.
Topics: Antigens, Protozoan; Antimalarials; Artemisinins; Artesunate; Chromatography, Liquid; Culture Media; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Mass Spectrometry; Parasitic Sensitivity Tests; Plasmodium falciparum; Protozoan Proteins | 2012 |
New treatment policy of malaria as a part of malaria control program in Indonesia.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Disease Eradication; Drug Resistance; Drug Therapy, Combination; Health Policy; Humans; Indonesia; Malaria, Falciparum; Malaria, Vivax; Practice Guidelines as Topic; Primaquine | 2012 |
Travel and fake artesunate: a risky business.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Counterfeit Drugs; Equatorial Guinea; Female; Fraud; Humans; Malaria, Falciparum; Travel; Treatment Failure | 2012 |
A prospective comparative study of knowlesi, falciparum, and vivax malaria in Sabah, Malaysia: high proportion with severe disease from Plasmodium knowlesi and Plasmodium vivax but no mortality with early referral and artesunate therapy.
Topics: Adult; Aged; Antimalarials; Artemisinins; Artesunate; Female; Humans; Malaria; Malaria, Falciparum; Malaria, Vivax; Malaysia; Male; Middle Aged; Parasitemia; Plasmodium falciparum; Plasmodium knowlesi; Plasmodium vivax; Prospective Studies; Risk Factors; Severity of Illness Index; Time Factors; Treatment Outcome; Young Adult | 2013 |
[New combination therapy against malaria].
Topics: Africa; Antimalarials; Artemisinins; Artesunate; Asia; Drug Combinations; Drug Resistance; Global Health; Humans; Malaria, Falciparum; Mefloquine; Naphthyridines | 2012 |
Editorial commentary: single-dose primaquine as gametocytocidal treatment in patients with uncomplicated falciparum malaria.
Topics: Antimalarials; Artemisinins; Artesunate; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum | 2013 |
Intravenous artesunate versus intravenous quinine in the treatment of severe falciparum malaria: a retrospective evaluation from a UK centre.
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Artemisinins; Artesunate; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Length of Stay; Malaria, Falciparum; Male; Middle Aged; Quinine; Retrospective Studies; Survival Analysis; Travel; Treatment Outcome; United Kingdom; Young Adult | 2012 |
[Artemisinine and artesunate in the treatment of malaria in Vietnam (1984-1999)].
Topics: Adult; Anti-Bacterial Agents; Antimalarials; Artemisinins; Artesunate; Child; Doxycycline; Drug Combinations; Drug Resistance; Drugs, Chinese Herbal; Humans; Malaria, Falciparum; Malaria, Vivax; Sesquiterpenes; Tetracycline; Vietnam | 2002 |
Glucuronidation of dihydroartemisinin in vivo and by human liver microsomes and expressed UDP-glucuronosyltransferases.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Female; Glucuronides; Glucuronosyltransferase; Humans; In Vitro Techniques; Malaria, Falciparum; Male; Microsomes, Liver; Recombinant Proteins; Sesquiterpenes | 2002 |
[Severe falciparum malaria with prolonged hemolytic anemia after successful treatment with intravenous artesunate].
Topics: Aged; Anemia, Hemolytic; Antimalarials; Artemisinins; Artesunate; Female; Humans; Injections, Intravenous; Malaria, Falciparum; Sesquiterpenes; Travel | 2002 |
Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum must be delayed in Africa.
Topics: Africa; Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 2002 |
[A case of falciparum malaria successfully treated with intravenous artesunate].
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Female; Humans; India; Injections, Intravenous; Malaria, Falciparum; Sesquiterpenes; Travel | 2002 |
A safety and efficacy trial of artesunate, sulphadoxine-pyrimethamine and primaquine in P falciparum malaria.
Topics: Artemisinins; Artesunate; Drug Combinations; Drug Therapy, Combination; Humans; Malaria, Falciparum; Prospective Studies; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2002 |
Diuretic effect of sodium artesunate in patients with malaria.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Diuresis; Diuretics; Humans; Injections, Intravenous; Malaria, Falciparum; Malaria, Vivax; Male; Natriuresis; Renal Insufficiency; Sesquiterpenes | 2002 |
Use of nested PCR for differential diagnosis of falciparum malaria reinfection and relapse in drug-resistant patients.
Topics: Alleles; Animals; Antimalarials; Artemisinins; Artesunate; Diagnosis, Differential; DNA, Protozoan; Drug Resistance, Multiple; Genes, Protozoan; Genetic Markers; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Genetic; Recurrence; Sesquiterpenes; Time Factors | 2002 |
Short-course artesunate treatment of uncomplicated Plasmodium falciparum malaria in Gabon.
Topics: Adolescent; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Female; Gabon; Humans; Malaria, Falciparum; Male; Plasmodium falciparum; Recurrence; Reverse Transcriptase Polymerase Chain Reaction; Sesquiterpenes; Treatment Outcome | 2003 |
Safety and therapeutic efficacy of artesunate suppositories for treatment of malaria in children in Papua New Guinea.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Cohort Studies; Developing Countries; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Endemic Diseases; Female; Follow-Up Studies; Humans; Malaria, Falciparum; Malaria, Vivax; Male; Monitoring, Physiologic; Papua New Guinea; Plasmodium falciparum; Plasmodium vivax; Prospective Studies; Sesquiterpenes; Sulfadoxine; Suppositories; Treatment Outcome | 2003 |
Distinguishing recrudescence from reinfection in a longitudinal antimalarial drug efficacy study: comparison of results based on genotyping of msp-1, msp-2, and glurp.
Topics: Amodiaquine; Animals; Antigens, Protozoan; Antimalarials; Artemisinins; Artesunate; Child, Preschool; DNA, Protozoan; Drug Combinations; Drug Resistance; Female; Genotype; Humans; Infant; Longitudinal Studies; Malaria, Falciparum; Male; Merozoite Surface Protein 1; Plasmodium falciparum; Polymerase Chain Reaction; Protozoan Proteins; Pyrimethamine; Recurrence; Sesquiterpenes; Sulfadoxine; Treatment Failure; Uganda | 2003 |
Drug-resistant malaria in Bangladesh: an in vitro assessment.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Bangladesh; Chloroquine; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinine; Sesquiterpenes | 2003 |
Recrudescence in artesunate-treated patients with falciparum malaria is dependent on parasite burden not on parasite factors.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; ATP-Binding Cassette Transporters; Cohort Studies; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Mutation; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Recurrence; Retrospective Studies; Sesquiterpenes; Thailand | 2003 |
Descriptive study on the efficacy and safety of artesunate suppository in combination with other antimalarials in the treatment of severe malaria in Sudan.
Topics: Administration, Rectal; Adolescent; Adult; Aged; Antimalarials; Artemisinins; Artesunate; Doxycycline; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Pyrimethamine; Sesquiterpenes; Severity of Illness Index; Sudan; Sulfadoxine; Treatment Outcome | 2003 |
Comparison of bioassay and high performance liquid chromatographic assay of artesunate and dihydroartemisinin in plasma.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Biological Assay; Chromatography, High Pressure Liquid; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Plasmodium falciparum; Sesquiterpenes | 2003 |
Efficacy of amodiaquine alone and combined with sulfadoxine-pyrimethamine and of sulfadoxine pyrimethamine combined with artesunate.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Plasmodium falciparum; Pyrimethamine; Rural Health Services; Rwanda; Sesquiterpenes; Sulfadoxine; Treatment Outcome; Urban Health Services | 2003 |
Clinical experience with intravenous quinine, intramuscular artemether and intravenous artesunate for the treatment of severe malaria in Thailand.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Injections, Intramuscular; Injections, Intravenous; Malaria, Falciparum; Male; Middle Aged; Prospective Studies; Quinine; Sesquiterpenes; Thailand; Treatment Outcome | 2003 |
Atovaquone-proguanil for recrudescent Plasmodium falciparum in Vietnam.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Artemisinins; Artesunate; Atovaquone; Child; Disease Outbreaks; Drug Combinations; Drug Resistance, Multiple; Female; Follow-Up Studies; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Naphthoquinones; Parasitemia; Plasmodium falciparum; Proguanil; Recurrence; Sesquiterpenes; Treatment Failure; Vietnam | 2003 |
Prevention of increasing rates of treatment failure by combining sulfadoxine-pyrimethamine with artesunate or amodiaquine for the sequential treatment of malaria.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Dihydropteroate Synthase; Drug Administration Schedule; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Infant; Malaria, Falciparum; Mutation; Plasmodium falciparum; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Failure; Treatment Outcome | 2003 |
[Factors affecting the in vitro microtest for drug sensitivity of Plasmodium falciparum].
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Blood; Chloroquine; Humans; Malaria, Falciparum; Naphthyridines; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinolines; Sesquiterpenes | 2003 |
Red cell exchange using cell separator (therapeutic erythrocytapheresis) in two children with acute severe malaria.
Topics: Antimalarials; Artemisinins; Artesunate; Child; Erythrocyte Transfusion; Humans; Malaria, Falciparum; Male; Platelet Count; Sesquiterpenes | 2003 |
Plasmodium falciparum-based bioassay for measurement of artemisinin derivatives in plasma or serum.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Biological Assay; Biotransformation; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Electrochemistry; Hot Temperature; Humans; In Vitro Techniques; Macaca mulatta; Malaria, Falciparum; Plasmodium falciparum; Reproducibility of Results; Sesquiterpenes | 2004 |
[Efficacy of therapeutic combinations with artemisinin derivatives in the treatment of non complicated malaria in Burundi].
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Artesunate; Burundi; Child, Preschool; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Rural Health; Sesquiterpenes; Treatment Failure; Urban Health; Vomiting | 2004 |
The in-vitro antimalarial activity of ferrochloroquine, measured against Cambodian isolates of Plasmodium falciparum.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Cambodia; Chloroquine; Drug Resistance; Humans; Malaria, Falciparum; Mefloquine; Membrane Proteins; Membrane Transport Proteins; Mutation; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Sesquiterpenes | 2004 |
In vitro monitoring of Plasmodium falciparum susceptibility to artesunate, mefloquine, quinine and chloroquine in Cambodia: 2001-2002.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Cambodia; Chloroquine; Drug Resistance; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Quinine; Sesquiterpenes; Statistics, Nonparametric | 2005 |
Artesunate-dapsone-proguanil treatment of falciparum malaria: genotypic determinants of therapeutic response.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Dapsone; Dihydropteroate Synthase; Drug Therapy, Combination; Female; Genotype; Humans; Malaria, Falciparum; Male; Middle Aged; Mutation; Plasmodium falciparum; Proguanil; Prospective Studies; Recurrence; Sesquiterpenes; Tetrahydrofolate Dehydrogenase; Treatment Outcome | 2005 |
A female patient with malarial nephropathy.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Female; Humans; Malaria, Falciparum; Middle Aged; Nephritis; Plasmodium falciparum; Quinine; Renal Dialysis; Sesquiterpenes | 2004 |
Adherence to antimalarial combination therapy with sulfadoxine-pyrimethamine and artesunate in rural Tanzania.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infant; Logistic Models; Malaria, Falciparum; Male; Patient Compliance; Pyrimethamine; Risk Factors; Sesquiterpenes; Socioeconomic Factors; Sulfadoxine; Tanzania | 2004 |
The chemotherapy of rodent malaria. LXII. Drug combinations to impede the selection of drug resistance, part 5: rates of development of resistance to some inhibitors of folate metabolism and to artesunate.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Dapsone; Drug Resistance; Drug Therapy, Combination; Folic Acid Antagonists; Malaria, Falciparum; Male; Mice; Parasitemia; Plasmodium berghei; Plasmodium chabaudi; Plasmodium yoelii; Proguanil; Sesquiterpenes; Triazines | 2004 |
In vitro sensitivity of Plasmodium falciparum to lumefantrine in north-western Thailand.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Data Interpretation, Statistical; Drug Resistance, Multiple; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Sesquiterpenes; Thailand | 2004 |
Declining mefloquine sensitivity of Plasmodium falciparum along the Thai-Myanmar border.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Mefloquine; Myanmar; Parasitic Sensitivity Tests; Plasmodium falciparum; Primaquine; Regression Analysis; Sesquiterpenes; Thailand; Treatment Outcome | 2004 |
The search for effective and sustainable treatments for Plasmodium falciparum malaria in Africa: a model of the selection of resistance by antifolate drugs and their combinations.
Topics: Africa; Animals; Antimalarials; Artemisinins; Artesunate; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Health Policy; Humans; Malaria, Falciparum; Models, Theoretical; Plasmodium falciparum; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 2005 |
New combination drug to treat malaria.
Topics: Adult; Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child; Drug Combinations; Humans; Malaria, Falciparum; Sesquiterpenes | 2005 |
Are transporter genes other than the chloroquine resistance locus (pfcrt) and multidrug resistance gene (pfmdr) associated with antimalarial drug resistance?
Topics: Animals; Antimalarials; Artemisinins; Artesunate; ATP-Binding Cassette Transporters; Chloroquine; Drug Resistance; Genes, MDR; Genes, Protozoan; Humans; Malaria, Falciparum; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymorphism, Genetic; Sesquiterpenes | 2005 |
Economic evaluation of a policy change from single-agent treatment for suspected malaria to artesunate-amodiaquine for microscopically confirmed uncomplicated falciparum malaria in the Oussouye District of south-western Senegal.
Topics: Adolescent; Adult; Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Therapy, Combination; Female; Health Care Costs; Health Policy; Humans; Infant; Malaria, Falciparum; Male; Quinine; Rural Health; Senegal; Sesquiterpenes | 2005 |
Fatty food does not alter blood mefloquine concentrations in the treatment of falciparum malaria.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Biological Availability; Dietary Fats; Drug Therapy, Combination; Humans; Malaria, Falciparum; Male; Mefloquine; Sesquiterpenes; Treatment Outcome | 2005 |
Artesunate plus sulfadoxine-pyrimethamine for treatment of uncomplicated Plasmodium falciparum malaria in Sudan.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Male; Pyrimethamine; Sentinel Surveillance; Sesquiterpenes; Sudan; Sulfadoxine | 2005 |
Association of failures of seven-day courses of artesunate in a non-immune population in Bangui, Central African Republic with decreased sensitivity of Plasmodium falciparum.
Topics: Adult; Animals; Antimalarials; Artemisinins; Artesunate; Central African Republic; Drug Resistance, Multiple; Female; Humans; Malaria, Falciparum; Male; Plasmodium falciparum; Sesquiterpenes; Treatment Failure | 2005 |
Short communication: high prevalence of the cytochrome P450 2C8*2 mutation in Northern Ghana.
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Aryl Hydrocarbon Hydroxylases; Child; Child, Preschool; Cytochrome P-450 CYP2C8; Drug Therapy, Combination; Female; Gene Frequency; Ghana; Humans; Infant; Malaria, Falciparum; Male; Mutation; Polymorphism, Genetic; Prevalence; Prodrugs; Sesquiterpenes | 2005 |
Artesunate versus quinine for severe falciparum malaria.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Child; Humans; Hypoglycemia; Malaria, Falciparum; Quinine; Randomized Controlled Trials as Topic; Sesquiterpenes | 2006 |
Artesunate versus quinine for severe falciparum malaria.
Topics: Antimalarials; Artemisinins; Artesunate; Humans; Malaria, Falciparum; Quinine; Sesquiterpenes | 2006 |
The efficacies of artesunate-sulfadoxine-pyrimethamine and artemether-lumefantrine in the treatment of uncomplicated, Plasmodium falciparum malaria, in an area of low transmission in central Sudan.
Topics: Adolescent; Adult; Age Distribution; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Prospective Studies; Pyrimethamine; Sesquiterpenes; Sudan; Sulfadoxine; Treatment Outcome | 2006 |
Artesunate plus sulfadoxine-pyrimethamine in the treatment of uncomplicated Plasmodium falciparum malaria during pregnancy in eastern Sudan.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Pyrimethamine; Sesquiterpenes; Sudan; Sulfadoxine; Treatment Outcome | 2006 |
In vivo sensitivity monitoring of mefloquine monotherapy and artesunate-mefloquine combinations for the treatment of uncomplicated falciparum malaria in Thailand in 2003.
Topics: Administration, Oral; Adolescent; Adult; Age Distribution; Aged; Antimalarials; Artemisinins; Artesunate; Child; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Sesquiterpenes; Thailand; Treatment Failure; Treatment Outcome | 2006 |
Pharmacokinetics of dihydroartemisinin following oral artesunate treatment of pregnant women with acute uncomplicated falciparum malaria.
Topics: Acute Disease; Adolescent; Adult; Analysis of Variance; Antimalarials; Artemisinins; Artesunate; Atovaquone; Drug Combinations; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Half-Life; Humans; Malaria, Falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Proguanil; Sesquiterpenes; Thailand | 2006 |
Operational response to malaria epidemics: are rapid diagnostic tests cost-effective?
Topics: Adolescent; Amodiaquine; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Cost-Benefit Analysis; Diagnostic Tests, Routine; Disease Outbreaks; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Health Care Costs; Humans; Lumefantrine; Malaria, Falciparum; Pregnancy; Pregnancy Complications, Infectious; Prevalence; Sensitivity and Specificity; Sesquiterpenes | 2006 |
[Relapse of Plasmodium falciparum malaria in a patient treated with artesunate].
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Female; Humans; Malaria, Falciparum; Mefloquine; Recurrence; Sesquiterpenes; Treatment Outcome | 2006 |
Deployment of early diagnosis and mefloquine-artesunate treatment of falciparum malaria in Thailand: the Tak Malaria Initiative.
Topics: Adult; Aged; Antimalarials; Artemisinins; Artesunate; Cross-Sectional Studies; Drug Therapy, Combination; Early Diagnosis; Female; Hospital Mortality; Hospitalization; Humans; Incidence; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Middle Aged; National Health Programs; Parasitic Sensitivity Tests; Pregnancy; Pregnancy Complications, Parasitic; Prevalence; Refugees; Sesquiterpenes; Thailand; Tropical Climate | 2006 |
Potentiation of antimalarial drug action by chlorpheniramine against multidrug-resistant Plasmodium falciparum in vitro.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Chlorpheniramine; Drug Resistance, Multiple; Drug Synergism; Histamine H1 Antagonists; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Parasitic Sensitivity Tests; Plasmodium falciparum; Sesquiterpenes; Thailand | 2006 |
Artemisinin combination therapies.
Topics: Adult; Africa; Antimalarials; Artemisinins; Artesunate; Asia; Child, Preschool; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Quinolines; Sesquiterpenes | 2006 |
We still need artesunate monotherapy.
Topics: Antimalarials; Artemisinins; Artesunate; Humans; Malaria, Falciparum; Sesquiterpenes | 2006 |
Low efficacy of the combination artesunate plus amodiaquine for uncomplicated falciparum malaria among children under 5 years in Kailahun, Sierra Leone.
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Drug Therapy, Combination; Female; Genotype; Humans; Infant; Malaria, Falciparum; Male; Parasitemia; Polymerase Chain Reaction; Sesquiterpenes; Sierra Leone; Treatment Outcome | 2006 |
From chloroquine to artemisinin-based combination therapy: the Sudanese experience.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Chloroquine; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Health Policy; Humans; Lumefantrine; Malaria, Falciparum; Product Surveillance, Postmarketing; Pyrimethamine; Sesquiterpenes; Sudan; Sulfadoxine; Time Factors | 2006 |
Molecular genotyping to distinguish between recrudescents and new infections in treatment trials of Plasmodium falciparum malaria conducted in Sub-Saharan Africa: adjustment of parasitological outcomes and assessment of genotyping effectiveness.
Topics: Africa South of the Sahara; Animals; Antigens, Protozoan; Antimalarials; Artemisinins; Artesunate; Child; Genotype; Humans; Malaria, Falciparum; Merozoite Surface Protein 1; Parasitemia; Plasmodium falciparum; Protozoan Proteins; Randomized Controlled Trials as Topic; Recurrence; Sesquiterpenes; Treatment Outcome | 2006 |
Surveillance of the efficacy of artesunate and mefloquine combination for the treatment of uncomplicated falciparum malaria in Cambodia.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Cambodia; Child; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Sesquiterpenes; Treatment Outcome | 2006 |
Submicroscopic Plasmodium falciparum infections before and after sulfadoxine-pyrimethamine and artesunate association treatment in Dienga, Southeastern Gabon.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Artemisinins; Artesunate; DNA, Protozoan; Drug Combinations; Gabon; Genotype; Humans; Malaria, Falciparum; Middle Aged; Plasmodium falciparum; Polymerase Chain Reaction; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 2006 |
Malaria treatment failures after artemisinin-based therapy in three expatriates: could improved manufacturer information help to decrease the risk of treatment failure?
Topics: Adult; Antimalarials; Artemether; Artemisinins; Artesunate; Cote d'Ivoire; Dose-Response Relationship, Drug; Drug Labeling; Ethanolamines; Female; Fluorenes; Guidelines as Topic; Guinea; Humans; Lactones; Lumefantrine; Malaria, Falciparum; Parasitemia; Recurrence; Risk; Sesquiterpenes; Sudan; Switzerland; Treatment Failure; World Health Organization | 2006 |
In vitro antimalarial activity of azithromycin, artesunate, and quinine in combination and correlation with clinical outcome.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Azithromycin; Clinical Trials, Phase II as Topic; Drug Evaluation; Drug Interactions; Drug Therapy, Combination; Humans; Malaria, Falciparum; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinine; Sesquiterpenes | 2007 |
Mechanism of antimalarial action of the synthetic trioxolane RBX11160 (OZ277).
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Calcium-Transporting ATPases; Heterocyclic Compounds, 1-Ring; Malaria, Falciparum; Microscopy, Confocal; Peroxides; Plasmodium falciparum; Sesquiterpenes; Spiro Compounds | 2007 |
In vivo sensitivity monitoring of mefloquine monotherapy and artesunate-mefloquine combinations for the treatment of uncomplicated falciparum malaria in Thailand in 2003.
Topics: Antimalarials; Artemisinins; Artesunate; Drug Combinations; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Sesquiterpenes; Treatment Outcome | 2006 |
[A case of severe falciparum malaria successfully treated with intravenous artesunate and continuous hemodiafiltration].
Topics: Antimalarials; Artemisinins; Artesunate; Combined Modality Therapy; Hemodiafiltration; Humans; Injections, Intravenous; Malaria, Falciparum; Male; Middle Aged; Sesquiterpenes | 2006 |
Quality control of active ingredients in artemisinin-derivative antimalarials within Kenya and DR Congo.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Capsules; Chromatography, High Pressure Liquid; Democratic Republic of the Congo; Dosage Forms; Endemic Diseases; Humans; Kenya; Malaria, Falciparum; Quality Control; Sesquiterpenes; Tablets | 2007 |
Case 32-2006: a girl with fever after a visit to Africa.
Topics: Antimalarials; Artemisinins; Artesunate; Child, Preschool; Exchange Transfusion, Whole Blood; Female; Humans; Malaria, Falciparum; Sesquiterpenes | 2007 |
In vitro antimalarial drug susceptibility and pfcrt mutation among fresh Plasmodium falciparum isolates from the Lao PDR (Laos).
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; DNA, Protozoan; Drug Resistance; Ethanolamines; Female; Fluorenes; Humans; Inhibitory Concentration 50; Laos; Lumefantrine; Malaria, Falciparum; Male; Mefloquine; Membrane Transport Proteins; Middle Aged; Plasmodium falciparum; Point Mutation; Polymerase Chain Reaction; Protozoan Proteins; Sesquiterpenes | 2007 |
In vitro assessment of artesunate, artemether and amodiaquine susceptibility and molecular analysis of putative resistance-associated mutations of Plasmodium falciparum from São Tomé and Príncipe.
Topics: Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Atlantic Islands; Child; Child, Preschool; Drug Resistance; Genes, Protozoan; Humans; Malaria, Falciparum; Mutation; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Sesquiterpenes | 2007 |
The comparative efficacies of malartin, with and without amodiaquine, in the treatment of Plasmodium falciparum malaria in the Buea district of Cameroon.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amodiaquine; Antimalarials; Artemisinins; Artesunate; Cameroon; Child; Child, Preschool; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Sesquiterpenes; Treatment Outcome | 2007 |
Analysis of sulphadoxine/pyrimethamine resistance-conferring mutations of Plasmodium falciparum from Mozambique reveals the absence of the dihydrofolate reductase 164L mutant.
Topics: Adolescent; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Codon; Dihydropteroate Synthase; Drug Combinations; Drug Resistance, Multiple; Female; Humans; Infant; Malaria, Falciparum; Male; Mozambique; Mutation; Plasmodium falciparum; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2007 |
Caregivers' acceptance of using artesunate suppositories for treating childhood malaria in Papua New Guinea.
Topics: Administration, Rectal; Adult; Antimalarials; Artemisinins; Artesunate; Caregivers; Child; Child, Preschool; Female; Health Knowledge, Attitudes, Practice; Home Care Services; Humans; Infant; Malaria, Falciparum; Male; Medically Underserved Area; Papua New Guinea; Patient Acceptance of Health Care; Sesquiterpenes; Suppositories; Surveys and Questionnaires | 2007 |
The in-vitro susceptibilities of Ghanaian Plasmodium falciparum to antimalarial drugs.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Child, Preschool; Chloroquine; Drug Resistance; Ghana; Humans; Infant; Malaria, Falciparum; Mefloquine; Phenanthrenes; Plasmodium falciparum; Quinine; Sesquiterpenes | 2007 |
The risk of malarial infections and disease in Papua New Guinean children.
Topics: Adolescent; Animals; Antibodies, Protozoan; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; DNA, Protozoan; Female; Humans; Incidence; Longitudinal Studies; Malaria, Falciparum; Malaria, Vivax; Male; Papua New Guinea; Parasitemia; Plasmodium falciparum; Plasmodium vivax; Polymerase Chain Reaction; Risk Factors; Rural Population; Sesquiterpenes | 2007 |
Preparation of a novel monoclonal antibody against the antimalarial drugs, artemisinin and artesunate.
Topics: Animals; Antibodies, Monoclonal; Antimalarials; Artemisia annua; Artemisinins; Artesunate; Enzyme-Linked Immunosorbent Assay; Malaria, Falciparum; Male; Mice; Mice, Inbred BALB C; Phytotherapy; Plasmodium falciparum; Sesquiterpenes | 2007 |
Resistance to artemisinin derivatives along the Thai-Cambodian border.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Cambodia; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Sesquiterpenes; Thailand | 2007 |
Efficacy and safety of artesunate plus amodiaquine in routine use for the treatment of uncomplicated malaria in Casamance, southern Sénégal.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Drug Combinations; Humans; Malaria, Falciparum; Outpatients; Plasmodium falciparum; Safety; Senegal; Sesquiterpenes; Treatment Outcome | 2007 |
Activities of artesunate and amodiaquine against intestinal helminth in children with Plasmodium falciparum malaria in endemic areas.
Topics: Adolescent; Africa South of the Sahara; Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Endemic Diseases; Feces; Helminths; Humans; Intestinal Diseases, Parasitic; Kaplan-Meier Estimate; Malaria, Falciparum | 2008 |
Plasmodium falciparum from Pará state (Brazil) shows satisfactory in vitro response to artemisinin derivatives and absence of the S769N mutation in the SERCA-type PfATPase6.
Topics: Adenosine Triphosphatases; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Brazil; Drug Resistance; Gene Dosage; Humans; Malaria, Falciparum; Multidrug Resistance-Associated Proteins; Mutation; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Protozoan Proteins; Sesquiterpenes | 2008 |
Clinically uncomplicated Plasmodium falciparum malaria with high schizontaemia: a case report.
Topics: Adult; Animals; Artemisinins; Artesunate; Blood; Humans; Injections, Intravenous; Malaria, Falciparum; Male; Mefloquine; Parasitemia; Schizonts; Sesquiterpenes; Thailand; Trophozoites | 2008 |
New combined pill to treat malaria is launched.
Topics: Antimalarials; Artemisinins; Artesunate; Drug Combinations; Humans; Malaria, Falciparum; Mefloquine; Sesquiterpenes; Tablets | 2008 |
Heterogeneous distribution of Plasmodium falciparum drug resistance haplotypes in subsets of the host population.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Cross-Sectional Studies; Drug Resistance; Haplotypes; Humans; Malaria, Falciparum; Oligonucleotide Array Sequence Analysis; Papua New Guinea; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Rural Population; Sesquiterpenes | 2008 |
Efficacy and tolerability of a sequential, artesunate suppository plus mefloquine, treatment of severe falciparum malaria.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Sesquiterpenes; Suppositories; Time Factors; Treatment Outcome | 1995 |
Circulating L-selectin is elevated in patients with Plasmodium falciparum malaria.
Topics: Animals; Antibodies, Protozoan; Antimalarials; Artemisinins; Artesunate; Cell Adhesion Molecules; Humans; L-Selectin; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Sesquiterpenes; Thailand | 1995 |
Serum concentrations of MIP-1 alpha and interleukin-8 in patients suffering from acute Plasmodium falciparum malaria.
Topics: Adolescent; Adult; Aged; Anemia; Artemisinins; Artesunate; Blood; Body Temperature; Chemokine CCL3; Chemokine CCL4; Cytokines; Enzyme-Linked Immunosorbent Assay; Female; Hematocrit; Humans; Interleukin-8; Macrophage Inflammatory Proteins; Malaria, Falciparum; Male; Middle Aged; Monokines; Sesquiterpenes; Thailand | 1995 |
Clinical trials of artemisinin and its derivatives in the treatment of malaria in China.
Topics: Antimalarials; Antiprotozoal Agents; Artemisinins; Artesunate; China; Clinical Trials as Topic; Humans; Injections, Intramuscular; Injections, Intravenous; Malaria, Cerebral; Malaria, Falciparum; Sesquiterpenes; Suppositories; Tablets | 1994 |
Artemisinin compounds in treatment of malaria.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Cambodia; Drug Approval; Drug Resistance; Humans; Malaria, Falciparum; Male; Military Personnel; Netherlands; Phenanthrenes; Sesquiterpenes | 1993 |
Treatment of acute uncomplicated falciparum malaria with a short course of artesunate followed by mefloquine.
Topics: Acute Disease; Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Sesquiterpenes | 1993 |
Antimalarial drugs reduce cytoadherence and rosetting Plasmodium falciparum.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Cell Adhesion; Erythrocytes; Humans; In Vitro Techniques; Malaria, Falciparum; Middle Aged; Phenanthrenes; Plasmodium falciparum; Quinine; Rosette Formation; Sesquiterpenes | 1996 |
Big endothelin in patients with complicated Plasmodium falciparum malaria.
Topics: Antimalarials; Artemisinins; Artesunate; Endothelin-1; Endothelins; Enzyme-Linked Immunosorbent Assay; Humans; Interleukin-6; Malaria, Cerebral; Malaria, Falciparum; Matched-Pair Analysis; Platelet Count; Protein Precursors; Renal Insufficiency; Sesquiterpenes; Tumor Necrosis Factor-alpha | 1996 |
Selective high-performance liquid chromatographic determination of artesunate and alpha- and beta-dihydroartemisinin in patients with falciparum malaria.
Topics: Antimalarials; Artemisinins; Artesunate; Chromatography, High Pressure Liquid; Humans; Isomerism; Malaria, Falciparum; Reproducibility of Results; Sesquiterpenes; Spectrophotometry, Ultraviolet | 1996 |
In vitro stage-specific sensitivity of Plasmodium falciparum to quinine and artemisinin drugs.
Topics: Adult; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Chloroquine; Drug Evaluation, Preclinical; Drug Resistance; Humans; In Vitro Techniques; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Quinine; Sesquiterpenes | 1996 |
Serum laminin and basic fibroblast growth factor concentrations in patients with complicated Plasmodium falciparum malaria.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; Artesunate; Fibroblast Growth Factor 2; Humans; Kinetics; Laminin; Malaria, Falciparum; Mefloquine; Middle Aged; Sesquiterpenes | 1996 |
Ataxia and slurred speech after artesunate treatment for falciparum malaria.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Ataxia; Humans; Malaria, Falciparum; Male; Sesquiterpenes; Speech Disorders | 1997 |
Severe falciparum malaria with hyperparasitaemia treated with intravenous artesunate.
Topics: Antimalarials; Artemisinins; Artesunate; Fatal Outcome; Humans; Kenya; Malaria, Falciparum; Male; Middle Aged; Quinine; Sesquiterpenes; Severity of Illness Index; Time Factors; Travel; Western Australia | 1997 |
Artesunate and cerebellar dysfunction in falciparum malaria.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Cerebellar Diseases; Humans; Malaria, Falciparum; Male; Sesquiterpenes | 1997 |
Pharmacokinetic and bioequivalence evaluation of two generic formulations of oral artesunate.
Topics: Administration, Oral; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Drugs, Generic; Humans; Malaria, Falciparum; Male; Plasmodium falciparum; Sesquiterpenes; Therapeutic Equivalency | 1998 |
Plasma levels of artesunate and dihydroartemisinin in children with Plasmodium falciparum malaria in Gabon after administration of 50-milligram artesunate suppositories.
Topics: Absorption; Antimalarials; Artemisinins; Artesunate; Child; Female; Fever; Gabon; Humans; Malaria, Falciparum; Male; Parasitemia; Sesquiterpenes; Suppositories | 1998 |
Measurement of serum nitrite/nitrate concentrations using high-performance liquid chromatography.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Child; Chromatography, High Pressure Liquid; Circadian Rhythm; Cohort Studies; Humans; Malaria, Falciparum; Middle Aged; Nitrates; Nitrites; Reference Values; Reproducibility of Results; Sensitivity and Specificity; Sesquiterpenes; Time Factors | 1998 |
Treatment of severe falciparum malaria with artesunate and mefloquine.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Retrospective Studies; Sesquiterpenes; Treatment Outcome | 1998 |
Plasma levels of the interleukin-6 cytokine family in persons with severe Plasmodium falciparum malaria.
Topics: Acute Kidney Injury; Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Biomarkers; Ciliary Neurotrophic Factor; Female; Humans; Interleukin-6; Malaria; Malaria, Cerebral; Malaria, Falciparum; Male; Middle Aged; Nerve Growth Factors; Nerve Tissue Proteins; Plasmodium falciparum; Receptors, Interleukin-6; Reference Values; Sesquiterpenes | 1999 |
In vitro sensitivity of Plasmodium falciparum to artesunate in Thailand.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Drug Resistance; Humans; Malaria, Falciparum; Nonlinear Dynamics; Plasmodium falciparum; Regression Analysis; Sesquiterpenes; Thailand | 1999 |
Short course of azithromycin/artesunate against falciparum malaria: no full protection against recrudescence.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Azithromycin; Developing Countries; Drug Administration Schedule; Humans; Malaria, Falciparum; Male; Pilot Projects; Recurrence; Sesquiterpenes; Treatment Outcome; Vietnam | 1999 |
Polyclonal anti-tumor necrosis factor-alpha Fab used as an ancillary treatment for severe malaria.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Area Under Curve; Artemisinins; Artesunate; Female; Humans; Immunoassay; Immunoglobulin Fab Fragments; Intercellular Adhesion Molecule-1; Interferon-gamma; Interleukin-1; Interleukin-2; Interleukin-6; Interleukin-8; Kinetics; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitemia; Pilot Projects; Plasmodium falciparum; Sesquiterpenes; Tumor Necrosis Factor-alpha | 1999 |
Population pharmacokinetics of mefloquine in patients with acute falciparum malaria.
Topics: Acute Disease; Adolescent; Adult; Antimalarials; Area Under Curve; Artemisinins; Artesunate; Child; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Linear Models; Malaria, Falciparum; Male; Mefloquine; Prospective Studies; Sesquiterpenes; Treatment Outcome | 1999 |
Serum concentrations of granulocyte-colony stimulating factor in complicated Plasmodium falciparum malaria.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Calcitonin; Calcitonin Gene-Related Peptide; Chemokine CCL4; Child; Enzyme-Linked Immunosorbent Assay; Erythrocytes; Erythropoietin; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Macrophage Inflammatory Proteins; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Nitrates; Plasmodium falciparum; Protein Precursors; Reference Values; Sesquiterpenes; Stem Cell Factor | 2000 |
A case-control auditory evaluation of patients treated with artemisinin derivatives for multidrug-resistant Plasmodium falciparum malaria.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Audiometry; Case-Control Studies; Child; Child, Preschool; Drug Resistance, Multiple; Drug Therapy, Combination; Evoked Potentials, Auditory, Brain Stem; Female; Follow-Up Studies; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Sesquiterpenes; Thailand | 2000 |
Acceptance of short course artesunate plus mefloquine drug combination by malaria patients in rural Myanmar.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; Artesunate; Cross-Sectional Studies; Drug Combinations; Female; Health Care Costs; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Myanmar; Patient Compliance; Rural Population; Sesquiterpenes | 1999 |
Artesunate therapy in falciparum malaria--alone or in combination.
Topics: Antimalarials; Artemisinins; Artesunate; Humans; Malaria, Falciparum; Male; Middle Aged; Sesquiterpenes | 1999 |
Antimalarial drug combination policy: a caveat.
Topics: Africa; Animals; Antimalarials; Artemisinins; Artesunate; Drug Administration Schedule; Drug Combinations; Drug Resistance; Endemic Diseases; Health Policy; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Sesquiterpenes; Thailand | 2000 |
Thrombopoietin in Plasmodium falciparum malaria.
Topics: Acute Kidney Injury; Antimalarials; Artemisinins; Artesunate; Humans; Malaria, Cerebral; Malaria, Falciparum; Platelet Count; Sesquiterpenes; Statistics, Nonparametric; Thrombopoietin | 2000 |
The mechanisms of parasite clearance after antimalarial treatment of Plasmodium falciparum malaria.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Erythrocytes; Humans; Malaria, Falciparum; Parasitemia; Plasmodium falciparum; Quinine; Sesquiterpenes | 2000 |
Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Cohort Studies; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Incidence; Malaria, Falciparum; Male; Mefloquine; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Prospective Studies; Random Allocation; Sesquiterpenes; Thailand | 2000 |
Mathematical modelling of the chemotherapy of Plasmodium falciparum malaria with artesunate: postulation of 'dormancy', a partial cytostatic effect of the drug, and its implication for treatment regimens.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Computer Simulation; Humans; Malaria, Falciparum; Models, Biological; Parasitemia; Plasmodium falciparum; Sesquiterpenes; Thailand | 2000 |
Drugs. Reinventing an ancient cure for malaria.
Topics: Animals; Antimalarials; Artemisia; Artemisinins; Artesunate; China; Clinical Trials as Topic; Drug Resistance; Drug Therapy, Combination; Drugs, Chinese Herbal; Humans; Malaria, Falciparum; Plants, Medicinal; Plasmodium falciparum; Sesquiterpenes; United States; United States Food and Drug Administration; World Health Organization | 2000 |
Parasitaemia and gametocytaemia after treatment with chloroquine, pyrimethamine/sulfadoxine, and pyrimethamine/sulfadoxine combined with artesunate in young Gambians with uncomplicated malaria.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Child; Chloroquine; Cost-Benefit Analysis; Disease Transmission, Infectious; Drug Combinations; Female; Gambia; Gametogenesis; Humans; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum; Pyrimethamine; Random Allocation; Rural Health; Seasons; Sesquiterpenes; Sulfadoxine; Time Factors; Treatment Outcome | 2001 |
Fake artesunate in southeast Asia.
Topics: Antimalarials; Artemisinins; Artesunate; Asia, Southeastern; Drug and Narcotic Control; Drug Contamination; Fraud; Humans; Malaria, Falciparum; Sesquiterpenes | 2001 |
Apparent drug failure following artesunate treatment of Plasmodium falciparum malaria in Freetown, Sierra Leone: four case reports.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Child; Drug Administration Schedule; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Phenanthrenes; Quinine; Sesquiterpenes; Sierra Leone; Treatment Failure | 2001 |
[A case of falciparum malaria successfully treated with intravenous artesunate].
Topics: Antimalarials; Artemisinins; Artesunate; Humans; Injections, Intravenous; Japan; Malaria, Falciparum; Male; Middle Aged; Nigeria; Sesquiterpenes | 2001 |
Bogus antimalarials: a forgotten tale.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Asia, Southeastern; Humans; Malaria, Falciparum; Plasmodium falciparum; Quality Control; Sesquiterpenes | 2001 |
Comparative pharmacokinetics and effect kinetics of orally administered artesunate in healthy volunteers and patients with uncomplicated falciparum malaria.
Topics: Administration, Oral; Adult; Antimalarials; Area Under Curve; Artemisinins; Artesunate; Chromatography, High Pressure Liquid; Humans; Malaria, Falciparum; Male; Sesquiterpenes | 2001 |
Malaria as a cause of multi organ failure.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Humans; Malaria, Falciparum; Male; Multiple Organ Failure; Sesquiterpenes; Time Factors | 2001 |
Central role of the spleen in malaria parasite clearance.
Topics: Adult; Animals; Antigens, Protozoan; Antimalarials; Artemisinins; Artesunate; Child; Erythrocytes; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Parasitemia; Plasmodium falciparum; Protozoan Proteins; Sesquiterpenes; Spleen; Splenectomy | 2002 |
[In vitro sensitivity of Plasmodium falciparum to chloroquine, piperaquine, pyronaridine and artesunate in Yuxi prefecture of Yunnan province].
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Resistance; Female; Humans; In Vitro Techniques; Infant; Inhibitory Concentration 50; Malaria, Falciparum; Male; Middle Aged; Naphthyridines; Plasmodium falciparum; Quinolines; Sesquiterpenes | 1998 |
Resistant malaria in a neonate.
Topics: Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infant, Newborn; Malaria, Falciparum; Mefloquine; Quinine; Risk Assessment; Sesquiterpenes; Severity of Illness Index; Treatment Outcome | 2002 |
Treatment of patients with recrudescent falciparum malaria with a sequential combination of artesunate and mefloquine.
Topics: Acute Disease; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Plasmodium falciparum; Prospective Studies; Recurrence; Sesquiterpenes | 1992 |